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Abstract
This thesis establishes important aspects of the pathogenesis of Murray Valley 
encephalitis virus (MVE) in C57BI/6 mice as a basis to study the role of natural 
killer (NK) cell-mediated and cytotoxic T (Tc) cell-mediated cytotoxicity in 
encephalitic flavivirus infection, using mice of the same genetic background but 
with defined deficiencies in immune pathways. Virus was administered to six- 
week-old mice by the intravenous route, analogous to the hematogenous portal 
entry in natural infections, using a virus dose in the range experienced following 
the bite of an infectious mosquito. In this model, infection with 0.1 to 105 PFU of 
virus gave mortality in -50% of the mice, despite low or undetectable virus 
growth in extraneural tissues (based on results from two assays, plaque titration 
in Vero cells and RT/PCR). In contrast to the absence of a dose-response in 
infections with 0.1-105PFU of MVE, infection with 108 PFU resulted in direct 
virus entry into the brain and 100% mortality.
B- and T-cell deficient (RAG-1-/-) mice that were infected with MVE showed 
increased susceptibility, but delayed mortality, compared to wild-type mice. The 
increased susceptibility was most likely due to the lack of antibody, given that 
passive transfer of MVE-primed B cells to MVE-infected wild-type mice resulted 
in complete protection from the encephalitic disease. The delayed mortality of 
MVE-infected RAG-1-/- mice suggested that T cells contribute to pathology in 
MVE infection. This was corroborated by experiments in which CD8+ T-cell 
deficient (ß2-M-/-) mice were infected with MVE, which showed that these mice 
had a reduced and delayed mortality relative to infected wild-type mice. The 
deleterious role of CD8+ T cells in this mouse model for flaviviral encephalitis 
was also apparent when mice with a deficiency in the cytolytic effector functions 
of Tc and NK cells were tested. When infected with MVE, the mortality of mice 
deficient in either the granule exocytosis- or Fas-mediated pathways of 
cytotoxicity was marginally delayed and reduced, relative to wild-type mice. To 
uncover a possible redundancy of the two cytolytic effector mechanisms in Tc or 
NK cell-mediated exacerbation of encephalitic disease, I used mice deficient in 
both granule exocytosis- and Fas-mediated cytotoxicity. These double-deficient 
mice were resistant to a low-dose peripheral infection with MVE, possibly as a 
result of reduced pathology at the blood-brain barrier in the absence of the 
cytotoxic functions of NK and Tc cells, which may have limited the spread of the 
neurotropic virus into the brain.
In summary, this investigation uncovered that NK and Tc cells do not make a 
beneficial contribution to the recovery from MVE infection, and highlights that, 
on the contrary, cell-mediated cytotoxicity can exacerbate disease in 
encephalitic viral infection.
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1.1 Introduction
Viruses have probably been around for as long as there have been cellular hosts 
for viruses to replicate in. Records of rabid dogs have been found in Mesopotamia, and 
in Egypt archaeologists found ancient drawings of people with polio. Smallpox played a 
key role in facilitating the European invasion of South and Central America, when the 
indigenous, immunologically-naive, human population succumbed rapidly to the virus 
brought by the Europeans. Western Africa has long been regarded as the home of the 
yellow fever virus, although the first records of yellow fever date from an outbreak that 
occurred between 1483 and 1484, on the Yucatan Peninsula (Gongora-Bianchi, 2000). 
The sacred Mayan books relate how an epidemic of vomiting blood or xekik (Mayan 
name for yellow fever) occurred among the Indians, due to their proximity to monkeys. 
Interestingly, and with an anticipation of how more than 500 years later Aedes aegypti 
would be identified as the vector of the virus, the Mayan scripts relate how xekik is 
transmitted via mosquitoes. Haemagogus mosquitoes were responsible for yellow fever 
transmission in the pre-Columbian era. When the Spanish brought A. aegypti to the new 
world, new outbreaks of yellow fever were facilitated, giving the surviving 
conquistadores the color of the gold they went to search for (Gongora-Bianchi, 2000).
Early in the twentieth century, it was found that yellow fever (YF) was produced 
by a filterable agent that could be transmitted to humans by bites of the mosquito A. 
aegypti (Strode, 1951; Rice, 1996). Yellow fever was the first virus to be isolated in 
1927 and the first virus to be cultivated in vitro in 1932 (Monath, 1996). The discovery 
of the YF virus (YF) led to the production of an effective and safe live vaccine (YF- 
17D). This vaccine has now been used for more than 60 years (Guirakhoo et al., 1999). 
It gives demonstrable lifelong immunity against YF occurs to over 95% of vaccinees, 
within 10 days (Monath, 1996).
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The twentieth century, which opened with the promise of eradication of most 
infectious diseases, has closed with the specter of the emergence and re-emergence of 
many deadly infectious diseases (Berns and Rager, 2000). Some flaviviral diseases, 
along with many other arthropod-borne infections, have been spreading geographically 
in conjunction with ecological changes that have favored increased vector densities, 
such as dam construction, irrigation, urbanization, deforestation and increased global 
warming. Increased human travel has also contributed significantly to the spread of 
infectious agents, introducing them into areas in which they had hitherto been absent 
(Gubler, 1998; Gratz, 1999).
Flaviviruses are medically the most important of the arthropod-borne viruses, 
causing human and animal disease with worldwide distributions (Rice, 1996). The 
amplification cycle of arthropod-borne flaviviruses that cause encephalitis involves 
mosquitoes and ticks as vectors, and viremic vertebrate species as reservoirs. Infected 
humans are dead-end hosts, which do not participate in perpetuation of virus 
transmission. Vector species vary, but culicine mosquitoes (principally Culex spp.) and 
ticks {Ixodes spp.) are responsible for amplification cycles (Monath, 1996).
Yellow fever virus is the prototype of the family Flaviviridae (flavus, Latin for 
yellow). The family Flaviviridae comprises three genera, the flaviviruses, the hepatitis C 
viruses (from Greek hepar, hepatos, or liver), and the pestiviruses (from Latin pestis, or 
plague). These three genera have diverse biological properties and show no serological 
cross-reactivity, but are similar in terms of virion morphology, genome organization, 
and RNA replication strategy (Monath, 1996).
Among the genus flavivirus, 28 of the more than 70 known members have been 
associated with disease in humans. An evolutionary tree of flaviviruses, drawn on the 
basis of their envelope (E) protein amino acid sequence homologies, is presented in
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Fig. 1.1. Infected hematophagous arthropod vectors (ticks or mosquitoes) transmit all 
flaviviruses that affect humans, which makes eradication of these viruses unlikely 
(Monath, 1996).
In humans, there are, broadly speaking, three clinical syndromes that are 
associated with the main pathogenic flaviviruses (e.g. YF, dengue (DEN), and Japanese 
encephalitis (JE)): 1) hemorrhagic fever; 2) fever with rash, often associated with 
myalgia and arthralgia; and 3) encephalitis and meningoencephalitis (Monath, 1996). 
The clinical spectrum of YF symptoms varies from a very mild, non-specific, febrile 
illness to a fulminating disease with pathognomonic features of jaundice and bleeding 
diathesis, with hepatorenal involvement. Infection with DEN produces a spectrum of 
clinical illness that ranges from a non-specific febrile syndrome to a severe and fatal 
hemorrhagic disease (Monath, 1996). Dengue is classified as an emerging disease, 
because its occurrence has increased in humans over the last 20 years (Tomori, 1999; 
Jelinek, 2000; Solomon and Mallewa, 2001; Werner, 2001). Japanese encephalitis virus 
(JEV) produces acute encephalomyelitis, and has a high fatality rate throughout Asia 
(Monath et al., 1999). West Nile vims (WNV) is the most widely distributed 
neurotropic flavivirus and a more ‘benign’ member of the JEV serogroup (Solomon and 
Mallewa, 2001).
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WNV infects humans, horses and birds in Africa, the Middle East, and 
southwestern Asia, and has recently (1999) been identified for the first time in North 
America (New York) (Briese et ah, 1999; Jia et ah, 1999). The outbreak of WNV in 
New York involved 50 persons who showed signs such as fever, arthralgia and rash. 
There were 5 fatal cases of acute encephalitis in elderly patients. This virus is now 
enzootic in the United States (Ostlund et ah, 2000). It is likely that WNV will keep 
spreading across the American continent as it follows the migratory patterns of the 
reservoir birds (Petersen et ah, 2002). A similar spread occurred in Canada, Mexico and 
in the Caribbean Islands (Diamond et ah, 2003a).
Aside from the successful vaccine against the prototype flavivirus YF, vaccines 
against two other flaviviruses, JEV and tick-borne encephalitis (TBE) virus, are also 
available today (Cardosa, 1998). There are no approved vaccines against the rest of the 
flaviviruses. To produce effective vaccines against other flaviviruses (including DEN), 
much more effort has to be made to understand the processes of pathogenesis and the 
role of antiflaviviral immunity in protection and recovery from infection. The 
therapeutic treatment is primarily supportive, since there are no specific measures of 
proven efficacy (Cardosa, 1998).
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1.1.1 Flaviviruses of major concern worldwide
Yellow fever
Despite landmark achievements in the understanding of the epidemiology of YF, 
and despite the availability of a safe and efficacious vaccine, the YF virus is still an 
important cause of hemorrhagic fever and related mortality, mainly among populations 
in the Americas and Africa. It affects an estimated 200,000 persons and causes close to 
30,000 deaths per year, and it poses a threat to unvaccinated populations (Monath, 1987; 
Leyssen et ah, 2000). Yellow fever is a zoonotic disease that has three transmission 
cycles with various combinations of transmission between monkeys, mosquitoes, and 
humans. It produces an acute disease, which is characterized by a sudden onset, and has 
two phases of development that are separated by a short period of remission. The 
primary transmission cycle involves wild non-human primates and various sylvatic 
(tree-hole-breeding) aedine mosquitoes. The second transmission cycle involves 
humans, who are tangentially exposed when they encroach on the sylvatic cycle.
Finally, the urban transmission cycle occurs when YF is spread from human to human 
through the mosquito vectors (Monath, 1996; Chen and Cosgriff, 2000).
Dengue
The geographical distribution of DEN has increased, and it has become 
numerically the most important arboviral disease in humans. This global problem 
affects approximately 100 million people per year (Solomon and Mallewa, 2001). The 
first reported epidemics of dengue fever occurred between 1779 and 1780 in Asia, 
Africa, and North America. The near-simultaneous occurrence of outbreaks on these 
three continents indicates that these viruses and their mosquito vectors (mainly A.
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aegypti) have had a worldwide distribution in the tropics for more than 200 years. 
Dengue was the second human disease, after YF, to be attributed to a ‘filtrable virus’ 
(Solomon and Mallewa, 2001).
The origin of the word dengue is currently attributed to the Swahili phrase ka 
dinga pepo where ka means ‘a kind of...’, dinga means ‘sudden cramp-like seizure’ and 
pepo means ‘plague’. In Cuba, this phrase was popularly replaced by the hispanicized 
word dengue (Rigau-Perez, 1998).
Classical dengue fever (DEN), dengue hemorrhagic fever (DHF), and dengue 
shock syndrome (DSS) are all caused by one or more of the four closely related, but 
antigenically distinct, virus serotypes (DEN 1-4). Infection by one of these serotypes 
does not provide long-lasting cross-protective immunity against the others (Rothman 
and Ennis, 1999). However, new research shows that a vaccine against all four types of 
DEN appears to induce immune responses for all four viruses (Rothman et al., 2001).
An effective dengue vaccine must induce antibodies against all the viruses, because a 
person who has developed antibodies against one of the serotypes is at risk of 
developing dengue hemorrhagic fever if infected with any of the other three serotypes 
(Kanesa-thasan et al., 2001; Rothman et al., 2001; Sabchareon et al., 2002). DEN 
viruses generally cause a benign syndrome with self-limited febrile illness, although 
more acute signs can occur when multiple infections with serotypes 1 through 4 lead to 
antibody-dependent enhancement (ADE) of infection. The spread of the four DEN virus 
serotypes has lead to the increased incidence of DHF, with approximately 2.5 billion 
people at risk. DHF is an acute, potentially life-threatening, capillary leak syndrome and 
is more common in secondary than in primary dengue virus infections. Important risk 
factors for DHF include the strain and serotype of the infecting virus, as well as the age, 
immune status, and genetic predisposition of the patient (Rothman and Ennis, 1999).
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Tropical and subtropical areas of many countries are now hyperendemic (i.e. they have 
a prevalence of two or more serotypes), which enhances the occurrence of DHF and 
DSS (Gubler, 1998).
Japanese encephalitis
JEV is the leading cause of lethal arthropod-borne human encephalitis 
worldwide (Ogata et al., 1991; Monath, 1996), with 50,000 cases and 10-15,000 deaths 
per year (Solomon and Mallewa, 2001). In Japan, a disease that resembles JE was 
recognized in horses and humans as early as 1871, and, in 1924, a filterable agent was 
extracted from human brain during a fulminating epidemic. It was not until 1935 that 
scientists virologically and serologically established the virus as being the prototype 
(Nakayama) strain of JEV, which is also the prototype of the encephalitic group of 
flaviviruses (Table 1.1). The virus was isolated in 1938 from Culex tritaeniorhynchus, 
and birds and pigs were recognized as the principal viremic hosts (Monath, 1996).
In Asian countries, rice-field-breeding culicine mosquitoes are the principal 
vectors of JEV. Children are primarily affected in endemic areas, whereas older age 
groups may not show any infection, or have infections that may be less severe because 
they have life-long protective immunity due to childhood exposure to the virus
(Monath, 1996).
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Table 1.1 The Japanese encephalitis -  West Nile complex of flaviviruses3
Virus Acronym s First Geographical Vectors Reservoirs
isolated range
St. Louis 
encephalitis
SLE 1933 North, Central, 
and South 
America
Culex pip iens
C. p. quinquefasciatus
Birds
West Nile WNV 1937 southern 
Europe, Africa, 
Mediterranean, 
western and 
southern Asia, 
North America
Culex univittatus 
C. antenatus  
C. molestus 
C. vishnui
Birds
Japanese
encephalitis
JEV 1935 eastern India, 
east and 
South-East 
Asia, PNG, 
northern
Culex tritaeniorhynchus 
C. gellidus  
C. vishnui
Birds
Australia
Murray
Valley
encephalitis
MVE 1951 Australia, New 
Guinea, west 
Iran
Culex annulirostris Birds
a Summarized from (Monath, 1996).
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There is no specific treatment for JE or any other flaviviral disease (Johnson et 
ah, 1985), however, some patients react well to ventilation support since respiratory 
paralysis could occur during encephalitic flavivirus infections (Tzeng, 1989). Vector 
control and vaccination are still the most effective control measures. The mouse brain 
vaccine, produced by the Research Foundation for Microbiological Diseases (Biken) in 
Osaka, Japan, has been in wide use since the 1960s. The presence of the JEV in Japan 
has not been diminished, as is shown by the data of antibody acquisition among pigs in 
Japan, but JE vaccination has probably contributed to the low incidence of infections 
among children. Cases of JE have also occurred among travelers to Asia; thus, 
vaccination is recommended before traveling (Sturchler and Steffen, 2001; Monath et 
ah, 2002; Kirkpatrick and Alston, 2003).
1.1.2 Flaviviruses in Australia
Flaviviruses endemic to Australia
The main Australian flaviviruses are Murray Valley encephalitis (MVE), Kunjin 
(KUN) and Kokobera (KOK) are described below. Three other Australian flaviviruses, 
of lesser public health impact, have also been related to human infection: Alfuy and 
Stratford, two additional members of the JEV serocomplex, and Edge Hill, a member of 
the Uganda serological group (Mackenzie et ah, 1994; Monath, 1996).
Murray Valley encephalitis
MVE is the major etiological agent of Australian encephalitis. Its similarity of 
symptoms in the clinical hosts to those of JEV, and its nucleotide sequence homology of 
71% make it closely related to JEV (Kimura-Kuroda and Yasui, 1986; McAda et ah,
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1987; Lobigs et al., 1988; Lee et al., 1990). In 1917, the disease was first described as 
Australian X disease, after an epidemic of encephalitis that occurred in eastern Australia 
in that year (Monath, 1996). Another major epidemic occurred in 1950-1951, in the 
Murray Valley area of southeastern Australia, during which the virus was first isolated 
from the brains of three fatal human cases (French, 1952). The first MVE mosquito 
isolates were obtained from Culex annulirostris in 1960 (Mackenzie et al., 1994). The 
predominant vertebrate hosts are thought to be migrating water birds, although certain 
domestic and wild mammals (including rabbits and kangaroos) have also been 
implicated on serological grounds (Mackenzie et al., 1994). The last major epidemic of 
MVE occurred in 1974, with 58 reported cases, 13 of which were fatal (Marshall, 1988). 
Currently, only sporadic cases occur in the Murray Valley area, however, there is a 
regular incidence of MVE in northern Australia, where cases of encephalitis often 
coincide with the increased mosquito activity during the December-June period 
(reviewed in (Marshall, 1988)). The most serious cases occur among aboriginal 
children, which may indicate that if the disease occurs early in life, it is more likely to 
be severe. People (of all ages) who have recently entered this region also seem to be 
susceptible to MVE infection (Mackenzie et al., 1993). While only one in about 1000 
infected individuals develops encephalitis, clinical cases have an approximate 25% 
mortality, and 50% of survivors have significant neurological sequelae (Broom et al., 
2000). The severity of the illness can range from fever to coma and death. Sequelae 
include paraplegia, impaired gait and motor coordination, and intellectual dysfunction
(Monath, 1996).
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Kunjin
KUN was first isolated from Culex annulirostris mosquitoes in 1960. KUN is 
less common than MVE, and produces a milder disease pattern in humans and horses 
(Hall et al., 2001). The clinical disease resembles MVE, although it has also been 
associated with non-encephalitic symptoms, involving fever and malaise (sometimes 
with joint involvement). The non-encephalitic symptoms occur more frequently than the 
traditional encephalitic symptoms (Mackenzie et ah, 1994). The first case of KUN in 
humans was reported during a small outbreak of encephalitis in Western Australia in 
1978, although KUN had already been implicated retrospectively as the causative agent 
of encephalitis in five cases from the iast major MVE epidemic in 1974 (Doherty et ah, 
1976). Although KUN shares a number of biological and epidemiological 
characteristics with MVE (Marshall, 1988), its genomic sequence has a very high level 
of homology to that of WN V, which implies that it has a close evolutionary relationship 
with WNV (Coia et ah, 1988). Moreover, recent phylogenic analyses show that some 
strains of WNV (including isolates from New York, Malaysia and Africa) are more 
similar to KUN virus and form a separate lineage to other WNV strains (Hall et ah, 
2001). These findings are in agreement with the Seventh Report of the International 
Committee for the Taxonomy of Viruses that designates KUN as a subtype of West Nile 
(Hall et ah, 2001).
Kokobera
KOK is the third most important of the Australian flaviviruses in terms of 
human health (Mackenzie et ah, 1994). The virus was first isolated from Culex 
annulirostris mosquitoes in northern Queensland in 1960 (Monath, 1996). Its vertebrate
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hosts are believed to be macropods (wallabies and kangaroos), although horses may also 
play a minor role as hosts (Mackenzie et al., 1994). The first report in humans that 
indicated that KOK had pathogenic potential was compiled from three patients from 
southeastern Australia, who suffered acute polyarticular illnesses in the summer months 
of 1983-1985. Kokobera virus was isolated in the dry season; an interesting finding, 
which suggests that the virus is capable of year-round survival in vector-vertebrate 
cycles (Mackenzie et al., 1994).
Flaviviruses introduced into Australia 
Dengue
Although epidemics of dengue fever were common in Australia in the late 19lh 
century, and DHF was first described in Australia in 1898 (Blok et al., 1988), the 
evidence that is presently available suggests that dengue is not endemic in Australia and 
that epidemics arise from virus introduced by viremic travelers (Mackenzie et al., 1994; 
Mackenzie et al., 1998b). Dengue disappeared from Australia after an epidemic that 
occurred between 1953 and 1955 and reappeared in 1981 as a dengue type 1 epidemic, 
which affected 196 individuals. The most common symptoms were fever, headache, 
rash, myalgia, skin itching and arthralgia. Hemorrhagic manifestations were noted in 14 
cases, but most other cases only showed skin petechiae. One individual also had 
bleeding from the gastrointestinal and urinary tracts. No cases of shock were recorded 
(Guard et al., 1984).
In 1993, an epidemic caused by dengue virus type 2 occurred in North 
Queensland (McBride, 1988). An analysis of symptoms was undertaken using a random
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sample of 1000 residents, to determine the symptoms and the subclinical infection rate, 
and to establish the true extent of the epidemic. Diagnoses of dengue fever were based 
on the presence of both serum dengue 2 -  neutralizing antibody and the presence of 
symptoms consistent with DEN infection. Approximately 20% of the population had 
been exposed to dengue and the rate of subclinical infections was 15%. Bleeding 
occurred more frequently in people who recalled that they also had a dengue infection 
12 years earlier during the dengue 1 epidemic (McBride, 1988). If Australia follows the 
pattern that has been observed elsewhere in the world, cases of DHF may again be 
recorded on Australian soil in the foreseeable future (McBride, 1999).
Japanese encephalitis
JEV was first identified in Australia in 1995, with the diagnosis of three clinical 
cases (two fatal) among residents on Badu Island in the Torres Strait, northern 
Queensland (Hanna et al., 1996; Hall et al., 2001). JEV activity was more widespread in 
north Queensland in the 1998 wet season than in the three previous wet seasons, but in 
that year the ecological circumstances (e.g. less intensive pig husbandry, fewer 
mosquitoes) appear to have limited the transmission on the mainland (Hanna et al., 
1999). Shortly after JEV activity was detected in humans and sentinel pigs on Badu 
Island in 1998, adult mosquitoes were collected, and 43 isolates of JEV were recovered. 
Researchers observed that there was between 99.1% and 100% nucleotide sequence 
identity between the 1995 and 1998 isolates of JEV from Badu Island. They also found 
that isolates of JEV from mosquitoes collected in Papua New Guinea in 1997 and 1998 
showed similar percentages of identity to the 1995 isolates. Circumstantial evidence 
therefore suggests that cyclonic winds carried the infected mosquitoes from Papua New
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Guinea to the Torres Strait islands and the Australian mainland (Hanna et al., 1999; 
Johansen et al., 2001).
1.2 Molecular characterization of flaviviruses
Flaviviruses are small and spherical (40-60 nm in diameter), and are surrounded 
by a host-derived lipid envelope, which encloses a single-stranded RNA of positive 
polarity (Westaway et al., 1985; Chambers et al., 1990; Rice, 1996) (Fig. 1.2). The viral 
envelope has a fringe of spike projections of about 5 nm (Rice, 1996). The most notable 
feature of the flavivirus genome is the presence of a single open reading frame (ORF), 
10-11 kb long, which codes for 3380-3433 amino acids (Chambers et al., 1990; Rice, 
1996; Heinz and Allison, 2000) and is flanked by noncoding regions at its 5' and 3' ends 
(Fig. 1.3). The RNA genome, type-1 capped at the 5' terminus, comprises untranslated 
regions (UTR), which contain conserved elements that are potentially involved in 
secondary structure formation (Rice, 1996). The nucleotide sequence of the 5' UTR is 
partially conserved in members of specific antigenic serocomplexes — the 3' UTR lacks 
a poly (A) tract, terminates with the conserved dinucleotide CU, and contains several 
conserved sequences that are specific for arthropod-borne viruses (Rice et al., 1986; 
Rice, 1996). For the mosquito-borne flaviviruses, the conserved RNA sequences CS1 
and CS2 are located 5' to the 3' terminal secondary (stem and loop) structure. CS1 is 
approximately 26 nucleotides (nt) long and is partially complementary to a sequence 
near the 5' end in the region that encodes the capsid protein, suggesting that the genomic 
RNA can circularize. CS2 is approximately 24 nt long and is located 12 to 22 bases 5' 
upstream of CS1 (Rice et al., 1986; Rice, 1996). The genomic RNA is the only viral 
RNA found in infected cells, and its translation gives rise to a polyprotein which is
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cotranslationally and posttranslationally processed into three viral structural proteins 
and seven non-structural proteins (Fig. 1.3) (Heinz and Allison, 2000).
The structural genes, which encode components of the virion, namely the capsid 
(C) protein, the membrane protein (prM/M) and the envelope glycoprotein (E), occupy 
one fourth of the ORF at its 5’ end. The sequence homology of C is low, although the 
presence of (+) charged residues in C is conserved in the different flaviviruses. The 
glycosylated precursor of the structural M protein (prM) undergoes a delayed cleavage 
to M and is found on intra-cellular virions, indicating that cleavage (furin-mediated) 
occurs immediately before, or together with, virion release. The envelope (E) protein is 
the largest structural protein. It consists of approximately 500 amino acids in three 
antigenic domains (Heinz and Allison, 2000; Solomon and Mallewa, 2001) and has a 
molecular weight of 53 to 54 kD. As in other enveloped viruses, the E protein in 
flaviviruses is thought to be principally involved in virion attachment (by binding to cell 
surface receptors) and in fusion, resulting in the release of the nucleocapsid into the
cytoplasm (Mathews et al., 1992).
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Most of the ORF (75%) encodes the non-structural (NS) proteins. The majority of these 
proteins are required for viral replication: NS1, NS2A, NS2B, NS3, NS4A, NS4B and 
NS5. The non-structural 1 (NS1) glycoprotein is membrane-associated and plays an 
essential role in RNA replication (Lindenbach and Rice, 1997). NS2A has a role in 
RNA replication. It colocalizes with double-stranded RNA in cytoplasmic foci and 
binds strongly to the 3’ UTR of the RNA, NS3 and NS5 (Rice, 1996; Mackenzie et al., 
1998a). NS2A has been implicated in the JEV-induced cytopathic effect (CPE) (Chang 
et al., 1999). The work of Kümmerer and Rice (Kümmerer and Rice, 2002) has shown 
that NS2A and NS3 play a role in the assembly and/or release of infectious YF particles. 
The NS2B protein is essential for viral replication; it is a component of the NS2B-3 
protease and is thought to function in polyprotein cleavage, in association with the NS3 
protein. NS3 is the second-largest viral protein (Rice, 1996; Scaramozzino et al., 2002). 
Sequence comparisons and biochemical analyses suggest that NS3 may be trifunctional, 
and may have protease, helicase and RNA triphosphatase activities (Rice, 1996). The 
NS3 protease activity is required for C protein cleavage, which triggers signalase 
cleavage of prM and secretion of spike heterodimer (Lobigs, 1993; Rice, 1996; Droll 
et al., 2000; Scaramozzino et al., 2002). NS4A binds strongly to most of the other non- 
structural proteins. NS4A binds to NS1 as a determinant of replicase function 
(Lindenbach and Rice, 1999). NS2B and NS4B (a transmembrane protein) are poorly 
conserved membrane-associated proteins whose functions are currently unclear, 
although it has been suggested that they may serve to anchor the viral replicase to 
cellular membranes (Chu and Westaway, 1992; Lindenbach and Rice, 1999). The strong 
association of the viral polymerase complex with the cell membrane suggests that 
NS2B, NS2A and NS4B may be necessary for localization and activity of the 
polymerase complex (Rice et al., 1985; Rice et al., 1986). NS5 is the largest and most
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highly conserved flavivirus protein. NS5 is thought to function as the viral RNA 
polymerase, and possesses a GDD motif, which it has in common with RNA-dependent 
RNA polymerases of other positive-stranded RNA viruses (Rice et al., 1985; Rice et al., 
1986). The N terminus of NS5 is homologous with several methyltransferase proteins 
and this domain may be involved in the methylation of the 5’ cap.
The genomic organization of flaviviruses is presented in Fig 1.3. The complete 
nucleotide sequences of flaviviruses from several serological complexes are currently 
available (Chambers et al., 1990). In a more recent phylogenic study, Kuno et al.,
(1998) established a genetic relationship among the viruses of the genus Flavivirus. The 
ranges in pairwise amino acid sequence identities on NS5 gene were 75 to 86% in DEN 
complex viruses, 83 to 96% in JE complex viruses and 72% between YF and Banzi 
viruses (Kuno et al., 1998).
1.3 Flaviviral replication cycle
Viruses are obligate intracellular pathogens that depend on host cell molecules 
to complete their replication cycles. Most flaviviruses require an arthropod vector 
(mosquitoes or ticks) for replication and a vertebrate host for their natural transmission 
cycle. Flavivirus replication studies are done in cell cultures derived from mammalian, 
avian and arthropod sources (Rice, 1996). Virus replication in arthropod cell lines is 
mostly noncytocidal, whereas replication in vertebrate cell lines generally produces 
pronounced cytopathic effects. Those observations are in accordance with the non- 
pathological effects that have generally been described in arthropods, and with the 
clinical disease that is often present in infected vertebrates. A schematic representation 
of flaviviral replication is shown in Fig. 1.4.
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There is evidence that the infection of cells is initiated by the entrance of the 
virus via receptor-mediated endocytosis (Rice, 1996; Heinz and Allison, 2000). It has 
been shown that a slightly acidic pH triggers fusion between the viral and the 
endosomal membranes, which, in turn, produces a conformational change in the viral 
E protein. This change is followed by an uncoating of the nucleocapsid in the cytoplasm 
(which is the site of flavivirus replication in the infected cell) to initiate translation and 
RNA replication (Rice, 1996; Heinz and Allison, 2000). Lee and Lobigs (Lee and 
Lobigs, 2000) demonstrated that a hydrophilic region (FG loop) of the E protein has a 
functional role in virus entry; which suggests that flaviviruses can enter cells by 
attaching themselves to glycosaminoglycans.
Antibody-dependent enhancement (ADE) has been described as an alternative 
entry route of flaviviruses into cells (Hawkes, 1964; Halstead, 1982). ADE involves the 
presence of subneutralizing concentrations of antibody that is bound to virus and which 
mediates the uptake of virus/Ab complex into Fc receptor-bearing cells. This mode of 
entry seems to be important in secondary flavivirus infection, in particular with dengue 
virus. For DEN and YF viruses, the initial interaction site of the virus with the host is 
heparan sulfate, which allows the virus to bind to the surface of the cell and infect the 
host (Germi et al., 2002). In this process virions localize to clathrin-coated pits on the 
cell surface and are rapidly taken up into coated vesicles. Lee and Lobigs (Lee and 
Lobigs, 2000) found evidence that cell-surface glycosamminoglycans are involved in 
attachment of MVE, with the degree of involvement depending on the dose and cell 
type that is used.
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Fig. 1.4 Replicative cycle of flaviviruses. 1, adsorption; 2, receptor- 
mediated endocytosis; 3, low-pH fusion in lysosomes; 4, uncoating; 5, cap- 
mediated initiation of translation; 6, translation of the viral RNA into viral 
precursor polyprotein; 7, cotranslationally and posttranslational proteolytic 
processing of the viral polyprotein by cellular and viral proteases; 8, membrane- 
associated synthesis of template minus-strand RNA and progeny plus-strand 
RNA; 9, assembly of the nucleocapsid; 10, budding of virions into the 
endoplasmic reticulum; 11, transport and maturation of virions in the 
endoplasmic reticulum and the Golgi complex; 12, vesicle fusion and release of 
mature virions, ss, single stranded. Modified from (Leyssen et al., 2000).
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The viral polyprotein is processed cotranslationally and posttranslationally into 
individual and functional viral proteins. This processing is carried out by cellular and 
viral proteases. The RNA-dependent RNA polymerase, associated with cofactors, 
produces minus- and plus-stranded RNA. After replication, the viral genome is 
encapsidated by association with C protein and acquires an envelope to become a 
mature virus (Leyssen et al., 2000). The virus particles, packed within secretory 
granules, are released at the cell surface by exocytosis. Virus is thus released via the 
same pathway as the cell’s normal secretory products (Monath, 1986).
1.4 Pathogenesis of flaviviral encephalitis
The flaviviruses that typically produce meningoencephalitis in humans are JEV, 
MVE, SLE, and TBE. Although WNV can also produce encephalitis in humans, its 
most characteristic symptoms resemble those of dengue and polio. Another 
characteristic of WNV and TBE, which differentiates them from JEV and MVE, is that 
they can frequently be isolated from the blood of patients during the acute phase. Other 
encephalitic flaviviruses do not produce detectable viremia (MacDonald, 1952; Huang, 
1963; Monath, 1996; Lee and Lobigs, 2002; Diamond et al., 2003b; Lobigs et al., 
2003b).
Experiments with mice provide the greatest body of information about flavivirus 
pathogenesis. Mice are suitable to reproduce pathogenesis of flavivirus encephalitis, but 
not to reproduce other syndromes that are associated with human flavivirus infection, 
such as hepatitis, arthralgia, rash, and hemorrhagic fever. Viruses (including DEN and 
YF) that produce these other syndromes in humans and primates cause encephalitic
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infections in laboratory rodents. The universal neurotropism of flaviviruses in rodents, 
and even in arthropod vectors (in which brain and ganglia are major sites of replication), 
may indicate that there has been an evolutionary conservation of the viral polypeptide 
structures that arc involved in receptor interactions and of cell membrane molecules 
which subserve the virus-receptor interactions (Monath, 1996).
The pattern of pathogenesis of flaviviral encephalitis depends upon the extent of 
the virus replication and on the degree of the inflammatory response in the host. 
Infection with encephalitic flaviviruses can thus have one of three general patterns of 
pathogenesis: 1) early viremia and extensive extraneural replication, which usually 
results in fatal encephalitis; 2) low viremia, late initiation of brain infection and 
clearance with minimal destructive pathology, which may lead to subclinical 
encephalitis; and 3) trace viremia and no neuroinvasion, which results invariably in an 
unapparent infection (Monath, 1996). The mechanisms involved in the definition of 
each of the above patterns of pathogenesis have not yet been fully defined. Major 
obstacles in attempts to define the role of humoral and cellular immune responses 
during flaviviral infections have been, like in humans, that mice show individual 
variability in susceptibility to infection and the lack of an effective immunocompetent 
animal model (Hall et al., 1996).
There are only a few reports on the pathogenesis of JEV in adult mice (Mathur 
et al., 1983; Lange and Sedmak, 1991; Lad et al., 1993) and many of its aspects still 
need to be elucidated. JEV is closely related to MVE and both would normally be 
regarded as sufficiently similar to allow findings with regard to the pathogenesis of one 
to help in the understanding of the pathogenesis of the other. While caution should be 
exercised when generalizing on the role of the immune response to JEV and MVE 
infections, there are grounds to suggest that MVE is a potential model for JEV.
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1.4.1 Factors influencing pathogenesis
In general, the spectrum of neurotropic flavivirus infection depends on the 
virus-host pairing, the virus dose, and on other factors that influence the host response. 
Among the host factors that influence pathogenesis, the most important factors are: age, 
genetic susceptibility, and pre-existing infection or immunity to heterologous agents 
(Monath, 1996). The level of neurovirulence and neuroinvasiveness of a particular virus 
strain also influences infection (Monath, 1996).
Infant mice are highly susceptible to flavivirus infection by all routes of 
inoculation. In humans, a bimodal (young-elderly) pattern of susceptibility is observed 
with JEV and MVE infections. In the case of SLE and WNV, however, susceptibility to 
encephalitis increases with advancing age, with the elderly being most severely affected 
(Monath, 1996). There are no known reports that there exists a model in laboratory 
animals that could represent the increased susceptibility to encephalitic flavivirus in old 
people (Monath, 1986). Susceptibility in the young seems to be related to immune 
immaturity (Ogata et al., 1991), and to the fact that the blood-brain barrier (BBB) is not 
yet fully established. Factors that may be important for the increased susceptibility seen 
in the old may include age-related waning of immunological responsiveness, and the 
presence of underlying diseases that impair the immune function or reduce the 
effectiveness of the BBB (Monath, 1996).
Sex differences in susceptibility of humans to flavivirus infections have not been 
demonstrated. Possible exceptions include MVE, which seems to occur more frequently 
in men than in women (although this may be related to the increased exposure of men to 
MVE-infected mosquitoes due to their more frequent outdoor activities), and DHF, 
which seems to affect female children preferentially (Monath, 1996).
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Genetic determinants play a central role in the pathogenesis of flavivirus 
infections. Miura et al. (1990) investigated resistance to JEV using inbred C57B1/6 and 
C3H/He mouse strains. C57B1/6 mice immunized with JEV were resistant, whereas 
most C3H/He mice treated the same manner died. Genetic resistance to flavivirus is due 
to different genes. However, the most adequately studied allele that confers flavivirus 
resistance is the single autosomal, dominant allele Flv (Brinton and Perelygin, 2003).
1.4.2 Extraneural infection
Extraneural flaviviral replication generally occurs in mice that are younger than 
3 weeks (Monath, 1996). After inoculation into the skin, the virus replicates in local 
tissues, spreads to regional lymph nodes, and is released into the bloodstream. This 
primary viremia seeds extraneural tissues, which, in turn, support further viral 
replication and act as a source for the release of virus into the circulation (Monath,
1996). Primary extraneural sites for flaviviral replication include connective tissue, 
skeletal and smooth muscle (myocardium), lymphoreticular tissues, and endocrine and 
exocrine glands (Monath, 1996).
In studies of virus distribution in MVE-infected mice, MacDonald (MacDonald, 
1952) showed that intramuscular inoculation of the highly passaged prototype virus 
MVE-1-51 (French, 1952) into 1-week-old outbred mice resulted in the simultaneous 
appearance of infectious virus at the inoculation site and in the bloodstream between 2 
and 4 days postinfection (pi), followed by infection of the central nervous system (CNS) 
between 3 and 5 days pi. In 3-week-old Swiss mice, infected with a highly 
neuroinvasive MVE strain (BH3479), virus was first detected in lymph nodes that drain 
the inoculated footpad at 24 h pi, in serum between 36 and 72 h pi, and in the CNS at 
day 4 pi (McMinn et al., 1996). MVE BH3479 appeared to enter the CNS via the 
olfactory lobes, since it spread in a rostral to caudal direction over 3-4 days. The fact
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that MVE was found simultaneously in the inoculation site and in the bloodstream 
during MacDonald's work (MacDonald, 1952), and that it appeared first in the olfactory 
bulb before entering the brain in McMinn's work (McMinn et al., 1996), suggests that 
MVE could use the hematogenous and/or neuronal routes of infection.
1.4.3 Neuroinvasion and pathological changes in the CNS
The entry of neurotropic viruses into the CNS is a central issue in the 
pathogenesis of these viruses, since the involvement of the brain appears essential for 
the virus to cause morbidity and mortality in the clinical hosts (Mathur et ah, 1982; 
Monath, 1996).
Animal studies indicate that flaviviruses cross the blood-brain barrier (BBB) 
and gain entry into the CNS via two routes: 1) The hematogenous route, where passive 
diffusion or transcytosis of virus through endothelial cells of cerebral capillaries results 
in budding of virus into the brain parenchyma (Liou and Elsu, 1998). This route of 
neuroinvasion probably occurs in mice of three weeks of age or younger, which sustain 
high viremia. However, there are doubts as to whether this route is relevant in clinically 
important hosts (humans and horses). 2) Because viremia in humans and horses is of 
brief duration and low magnitude, the neuronal route, where virus infects olfactory 
neurons at the olfactory epithelium (unprotected by the BBB) may be an alternative 
pathway to gain access to the CNS (Monath et al., 1983; Monath, 1986; Kobiler et al., 
1989; Hase et al., 1990; Lustig, 1992).
Generally, the distribution of flavivirus antigen in the brains of laboratory 
rodents is similar to that in the brains of humans. The most severely affected areas in the 
CNS are the thalamus, caudate nucleus, putamen, and substantia nigra (Ogata et al., 
1991). Pathological changes include neuronal and glial damage by direct viral injury,
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enhanced lesions by inflammatory responses, cellular nodule formation composed of 
activated microglia and mononuclear cells (Koprowski et al., 1993; Monath, 1996), and 
cerebral interstitial edema (Monath, 1996; Wasay et al., 2000). Neuronal and glial 
damage is characterized by central chromatolysis, cytoplasmic eosinophilia, cell 
shrinkage and neuronophagia (Monath, 1996). Studies by Despres et al. (1996) have 
shown that DEN virus and JEV induce apoptosis in infected neuroblastoma cells in 
vitro, suggesting that this may be a mechanism by which flavivirus infection may 
damage neurons within the CNS.
Although flaviviruses are generally considered to be cytopathic viruses, a study 
by Andrew's showed that MVE infection of neurons does not result in cell lysis, despite 
the detection of high levels of viral replication in the CNS (Andrews et al., 1999). 
Andrews’ findings in mice are consistent with those of Johnson et al. (1985), who 
studied fatal encephalitis in children. In Johnson et al.’s studies, encephalitis in infants 
results mainly from infection in neurons, although there is little neuronal lysis. Thus, 
direct virus-induced cell injury may not be an important mechanism in the pathogenesis 
of certain flavivirus-mediated encephalitis.
The occurrence of encephalitis may be explained by functional alterations in 
infected neurons rather than by cell destruction or by inflammatory responses that may 
enhance lesions and accelerate death (Monath, 1996). Inflammation of the brain 
parenchyma includes perivascular infiltration of small vessels with lymphocytes, plasma 
cells, and macrophages (Johnson et al., 1985; Monath, 1996). In Johnson et al.’s study 
of the composition of the mononuclear inflammatory response in children that died of 
JE, quantitation of perivascular inflammatory responses showed a preponderance of 
cytotoxic T cells of 7 to 30% (Johnson et al., 1985). Neutrophil recruitment into the 
CNS in response to infection, trauma and infarction, has also been shown to have a
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deleterious effect on brain function. This may be due to the release of toxic 
inflammatory mediators or due to a secondary effect of the neutrophil-mediated 
breakdown of the BBB, which results in an altered CNS homeostasis (Andrews et ah, 
1999).
Many of the clinical manifestations of encephalitis appear to be due to functional 
alterations of certain areas of the brain. The predominant involvement of the thalamus 
and brain stem is consistent with frequent tremors that are seen during the acute disease. 
The infection and destruction of neurons, together with an increase in intracranial 
pressure, explains the deep coma and respiratory arrest. The Purkinje cell loss 
presumably results from hyperthermia or anoxia (Johnson et al., 1985), while spasticity 
is associated with damage to the corpus striatum, and flaccid paralysis is associated with 
the infection of the spinal cord central horn motor neurons (McMinn et ah, 1996).
Persistence of flavivirus in the host may result in a chronic illness (Monath, 
1996). For example, Ravi et ah, (1993) observed that there was persistence of JEV in 
the human CNS in 5% of their studied cases; and Mathur found that in congenitally 
infected Swiss mice (after their mothers had been given JEV intraperitoneally during 
pregnancy) there was latent JEV infection, and that 2.7% of the mice showed 
persistence of infectious virus until they were 35 days old (Mathur et ah, 1986). Monath 
also demonstrated that JEV persists for prolonged periods in lymph nodes of athymic 
nude mice in the absence of clinical signs (Monath, 1986), and that residual 
neurological deficits, electroencephalitic changes and psychiatric disturbances in 
humans persist in more than half of the survivors after they recover from acute 
encephalitis (Monath, 1986). TBE has also been shown to persist in human kidney (RH) 
cells for at least 60 days, probably due to the production of modified NS 1 protein 
oligomers that can induce slow virus replication (Bugrysheva et ah, 2001).
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1.5 The innate immune response
Given that some viruses are capable of completing an infectious cycle in just a 
few hours, and that specific immune mechanisms require 3 to 4 days to reach even 
minimally effective levels, the potential for damage is enormous (Yewdell, 1997). In the 
case of flaviviruses, progeny first becomes visible in infected cells by electron 
microscopy 8 to 12 hours after infection (Westaway et al., 1985). Thus, in the initial 
encounter with a virus the innate immune response plays a crucial holding action in 
preventing massive tissue destruction and virus dissemination (Yewdell, 1997).
1.5.1 Cytokines and other antiviral soluble factors
Cytokines are a group of non-enzymatic protein hormones whose actions affect 
a variety of functions, including cellular metabolism, growth and differentiation, 
immune function, and tumor development (reviewed in (Kelso, 1998)). Cytokines are 
released by many types of cells in response to being infected, or in recognition of 
infection, and their functions are mainly immunoregulatory (Harty et al., 2000). 
Flavivirus infection can be inhibited by cytokines (mainly interferons a  and ß) in the 
absence of specific antibodies (Hasegawa et al., 1990; Goodboum et al., 2000; Biron, 
2001; Lobigs et al., 2003b).
The interferons (IFNs) are a family of cytokines that are essential to the host 
antiviral response, which is normally induced within hours of systemic viral infection 
and decreases with resolution of the infectious state (Slifka et al., 1999). The IFNs 
comprise two major subgroups (based on their properties and cellular receptors), termed 
type I (IFN-a and IFN-B) and type II (IFN-y).
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IFN-a is produced predominantly by leukocytes (in particular dendritic cells and 
macrophages), whereas IFN-B is produced by a large variety of cells, including 
fibroblasts, epithelial cells, and macrophages. Type I IFNs share a common receptor and 
have closely overlapping biological actions.
Expression of type I IFNs can be induced by many factors, but is particularly 
induced by infection with viruses (Slifka et al., 1999; Harty et al., 2000). Besides 
induction of important antiviral activities in infected cells, type I IFNs also activate NK 
ceils and enhance the antigen processing and presenting capacity of antigen-presenting 
cells (APCs) (Yewdell, 1997). Expression of the type IIFN genes may be induced in the 
CNS in different viral infections (e.g. lymphocytic choriomeningitis virus (LCMV) 
infection in mice). Glial cells (astrocytes and microglia) have been shown to produce 
type I IFNs in vitro, which suggests that these cells may provide a local source of IFN 
that is produced to defend the brain against a viral insult. Type I IFNs may be important 
contributors to the recovery from encephalitic flavivirus infection because their inducers 
have been shown to have a prophylactic and therapeutic effect (Haahr, 1971; Vargin et 
al., 1977; Taylor et al., 1980), and because recombinant IFNs modulate nonspecific 
immunity and are effective antiviral agents in vivo (Pinto et al., 1988; Brooks and 
Phillpotts, 1999). However, there is also evidence to suggest that the type I IFNs may be 
toxic to the brain (Akwa et al., 1998).
Type II IFN or IFN-y possesses several characteristics that are unique and relate 
particularly to its immunoregulatory functions, but also shares many characteristics 
(overlapping and synergic actions) with type I IFNs (Akwa et al., 1998). Activated 
T lymphocytes and natural killer (NK) cells produce type II IFN, which binds to a 
unique receptor (Yewdell, 1997; Harty et al., 2000). Akwa et al. (1998) generated 
transgenic mice that produce IFN-y chronically in astrocytes, which protects them
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against lethal neurotropic viral infection (e.g. LCMV) but also induces inflammation 
and neurodegeneration. Mice with targeted disruption of the IFN-y gene are not 
significantly different from wild-type mice in their susceptibility to DEN (Johnson and 
Roehrig, 1999), YF (Liu and Chambers, 2001) or MVE (Lobigs et al., 2003b). It may be 
that the potentially deleterious inflammatory response, resulting from the production of 
IFN-y during DEN and YF infections, is compensated by the IFN-y antiviral effect.
Tumor necrosis factor alpha (TNF-a) is a multifunctional pro-inflammatory 
cytokine, which has a pivotal regulatory function during infection and inflammation and 
is also implicated in the pathogenesis of autoimmune diseases (Stalder et ah, 1998). The 
sources of TNF-a may be infiltrating neutrophils, macrophages and T cells. Astrocytes, 
microglia and possibly neurons may also produce TNF-a locally in the CNS (Stalder 
et ah, 1998). TNF-a is activated in the CNS during various insults, and has both 
detrimental and protective functions. For example, knockout mice that are deficient in 
the TNF genes show an increase in experimental allergic encephalitis (EAE), but are 
resistant to cerebral malaria (Canque, 1992; Lucas et ah, 1997). Stalder et ah (1998) 
showed that persistent TNF-a expression in astrocytes is sufficient to induce a chronic 
inflammatory encephalopathy in which macrophage/microglial cells play a central role 
in the mediation of injury. MVE induces an inflammatory response in the CNS of 
weanling mice five days pi, preceded by an increased expression of TNF (Andrews 
et ah, 1999). A possible explanation for the TNF-a-induced immunopathology that 
occurs during MVE infection of mice may be that resident CNS cells stimulate the 
expression of the neutrophil chemo-attractant N51/KC (murine homologue of human 
interleukin-8), and that this results in neutrophils infiltrating across the cerebral 
endothelium into the CNS parenchyma. Chemotaxis of neutrophils across the cerebral 
endothelium leads to disturbance of the integrity of the BBB. Neutrophils in the CNS
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parenchyma affect the release of inflammatory mediators such as nitric oxide (NO), and 
disturb CNS homeostasis and neuronal function (Andrews et ah, 1999).
Nitric oxide is a potent microbicidal and tumoricidal agent, and a mediator of 
antiviral defense. NO is produced by neutrophils and macrophages. As a disregulated 
production of NO may lead to extensive tissue damage, it is important that the 
production of this mediator remains highly regulated (Kreil and Eibl, 1996). However, 
the antiviral activity of NO in vitro may be confined to certain viruses, while its effect 
on other viruses may be neutral (Kreil and Eibl, 1996; Andrews et al., 1999). Viral 
infections may alter the regulation of NO by either priming for, or down-modulating 
NO production. Because NO is generally considered to be an antiviral agent, the down- 
modulation of NO production during viral infection would be opposite to antiviral 
protection (Kreil and Eibl, 1996). The antiflaviviral activity of NO has been 
demonstrated for JEV (Lin, 1997; Saxena et al., 2000), several poxviruses and herpes 
simplex virus infections (Kreil and Eibl, 1996). However, Kreil and Eibl (1996) showed 
that high levels of NO production do not have an inhibitory influence on TBE 
replication in vitro, and that when aminoguanidine, an inhibitor of NO production, is 
administered in vivo to TBE-infected mice, it significantly increases their survival time. 
This is evidence that NO production may even contribute to pathogenesis of viral 
infection in vivo (Kreil and Eibl, 1996). Andrews et al. (1999) showed that NO also 
contributes to the disturbance of CNS homeostasis and to the neural function of 3-week- 
old mice infected with MVE. The combined effect of NO and TNF-a could affect the 
integrity of the BBB of MVE-infected mice (Andrews et al., 1999).
The complement system plays different roles during the immune response, 
including immunoregulation, phagocytosis, membrane lysis, inflammation, and 
antibody-dependent enhancement (ADE) (Yewdell, 1997).
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1.5.2 The cellular innate antiviral responses
Different cell types have been implicated in the early antiviral responses:
1) phagocytic cells (macrophages and neutrophils) which engulf and destroy viruses,
2) cells which release cytokines with antiviral or immunoregulatory activities 
(macrophages, neutrophils, mast cells, basophiles), 3) natural killer (NK) cells which 
recognize virus-infected cells based on alterations that are common to many virus 
infections and that either destroy the infected cells or release cytokines (Yewdell, 1997), 
and 4) yb T cells which reduce the susceptibility of mice to WNV infection (primarily 
due to the IFN-y- production of yb T cells) (Wang et al., 2003). Presumably, these host 
defense mechanisms (together with IgM antibodies) are often sufficient to limit 
infection with flaviviral strains of marginal neuroinvasiveness (Monath, 1986).
Macrophages play an important role in the defense against most infections 
(Blanden, 1982). During the early stages (one to seven days) of viral infection, virus 
clearance from blood, and host resistance conferred by macrophages, is due to virocidic 
properties, whereby highly cytotoxic macrophages appear in the peritoneum and lymph 
nodes prior to detectable specific antibodies (Rodda and White, 1976; Khozinsky et al., 
1985; Hill, 1993; Yewdell, 1997). Macrophages that are obtained late after infection 
with flaviviruses mediate specific antibody-dependent cell cytotoxicity (Hill, 1993). 
Macrophages also function as major antigen-presenting cells (APCs) (Hill, 1993). The 
complexity of flavivirus-macrophage interaction indicates that permissiveness to virus 
growth varies with the physiological state of macrophages, age and strain of mouse, and 
receptor pathways of virus entry (Cardosa et al., 1986). Infection with TBE, combined 
with temporary inhibition of phagocytosis by macrophages, results in an increased 
lethality (Khozinsky et al., 1985). Induction of peritoneal macrophages by concavalin A 
mediates a protective effect against JEV infection (Hill, 1993). In primary flavivirus
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infection, macrophages have been shown to have an effect on pathogenesis, although 
information is still limited (Monath, 1996). Interactions between macrophages, viruses 
and antiviral antisera may paradoxically result in an increase in viral infectivity, which 
could be produced by ADE (Peiris and Porterfield, 1979).
Neutrophils are mediators in innate immune reactions. However, work by 
Andrews et al. (1999) has implicated neutrophils in the pathogenesis of MVE. They 
found that neutrophils predominated in a mixed-cell inflammatory infiltrate from brains 
of MVE-infected mice, and that their appearance correlated with the onset of lethal 
encephalitis between 5 and 6 days pi. Depletion of neutrophils resulted in prolonged 
survival and decreased mortality. The prolonged survival of neutropenic MVE-infected 
mice was not due to reduced viral neuroinvasion, because virus entered the CNS at 5 
days pi, in both neutrophil-depleted and mock-depleted mice, and because virus titers in 
the CNS of both groups were almost identical. MVE-encephalitis was not due to 
induction of apoptosis of infected neurons, since < 0.1% of infected neurons showed 
evidence of apoptosis. Encephalitis was presumably due, in addition to infiltration of 
neutrophils in perivascular regions and CNS, to the consequent increased expression of 
TNF-a and induced nitric oxide sythase activity (Andrews et al., 1999).
Natural killer (NK) cells are a lineage of lymphocytes that do not express 
antigen-specific cell surface receptors (Renard et al., 1997). They can lyse some tumors 
and virus-infected cells and can mediate acute rejection of bone-marrow cell grafts 
(George et al., 1997). NK cells recognize and eliminate potentially pathological cells 
that fail to express, or have reduced, self -  major histocompatibility complex (MHC) 
class I molecules (Ljunggren and Karre, 1990). NK cells can directly interfere with viral 
replication by releasing cytokines (predominantly IFN-y and-ß) with antiviral activity, 
or by lysing virus-infected cells. NK cells can directly lyse cells in one of two ways: 1)
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by antibody-dependent cell-mediated cytotoxicity (ADCC); or 2) by cell-mediated 
cytotoxicity of virus-infected cells, where lysis is usually mediated by the 
perforin/granzyme mechanism also used by T cells (detailed in section 1.6.2). Viral 
infections in general elicit pronounced NK cell activity two to three days post-infection 
(pi) (Hill, 1993). However, the typical upregulation of MHC class I expression observed 
on cells infected with flaviviruses such as WNV, YF, DEN, MVE, KUN and JEV may 
be responsible for the greatly impaired NK-cell lysis of flavivirus-infected target cells 
(King, 1988; King et al., 1989; Liu et al., 1989b; Mullbacher, 1995; Lobigs et ah, 1996; 
Momburg, 2001). Hill and colleagues (Hill, 1993) investigated the induction of NK 
cells after infection with WNV in mice, and their ability to lyse WNV-infected target 
cells. They found that the NK response was only marginally elevated in comparison to 
that in the spleen of infected mice from control animals, suggesting that the increased 
class I MHC expression on the surface of infected cells may have impaired induction 
and function of NK cells (Hill, 1993; Momburg, 2001). Liu et al. (1989a) demonstrated 
that there is induction of NK-like cells in the CNS after intracranial (ic) infection with 
WNV in mice, which suggests that there is NK activation at the site of flavivirus 
replication in vivo. However, given that virus will leak from the ic inoculation site into 
extraneural sites, it is not clear if the induction of the NK cell response occurred in the 
CNS from a peripheral reaction. Liu et al. recorded an additional upregulation of MHC 
class I gene expression, which was most likely caused by productive WNV infection of 
astrocytes. However, even prior to finding detectable levels of class I MHC protein on 
astrocytes, these cells were still refractory to virus-induced NK cell lysis (Liu and 
Mullbacher, 1988). Consequently, cytokines released from flavivirus-induced NK cells 
may have had a direct or indirect influence on the outcome of such infections (Hill,
1993).
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1.6 The adaptive immune response
The immune response to neurotropic viruses competes in a ‘race’ with the rate 
and extent of vims replication, resulting in neuroinvasion and encephalitis when the 
development of immune responses has not been effective (McMinn et al., 1996). The 
components of the adaptive immune system consist of T and B cells. Both types of 
immune cells express, in a clonally restricted manner, receptors on their surface that 
interact specifically with a limited set of related antigens (Yewdell, 1997).
There are two dominant types of peripheral T cells, CD8+ T cells and 
CD4+ T cells, and both express a surface antigen T-cell receptor (TCR). Antigen- 
specific T-cell responses are induced by the binding of the TCR with MHC-peptide 
complex, with short (8-10) or somewhat longer (10-34) peptides. The short peptides are 
presented by MHC class I molecules, and the longer peptides are presented by class II 
molecules (Appella, 1995; Harty et al., 2000). CD8+ T cells predominantly recognize 
cells that present fragments of endogenously derived peptides presented via MHC class 
I molecules. Presentation of antigens to CD4+ T cells occurs after endocytosis or 
phagocytosis of an Ag, which is processed in a lysosomal compartment to peptides and 
presented by MHC class II molecules. Antigen-presenting cells (APCs) express great 
concentrations of classes I and II MHCs on their surface, together with the foreign 
antigen. The professional APCs are dendritic cells, macrophages and B lymphocytes 
that present antigens to the CD4+ T cells (Th, or helper cells). Thus, there is a 
synergistic Th and B cell effect in both directions: B cells are activated to proliferate 
and to produce antibodies, while Th cells are stimulated by the antigen that is taken up, 
processed and presented on the surface of B cells (Hill, 1993).
Antibodies produced by B cells are immunoglobulins (Ig) that bind antigen 
molecules. B cells first produce a membrane-bound form of Ig, the B cell receptor
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(BCR), as part of B cell differentiation. Each B cell expresses one Ig, but the population 
of B cells in each individual displays a wide variety of antigen specificity, with each cell 
expressing Ig on its surface as part of the B cell receptor complex. There are five classes 
of human Igs: IgM, IgA, IgD, IgE, and IgG. Human patients with acute encephalitis 
have mainly virus-specific IgM that peaks at day 7 after hospitalization (Burke et ah, 
1985b). Relatively little is known about the immune responses during human flaviviral 
encephalitis, and most of the existing knowledge has been derived from experiments in 
mice (Monath, 1986).
1.6.1 The humoral immune response
Antibody production has been demonstrated to be the main mechanism of 
protection in several flaviviral studies in mice (Monath, 1986). In mice inoculated with 
encephalitic flaviviruses, neutralizing Ab appears between 4-6 days postinoculation 
(Webb et al., 1968; Monath and Borden, 1971; Camenga et al., 1974), with IgM 
predominating in the early phase of infection (Webb et al., 1968; Monath and Borden, 
1971). The antibody production to some flaviviruses (e.g. JEV) is thymus-dependent 
and appears to be fully dependent on helper T cells (Mathur et al., 1982; Lad et al., 
1993). Passively administered antibody against flaviviruses protects the recipient mice 
against infection, even if neuroinvasion has already occurred (Mathur et al., 1982; 
Monath, 1986, 1996). The protective role of B cells is further demonstrated when mice 
that are defective in B cells or CD4+ T cells do not survive a lethal JEV challenge (Pan, 
2001).
IgM antibodies predominate in the early phase of flaviviral infection of mice and 
have a half-life of about 4 days (Mathur et al., 1982; Monath, 1986). McMinn et al.
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(McMinn et al., 1996) found that there is a clear association between the time of 
appearance of anti-MVE IgM and the first significant fall in the level of viremia 
(between 3 and 4 days pi). Protection is abrogated in JEV-infected mice by pretreatment 
of the early serum with 2-mercaptoethanol to dissociate IgM (Mathur et al., 1982). 
Boosting and sustaining the production of IgM has been demonstrated to be essential for 
protection and may be considered as the main host defense mechanism against 
encephalitic flaviviruses (Mathur et al., 1982).
Monath (1986) found that IgM and IgG may co-circulate in blood during a brief 
period of immune clearance. In experiments with MVE in mice of 3 weeks of age, anti- 
MVE IgG is first detected at 6 days pi and peaks between 9 and 14 days pi (McMinn et 
al., 1996). The anti-MVE IgG response appears to be associated with clearance of 
infectious virus from the CNS (McMinn et al., 1996). In humans, studies of systemic 
infection and local CNS antibody response to JEV have shown that there is a strong 
correlation between survival and an early, and quantitatively strong, antibody response 
(Burke et al., 1985a). Monath (1986) also found that patients who survive JEV have 
serum IgG antibody during the first five days of admission to hospital, whereas fatal 
cases only become seropositive later.
Antibodies have the ability to signal the complement system, which coats the 
antigen, thus rendering it prone to phagocytosis. Although blocking the attachment of 
flavivirus to target cells is by far the most common means of antibody neutralization 
(Cardosa, 1998), some of the E protein epitopes are abolished by the conformational 
transitions that take place at low pH. Such conformational transitions are postulated to 
be important in the fusion event, which is necessary for the establishment of infection. 
Prevention of pH-dependent fusion is an alternate mechanism to neutralize flavivirus
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infection. Thus, blocking of virus attachment to the target cell is not the only 
mechanism of neutralization of flaviviruses (Vorovich et al., 1991).
Antibody-dependent enhancement (ADE) of viral infectivity occurs when cells 
that bear Fc receptors on their surface are infected with virus that has been in contact 
with antiviral antibody that is insufficient to cause viral neutralization. ADE of infection 
with flaviviruses has been demonstrated in vitro for DEN (Peiris and Porterfield, 1979; 
Legrand et al., 1986; Mady et al., 1991), WNV (Peiris and Porterfield, 1979), TBE 
(Phillpotts, 1985, 1987; Kopecky et al., 1991), JEV (Phillpotts, 1985), YF (Phillpotts,
1985) ; and in vivo for YF (Barrett and Gould, 1986), DEN (Morens, 1994) and JEV 
(Gould and Buckley, 1989). In vivo enhancement of TBE infection has not been 
demonstrated, even though ADE has been demonstrated in vitro using the same 
combination of TBE antibodies and virus. Thus, ADE of viral infection in vitro does not 
always predict enhancement in vivo (Kreil and Eibl, 1997). It has been suggested that 
ADE represents immunopathological processes that occur in vivo', mainly for 
DHF/DSS, and that ADE may be a limitation for vaccine development against DEN 
(Morens, 1994; Cardosa, 1998).
Mouse monoclonal antibodies have been described as being able to neutralize 
flaviviruses (Cardosa, 1998). The humoral immune response is predominantly directed 
against the viral envelope (E) protein and a cell surface localized non-structural protein 
(NS1) (Monath, 1986). Antibodies directed against NS1 on the surface of infected cells 
appear relatively late and probably play an important role in viral clearance (Monath,
1986) . Schlesinger and co-workers (Schlesinger et al., 1985) first showed that 
immunization with purified NS1 of YF and passive transfer of monoclonal antibody to 
NS1 both result in protection against YF17D-induced encephalitis. DNA immunization 
of mice with JEV NS1 gene also results in protective immunity (Lin et al., 1998).
Chapter 1: Background 43
Much interest has been centered on the identification of protective B- and T-cell 
antigens, in order to develop anti-flavivirus vaccines, particularly against dengue 
(Brandt, 1988), and to improve the existing JE vaccine. When certain flaviviral antigens 
are encoded in the host through recombinant DNA technology, humoral as well as 
cellular responses against flaviviruses are observed (Monath, 1986; Klinman et al., 
1999). Pan (2001) demonstrated the importance of B cells in the protection from lethal 
virus challenge using DNA-vaccination against JEV E protein. Colombage et al. (1998) 
investigated the immunogenicity and protective efficacy of DNA-based vaccination 
with plasmids that encoded the membrane proteins prM and E of MVE. They elicited 
long-lived virus-neutralizing antibody responses in mice by intradermal delivery of 
DNA, which encodes the prM and E proteins. This resulted in protection, although mice 
were challenged with high titers of MVE inoculum. Induced MVE-specific IgGl 
antibodies were prevalent after intradermal DNA vaccination, but not after the whole 
virus was injected by the same route (Colombage et ah, 1998). This result represents 
interesting possibilities for DNA vaccination.
1.6.2 The cellular adaptive immune response
Cellular-specific adaptive immune mechanisms are basically executed by 
T cells. These are generally important for the recovery from intracellular pathogens such 
as viruses. Both CD8+ MHC class I -  restricted and CD4+ MHC class II -  restricted 
T cells may be responsible for either: 1) Viral clearance and recovery. Viral clearance 
may be facilitated in the case where target cells are lysed before the assembly of 
progeny virus. 2) Additional dissemination of the virus. This may be facilitated if target 
cells are lysed after the assembly of a significant amount of progeny virus.
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3) Immunopathology (Hill, 1993). Virus-specific T lymphocytes have been shown to be 
critical for clearance of poxvirus (Blanden, 1974; Welsh, 1981; Karupiah et al., 1990; 
van Binnendijk et al., 1990; Karupiah et al., 1996) and influenza virus (Topham et al., 
1996; Topham et al., 1997; Cerwenka et al., 1999; Riberdy et al., 2000). However,
T lymphocytes can also exacerbate tissue injury and induce disease. This has been 
demonstrated in mice infected with LCMV, respiratory syncytial virus, and other 
viruses (Rothman and Ennis, 1999). T-lymphocyte-mediated immunopathology may be 
relevant in the induction of DHF during secondary dengue virus infections (Rothman 
and Ennis, 1999). Activation of DEN virus-specific T lymphocytes during interactions 
with dengue-virus infected monocytes may result in an increased capillary permeability 
through cytokine production and cytolytic mechanisms of dengue virus-specific T cells 
(Rothman and Ennis, 1999). Certain types of T cells play different roles during 
infections, i.e. MHC class I -  restricted CD8+ T cells have been shown not to be 
required for resistance to vaccinia virus, vesicular stomatitis virus or Semliki Forest 
virus; while antibodies, MHC class II -  restricted CD4+ T cells and cytokines contribute 
significantly to clearance of these viruses (Kagi et al., 1995).
During flavivirus infections, the participation of T cells to the course or outcome 
of the infection is influenced by the vims strain (Monath, 1986). Mild flaviviral 
replication can be aborted by the non-specific defense mechanisms, while T cells, 
together with other responses, are required for clearance of more virulent viral strains 
(Monath, 1986). Flavivirus-induced upregulation of MHC class I molecules on infected 
cells leads to a more efficient lysis of infected cells by cytotoxic T (Tc) cells, although 
the susceptibly to NK-cell-mediated lysis may be reduced (Liu et al., 1989b; Lobigs
et al., 1996).
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Some researchers have postulated that T cells play a role in the control of 
primary flaviviral infection, based on reconstitution experiments and 
immunosuppression, T-cell cytotoxicity, measurement of delayed-type hypersensivity 
(DTH) responses and leukocyte migration inhibition (LMI) (Mathuret al., 1983;
Monath, 1986). As most of these studies are done in vitro, the question of whether an 
equivalent situation occurs in vivo is raised. New methods for the study of Tc cells, such 
as staining with tetrameric MHC class I peptide complexes, intracellular cytokine 
staining and ELISPOT analysis have been used for the understanding of the T-cell 
response to infection (Harty et al., 2000).
During flavivirus infections of mice, in vitro T-cell immunity has been 
demonstrated through cytotoxic assays (reviewed in (Monath, 1986)). Humoral as well 
as cellular responses have been observed after certain flavivirus antigens have been 
encoded in the host by recombinant DNA technology. For example, Parrish et al. (1991) 
created a panel of recombinant vaccinia viruses (VVs), which together express cDNA of 
the entire KUN genome.
Reconstitution experiments of immune spleen cells from flavivirus-infected 
mice have shown that T cells play a protective role under the following conditions:
1) When there is adoptive transfer of splenocytes up to 2 weeks after immunization. If 
JEV escapes immune surveillance during this period, a persistent infection may result 
(Mathur et al., 1982). 2) When immune T cells are given before flaviviral neuroinvasion 
has occurred (Monath, 1996). 3) When there is a transfer of more than 108 cells. Such a 
transfer is needed locally to prevent encephalitis during JEV inoculation into the brain 
of mice (Mathur et al., 1982). In several cases, the peripheral transfer of immune T cells 
to infected hosts does not reduce mortality after flavivirus infection, which suggests that 
cell-mediated immunity is of lesser importance during the recovery from neurotropic
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arbovirus infections than when there is peripheral transfer of antibodies (Camenga et al., 
1974).
In vivo studies of the T-cell response against flaviviruses have been done by the 
use of serum against T cells and by the use of nude (nu/nu) athymic mice. Hall et al. 
(1996) found that depletion of CD8+ T cells in mice immunized with vaccinia 
expressing MVE NS1 abrogated protection against MVE challenge, but not in mice 
immunized with vaccinia expressing PrM-E. Lad et al. (1993) showed that JEV 
infection in nu/nu mice, athymic littermates (+/nu) and Swiss syngeneic mice only 
produced sickness in nu/nu mice. This suggests that functional T cells play a role in the 
induction of active immunity as well as in the protection against JEV infection in mice 
(Lad et al., 1993). However, T-cell help is required to switch B-cell immunoglobulin 
synthesis to the IgG isotype (which has a virus-neutralizing property) (Uren, 1987; 
Mathews et al., 1991; Mathews et al., 1992). Thus, the lack of protection of nu/nu mice 
from JEV challenge could be due to the lack of T-cell help for the proper Ab response. 
Selective depletion of T lymphocytes with antiserum can potentially cause flaviviral 
encephalitis, as well as prolong survival time (Monath, 1986). However, the protective 
effect of immune spleen cells in JEV-infected mice can be abolished by pretreatment of 
the immune T cells with anti-Thy 1.2 antiserum and complement (Mathur et al., 1982). 
There are also cases where immunosuppression results in protection. For example, 
various research projects have shown that when mice are immunosuppressed during 
infection with encephalitic flaviviruses, they will have a prolonged survival and a 
reduced mortality compared with the immunocompetent mice, and they will show less 
inflammatory cell infiltration into the CNS (Hirsch and Murphy, 1968; Camenga and 
Nathanson, 1975; Semenov, 1975; Semenov et al., 1975). Thus, the role of the immune 
response in the protection or contribution to flavivirus pathogenesis is still unclear.
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The CD8+ T-cell response
CD8+ T cells that are MHC class I -  restricted are the most important cytotoxic 
T (Tc) cells. They exert their effector function by two very different mechanisms, one 
mediated by cytokines, and the other mediated by cytotoxic molecules that program 
their targets to undergo apoptosis (Rouvier et al., 1993; Kagi et al., 1994b; Lowin et al., 
1994). The nature of the pathogen-host interaction may determine which CD8+ T 
effector mechanisms are required for immunity (Harty et ah, 2000).
Generation of Tc cells in the spleen has been demonstrated in mice that were 
peripherally infected with live encephalitogenic flaviviruses such as WNV, KUN, MVE 
and JEV (Gajdosovaet ah, 1981; Kesson et ah, 1987; Parrish et ah, 1991; Lobigs et ah, 
1994; Lobigs, 1997; Regner, 2001). The WNV genes that code the antigenic peptide 
determinants recognized by Tc cells have been identified using VV-KUN recombinants 
in a similar way as they were identified for CD4+ T cells (Parrish et ah, 1991; Hill,
1993) . The dominant determinant in H-2k, H-2d, H-2q and H-2S haplotypes has been 
mapped to the NS3/NS4A region, the source of the Kk-restricted peptide determinant of 
the Tc-cell response against MVE has been mapped to the NS3 protein (Lobigs et ah,
1994) , and the sources of the MVE-specific Dk- and Derestricted responses have been 
mapped to the NS4B and NS2B-3 proteins, respectively (Lobigs, 1997). Takada (2000) 
investigated the Tc cell response to JEV, and also found that determinants that are 
derived from different viral gene products are recognized by flavivirus-immune Tc cells 
(depending on the haplotype of mice used). They concluded that an effective vaccine 
should encompass the whole virus genome in order to protect the human outbreed 
population.
The induction of memory Tc cells to flavivirus of the JEV serocomplex in mice 
does not last for their entire life (Mullbacher and Flynn, 1996). In vitro stimulation of in
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v/vtf-primed splenocytes that will generate secondary virus-immune Tc cells only occurs 
efficiently if it is done approximately 2 weeks after priming (Kesson et al., 1988; Lobigs 
et al., 1996). This may mean that successful in vitro boosting only occurs when Tc cells 
are still in an activated state, and that they become refractory at a later stage (after 
encountering flavivirus-infected cells). This unresponsiveness to viral restimulation of 
memory flavivirus-immune Tc cells may be due to the increased MHC class I 
expression on flavivirus-infected stimulator cells, which results in an increased 
presentation of viral and self peptides (Lobigs et al., 1996). Increased expression of self 
peptides in this situation may be above the threshold required for activation of self­
reactive Tc cells (Blanden et al., 1987) and may lead to transient T-cell autoimmunity, 
followed by down-regulation of autoimmunity and Tc-cell memory responses. This is 
consistent with the observation that Tc cells induce high lysis of mock-infected target 
cells when there is restimulation of flavivirus-primed splenocytes after a lengthy period 
of priming (Kesson et al., 1988; Lobigs et al., 1996). Persistent memory flavivirus­
immune Tc cells are generated after a primary flavivirus immunization with a 
recombinant subunit vaccine (Regner, 2001; Regner et al., 2001), although the 
protective value of vaccination by induction of Tc-cell immunity against the 
encephalitic flaviviruses is relatively poor due to the highly self-reactive memory
Tc cells.
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The CD4+ T-cell response
CD4+ T cells become activated and proliferate after they recognize appropriate 
MHC class II/peptide complexes; they mature into either Thl or Th2, depending on the 
stimulatory conditions. During flaviviral infections, CD4+ T cells are considered to be 
important to the host defense mechanism. They provide help to mount a protective Ab 
response and they are also required to switch B-cell immunoglobulin synthesis to the 
IgG isotype, which has a virus-neutralization property. (Uren, 1987; Mathews et al., 
1991; Mathews et al., 1992). Cytotoxic T cells are mostly MHC class I -  restricted 
CD8+ T cells, but MHC class II -  restricted CD4+ T cells can also exert cytotoxicity via 
a direct killing process through the Fas pathway (CD4+ Thl) or the granule exocytosis 
pathway (CD4+ Th2) (Henkart, 1994). An exceptionally dominant CD4+ T-cell 
cytotoxicity has been observed during flaviviral infections with dengue in humans 
(Kurane et al., 1989) and with JEV (Aihara et al., 1998). Expression of MHC class II 
antigens is also induced after in vitro infection of astrocytes with WNV (Liu et al., 
1989b). The process that induces the unusual cytotoxic CD4+ T clones during those 
flaviviral infections is not clear. The induction may be due to the in vitro restimulation 
or to infections with inactivated virus preparations (except virus inactivation produced 
by gamma irradiation which induces the classical cytotoxic CD8+ T cells) (Braciale and 
Yap, 1978; Aihara et al., 1998). CD4+ T cells do not appear to play a significant role in 
the CNS inflammatory response. Experiments by Liu show that leukocyte infiltration in 
the CNS of mice after WNV infection consist of CD8+ T and NK cells but not of 
CD4+ T cells, and that it is unclear if flavivirus-immune CD4+ T cells are required for 
the induction and/or activation of CD8+ T cells (Liu et al., 1989a).
Several studies have been done to identify the flavivirus peptide determinants 
that are recognized in association with MHC class II molecules by flavivirus-immune
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CD4+ T cells. CD4+ T cells respond to peptides that are predominantly encoded within 
the E and the NS1 protein (Mathews et ah, 1991; Mathews et ah, 1992). The fact that 
both E and NS 1 proteins are also responsible for most of the Ab responses against 
flaviviruses coincides with the other important function of B cells, i.e. as APCs for 
CD4+ T cells. VV-KUN recombinants that encode the structural polyprotein region and 
the non-structural proteins NS1 and NS2 produce substantial responses in the H-2b,
H-2d and H-2k murine haplotypes (Hill, 1993). Peptide determinants encoded within the 
NS4B-NS5 region are also immunogenic to the same haplotypes. Murine responses 
against WNV, KUN and MVE show extensive cross-reactivity in CD4+ MHC class II -  
restricted T-cell clones, and have a strong cross-reactivity after heterologous virus 
priming (Doherty, 1987; Uren, 1987; Mathews et al., 1991). A similar situation occurs 
in humans during responses against dengue infection, when serotype cross-reactive 
memory T lymphocytes, induced by the primary dengue virus infection, proliferate most 
rapidly during the second exposure to dengue virus and induce an Ab response 
primarily directed against the DEN type previously encountered (Rothman and Ennis, 
1999). There are two mechanisms proposed to explain the detrimental role of the 
preexisting antiviral immunity: 1) ADE (Hawkes, 1964; Halstead, 1982), and 2) the 
‘original antigenic sin’ (Francis, 1953; Fazekas de St and Webster, 1966a, b). These are 
the mechanisms by which preexisting anti-dengue immunity can be detrimental in 
subsequent infection with dengue virus serotypes. Infection-enhancing immunity of 
encephalitic flaviviruses was shown for the first time in mice that were challenged with 
JEV, after vaccination with killed MVE (Lobigs et al., 2003a). Thus, 
immunopotentiation of disease against the most important encephalitic flaviviruses 
(such as JEV and WNV) in humans could occur, especially in areas where other viruses 
of the JEV serocomplex occur as well.
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1.7 Cytotoxic mechanisms
Although cytotoxic mechanisms are part of the cellular immune response, I will 
discuss them in this separate section because they are the specific study objects of this 
thesis. Cytotoxic mechanisms are of primary importance during infection by viruses, 
due to the capacity of cytotoxic T cells to detect intracellular pathogens. The cells that 
are mainly responsible for cytotoxicity are the CD8+ T cells and NK cells, which 
express both mechanisms of cytotoxicity. CD4+ T cells are also capable of lysis, but to a 
lesser extent than the NK cells: the Thl cells express FasL and the Th2 cells elicit the 
granule exocytosis pathway (Henkart, 1994; Kagi et al., 1994b). The recognition of an 
APC via the TCR induces the naive T cell to begin the synthesis of cytolytic proteins 
and the specialized compartments in which these proteins are stored (Griffiths and 
Argon, 1995).
Two mechanisms of lymphocyte-mediated cytotoxicity have been demonstrated 
at the molecular level: 1) the granule exocytosis pathway, which is dependent on a pore­
forming molecule (perforin) and on granule-enzymes (granzymes); and 2) the 
upregulation of Fas ligand (FasL or CD95L) on the killer cell, which can initiate a 
programmed cell death through the aggregation of Fas receptor (FasR or CD95) on 
target cells (Kagi et al., 1994a). The two mechanisms of cytotoxicity can be 
distinguished experimentally in effector cells: while the degranulation pathway is 
calcium-dependent, the cell death that follows the engagement of Fas is calcium- 
independent. Both pathways are activated in response to signals from the TCR and lead 
to an apoptotic death of the target cells (Fig. 1.5). In most standard cytotoxic assays, the 
dominant mechanism involved in the elimination of virus-infected cells is the granule 
exocytosis pathway. As the assay time becomes longer, the Fas pathway can become
Chapter 1: Background 52
dominant, e.g. in overnight cytotoxicity assays this pathway can be very effective 
(Henkart, 1997; Simon et al., 1997; Mullbacher et ah, 1999a; Mullbacher et ah, 2002).
The availability of mice with different combinations of mutations — perforin 
knockout (perf-/-) mice, granzyme A and B knockout (gzmA-/- or gzmB-/-, 
respectively) mice, Fas receptor mutant (Ipr) mice and Fas ligand mutant (gld) mice — 
provides an excellent means to assess the importance of the degranulation and the Fas 
pathway of cytotoxicity during the infection with different intracellular pathogens. The 
granule exocytosis model was initially confirmed when Kagi et al. (1994b) observed 
that there was low cytotoxic activity in the activated lymphoid cell populations of 
effector cells from perf-/- mice. When they used perf-/- cells as effector cells, some 
cytotoxicity still occurred in wild-type cells, but not in Ipr cells. They observed that 
when effectors were unable to exert perforin-based lysis and when targets were unable 
to be lysed through the Fas pathway, there was no other mechanism that operated (Kagi 
et al., 1994b). Based on the use of perforin or granzymes (gzms) knockout mice, it is 
evident that the granule exocytosis (or degranulation) pathway contributes to the 
resistance against certain virus infections (Kagi et al., 1995; Mullbacher and Flynn, 
1996; Mullbacher et al., 1999b; Harty et al., 2000). Perforin-dependent cytolysis is not 
required for resistance against cytolytic infections such as vaccinia virus (Kagi et al., 
1996), Semliki Forest virus (Kagi et al., 1995), vesicular stomatitis (Kagi et al., 1995) 
and cowpox virus (Mullbacher et al., 1999b) and even contributes to pathology during 
these infections.
Deletion of LCMV-specific CD8+ T cells in perf-/- mice is less efficient for 
protection than it is in C57B1/6 mice, where mortality is reduced through the depletion 
of CD8+ T cells. These findings indicate that, on the one hand, the perforin-dependent
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cytolysis is important for virus clearance and that, on the other hand, it is capable of 
mediating pathology (Harty et al., 2000).
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Fig. 1.5 Schematic representation of the two pathways of Tc-cell-mediated 
cytotoxicity. For the perforin/granzymes- and Fas-dependent pathways, the 
engagement of the specific TCR complex and the T activation are primary 
events. On the one hand, the perforin-dependent granule exocytosis pathway is 
initiated at the interface between effector T cell and target cell by the 
accumulation of cytoplasmic granules that contain perforin and granzymes.
This is followed by directed exocytosis of these granules upon the target cell. 
Compared with the granular compartment, the extracellular space has an 
elevated free Ca2+concentration, which induces a conformational change of the 
perforin molecules. This renders the perforin molecules amphipathic and 
enables them to insert into the target cell membrane so that it becomes 
permeable to water and small ions. Eventually, this permeabilization will, in 
combination with the effects of molecules such as granzymes that enter 
through the polyperforin pores into the target cell cytoplasm, lead to the death 
of the target cell. On the other hand, the Fas-dependent pathway is initiated by 
upregulation of Fas ligand expression on the T cell. Binding and cross-linking of 
the Fas ligand molecule, which is most probably present on the membrane in a 
trimeric form, with Fas molecules on the target cell leads to the induction of 
apoptosis. A death-inducing cytoplasmic domain on the Fas molecule triggers 
an apoptosis program. This program probably involves several interacting 
molecules, one of which may be interleukin converting enzyme (ICE) and/or a 
related protease. Modified from (Bustamante, 1986; Kagi et al., 1996; Chen and 
Cosgriff, 2000).
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1.7.1 The degranulation pathway of cytotoxicity
During the degranulation pathway of cytotoxicity, perforin and granzymes from 
the cytotoxic lymphocytes trigger apoptosis in the target cell. Perforin molecules 
dissolve and undergo a calcium-triggered conformational change, which allows them to 
insert into the lipid membranes of the target cell. There they aggregate and form pores 
that can let ions and macromolecules, including granzymes, pass (Henkart, 1994). 
Cytotoxic lymphocytes need to inflict more than membrane damage to kill their targets 
in vivo, due to the fact that many cells can repair membrane damage (Henkart, 1994). 
Efficient lysis by the granule exocytosis pathway requires the coordinated delivery of 
perforin and granzymes into the target cell (Harty et al., 2000). Granzymes (gzms) are 
serine proteases, the major protein components of the lytic granules found together with 
perforin in Tc and NK cells. Granzymes enter the target cell and trigger an ‘internal 
disintegration’ pathway, which in turn leads to damage to the target cell (mainly caused 
by DNA fragmentation) (Henkart, 1994). Four gzms in humans (A, B, H and K) and 
seven gzms in mice (A-G) have been described. Granzymes A and B can also act 
directly on critical death substrates when they bypass all of the ICE-like proteases 
(Pham and Ley, 1997). Mice that lack gzm A and gzm B are as incapable as perf-/- mice 
to control primary ectromelia infection. As well as perforin, gzms A and B are 
indispensable for the protection against natural viral pathogens (Mullbacher et ah, 
1999a). Granzyme-A deficient mice have an essentially normal Tc-cell function, 
probably because gzm A is only involved in late cytotoxicity, which induces apoptosis 
approximately 14 h after Tc-target-cell contact. In Tc cells, gzm B is the most 
abundantly expressed gene in the cluster. Gzm B is absolutely required by Tc cells and 
NK cells and is used for the rapid induction of DNA fragmentation, which induces 
apoptosis of allogenic target cells after 15 min of incubation (Henkart, 1994). Granzyme
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B activates the p34cdc2 kinase, which initiates the dissolution of the nuclear envelope 
and induces the cleavage of ICE family proteases (which are the effectors of apoptosis) 
(Henkart, 1994).
1.7.2 The Fas pathway of cytotoxicity
Fas (for fibroblast-associated) is a transmembrane receptor that belongs to the 
NGF/TNF receptor superfamily. In normal circumstances, the Fas system is 
constitutively expressed in the B, T and NK cells. Fas-receptor-mediated cell death 
(apoptosis) requires Fas receptor cell-surface expression at sufficient density, 
multimerization by a soluble or membrane-bound Fas ligand (FasL), and an apoptosis- 
sensitive cell in which anti-apoptotic programs have been switched off (Krammer et al., 
1994). Fas-mediated apoptosis is a mechanism of immunosuppression, which down- 
regulates the excess in the immune response to prevent the uncontrolled expansion of 
specific, antigen-reactive lymphocytes. The Fas system of death signaling is mainly an 
immunoregulatory, rather than a destructive, function of the cells that bear the antigens 
of intracellular microorganisms, and is responsible for about 25% of the total cytolysis 
(Henkart, 1994). Lymphocytes that escape this process may replenish the pool of cells 
that determine immunological memory (Krammer et al., 1994). Outside the immune 
system, Fas is expressed in several organs such as the liver, Sertoli cells and two 
immunologically-privileged tissues: the eye and the testis. The Fas pathway can be 
subdivided into three steps: 1) reception of the death signal, 2) transduction of the death 
signal, and 3) activation of the cell death machinery (Pham and Ley, 1997). The 
engagement of the cell death surface-receptor by FasL results in apoptotic cell death, 
mediated by caspase activation (Bird et al., 1998; Peter and Krammer, 1998;
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Tschopp et al., 1998; Waring and Mullbacher, 1999; Marti et al., 2000; Hetz et al.,
2002; Sugahara et al., 2002). Caspases are widely expressed in the cytoplasm of many 
normal cell types as inactive proenzymes, but these proenzymes become proteolytically 
processed and enzymatically activated during apoptotic death. Viruses have developed 
various strategies to block apoptosis of infected cells, and one of these strategies is the 
production of caspase inhibitors. The best-studied caspase inhibitors are Crm A and 
baculovirus p35. Upregulation of Fas receptor after DNA damage appears to be p35- 
dependent. Expression of these inhibitors by transfection in numerous cell types confers 
protection from multiple inducers of cell death in vitro. In vivo expression of caspase 
inhibitors in transgenic animals also confers resistance to apoptotic death (Waring and 
Mullbacher, 1999).
Two mutations in the Fas pathway cause complex disorders of the immune 
system, and manifest themselves as lymphoproliferation and autoimmunity. One is the 
Ipr (for lymphoproliferation) mutation, a recessive mutation of the Fas receptor gene, 
the other is the gld (for generalized lymphoproliferative disease) mutation of the FasL 
gene. Both mutations cause a very similar disease. In both cases there is unusual 
accumulation of T cells which express the Thy-1 antigen — an antigen that is 
characteristic of T cells that lack both the CD4 and CD8 surface molecules (‘double 
negative’ cells) (Falk et al., 1992). The inability of peripheral Ipr T cells to undergo 
TCR-induced FasR-mediated apoptosis may cause accumulation of aberrant T cells in 
the mutant mice, and may result in enlarged spleen and lymph nodes. Gld mice that 
express a non-functional FasL gene may generate similar symptoms through the same 
pathophysiologic mechanism (Krammeret al., 1994).
To prevent the possibility of redundancy of the two major pathways of 
cytotoxicity, mice that lack either the perforin or the Fas subset can be generated
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(Topham et al., 1997; Parra et al., 2000; Topham et al., 2001). When the Fas mechanism 
is absent, perforin is considered to be the main immunoregulatory mechanism. Thus, 
perf-/-xg/r/ double-deficient mice show acute autoimmunity because they lack 
immunoregulation and constantly develop highly activated neutrophils. Because of the 
presence of CD8+ T cells in the lymph nodes, spleen, pancreas, liver and kidneys of 
these mice, they suffer weight loss and ultimately death at an age between 4 and 16 
weeks (Spielman et al., 1998; Kagi et al., 1999). About one third of the double-deficient 
mice die when they are between 6 and 9 weeks old (Licon Luna, 2002), while the other 
two thirds of perf-/-xg/d mice can possibly be used to conduct experiments.
There are no known studies that relate the perforin-Fas mechanisms of cell- 
mediated cytotoxicity to the encephalitic flaviviruses. However, the rare CD4+ T-cell 
cytolytic function seems to be responsible for some of the pathology that occurs during 
dengue hemorrhagic fever (DHF) in humans (Kurane et al., 1989). CD4+ cytotoxic 
T clones may contribute to the immunopathology observed after secondary dengue virus 
infections through direct cytolysis and/or cytokine production (Gagnon et al., 1999). 
Clones from dengue virus capsid-protein specific CD4+-cytotoxic T lymphocytes are 
capable of mediating lysis of cognate, antigen-presenting target cells through a 
mechanism that primarily involves perforin, while lysis occurs through the Fas 
mechanism of cytotoxicity. CD4+ T-cell clones also produce IFN-y, TNF-a and TNF-ß 
(Gagnon et al., 1999). Studies of flavivirus infections in mice that are deficient in 
different combinations of the subsets of the granule exocytosis- or the Fas-mediated 
pathway of cytotoxicity will enable the in vivo examination of their respective 
contributions to virus control and pathogenesis of encephalitis.
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2.1 Mice
The Animal Breeding Facility of The John Curtin School of Medical Research 
(JCSMR) at The Australian National University (ANU) in Canberra supplied C57B1/6 
(H-2b) mice. Wild-type and mutant mice were obtained from the JCSMR Animal 
Breeding Facility and from external sources (Table 2.1). Animals were housed under 
controlled specific pathogen free (SPF) conditions that included testing of sentinels for a 
standard panel of pathogens. All experiments were conducted in accordance with the 
guidelines of the ANU Animal Ethics Committee.
2.1.1 Mutantstrains 
Beige mice
Beige mice are mutant C57B1/6 mice that lack natural killer (NK) cell activity 
(NK cells are lymphocytes that are non-T and non-B). Beige mice have normal numbers 
of NK cells, but these cells are not active (Roder and Duwe, 1979). On the other hand, 
the activity and the number of NK T cells in beige mice is normal (Bannai et al., 2000). 
Beige mice were purchased from the Animal Resources Centre (ARC), Western
Australia.
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Table 2.1 M utant m ouse strains (C57B I/6  background, H -2b 
for M VE-pathogenesis  studies
haplotype) used
M ouse strain M utation Im m un o d efic iency  in R eference
abeige Spontaneous mutation in 
the bg/bg gene
NK-cell cytotoxicity (Roder and Duwe, 
1979)
aRAG-1-/- Recombinase-activating B- and T-cell (Mombaerts et al.,
gene knockout maturation 1992)
bB2-M-/- ß2-microglobulin knockout CD8+ T cells (Koller et al., 1990)
öIFN-y-R-/- Gamma interferon- 
receptor knockout
IFN-y-receptor (Huang et al., 
1993)
öperf-/- Perforin gene knockout Degranulation 
pathway of cytotoxicity
(Kagi et al., 1994)
ögzmAxB-/- Granzyme A and B gene 
knockout
Degranulation 
pathway of cytotoxicity
(Simon et al., 1997)
bperfxgzmAxB-/- Combination of above two Degranulation 
pathway of cytotoxicity
(Mullbacher et al., 
1999a)
bgld Fas ligand point mutation Fas pathway of 
cytotoxicity
(Roths et al., 1984)
blpr Fas receptor point Fas pathway of (Samelson et al.,
mutation cytotoxicity 1986)
bper\-/-xgld Perforin and Fas ligand Degranulation and (Spielman et al.,
mutations Fas pathways of 
cytotoxicity
1998)
a ARCWA: Mice purchased from the Animal Resources Centre, Western Australia.
b JCSMR: Mice bred and kept under SPF conditions in the Animal Breeding Facility of The John 
Curtin School of Medical Research.
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Recombinase-activating gene-1 knockout mice
The recombination activating genes (RAG) are an essential component of the 
site-specific V(D)J recombinases (Mombaerts et al., 1992) that are required to produce 
immunoglobulins and TCR molecules. No mature B or T cells are produced in 
RAG-1-/- mice, but NK and macrophage cell numbers and function remain normal (Wu 
and Perlman, 1999). RAG-1-/- mice were purchased from the Animal Resources Centre 
(ARC) in Western Australia, and maintained under standard conditions (including 
autoclaved food, water, bedding and micro-isolator cages).
ß2-microglobulin knockout mice
Mice that are homozygous for a targeted disruption of the ß2-microglobulin 
(ß2-M-/-) gene, which is required for MHC class I antigen presentation (Koller et al., 
1990), were bred and maintained in the animal facilities of the JCSMR.
Interferon-gamma-receptor knockout mice
Mice that lack the IFN-gamma receptor (IFN-y-R-/-) have no overt anomalies, 
and their immune system appears to develop normally, however, IFN-gamma is 
necessary for a normal antigen-specific response (Huang et al., 1993) and plays an 
important role in protection after viral infection in many cases.
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Perforin knockout mice
Transgenic perforin-deficient (perf-/-) mice (Kagi et al., 1994) lack the major 
cytolytic molecule of the T-cell-mediated cytotoxic mechanisms. They were originally 
obtained from Dr M. Simon (Max Plank Institute, Freiburg, Germany) and used to 
establish a breeding colony at the animal facilities of the JCSMR.
Granzymes A and B knockout mice
Mice with a deficiency in both granzymes A and B (gzmAxB-/-) were generated 
by crossing gzmA-/- mice (Ebnet et al., 1995) with gzmB-/- mice (Heusel et al., 1994), 
and by subsequently intercrossing the heterozygous FI animals. Granzymes A and B 
have been implicated in Fas-independent nucleolytic and cytolytic processes that are 
exerted by cytotoxic T (Tc) cells (Simon et al., 1997).
Perforin, granzymes A and B knockout mice
The triple knockout perfxgzmAxB-/- mice are a result of the backcross of perf-/- 
mice with gzmAxB-/- mice and the subsequent intercrossing of the heterozygous FI 
animals (Mullbacher et al., 1999b). These mice were maintained at the JCSMR under 
SPF conditions.
Fas ligand mutant mice
Mice that bear an autosomal recessive mutation in the Fas ligand locus (gld) 
express a generalized lymphoproliferative disease that becomes apparent at
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approximately 12 weeks of age (Roths et al., 1984). GUI mice were originally obtained 
from the Centenary Institute, Sydney, Australia.
Fas-receptor mutant mice
Fas-receptor deficient mice that are homozygous for the Ipr 
(lymphoproliferation) mutant gene develop a disease that is characterized by massive 
lymphadenopathy. With increasing age, the lymphoid organs in these mice are replaced 
with a greatly expanded population of abnormal T lymphocytes (double negative 
CD4 CD8 B220+) (Samelson et al., 1986). These mice also suffer from autoimmune 
disease such as systemic lupus erythematosus by producing autoantibodies (Lake and 
Staines, 1988; Rathmell and Goodnow, 1994). Lpr mice were initially obtained from 
The Walter and Eliza Hall Institute (WEHI), Melbourne. I used both lpr and gld mice, 
most at an age of six weeks, when lymphoproliferative disease was minimal.
Perforin and Fas ligand mutant mice
Mice with a deficiency in perforin and Fas ligand (perf-/-xgld) cannot be 
established as a strain because females are infertile due to tissue destruction by 
monocyte, macrophage and CD8+ T cell infiltration in the uterus (Spielman et al.,
1998) . Moreover, females and males die between four and 12 weeks of age, due to 
severe mononuclear infiltration in the pancreas, liver, kidneys and spleen (Kagi et al.,
1999) . Thus, in order to obtain the double-deficient mice, breeders that are heterozygous 
for perforin (perf+/-) and homozygous for the Fas ligand (gld) mutation were crossed to 
generate the 25% of progeny that are homozygous for both perforin-/- and gld genes.
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Tail biopsies were taken for DNA genotyping by PCR. The mice that were homozygous 
for the perforin deficiency (perf-/-) were kept for experimentation.
2.1.2 Tail biopsies and DNA extraction
The personnel from the animal facilities provided tail biopsies (3-5 mm) from 
weanling offspring of perf+/-xgld mice. I added the tissues to Eppendorf tubes that 
contained 500 pi of digestion buffer (100 mM Tris-HCl, pH 8.0, 5 mM EDTA, 0.1% 
SDS, and 3.5 pi of 20 mg/ml proteinase K) (Boehringer-Mannheim, Indianapolis, IN). 
The digestion was performed in a rotating oven at 56°C overnight. I centrifuged 
samples at 8,000X g for 15 min at room temperature to pellet undigested material. After 
I collected the supernatant and added an equal volume of isopropanol, I centrifuged it at 
10,000X g for 15 min at room temperature to pellet genomic DNA. I washed the pellet 
once with 70% ethanol, and I dried the DNA samples in a Savant SpeedVac 
concentrator (model SVC-100H) for approximately 10 min. The DNA pellet was then 
resuspended in 200 pi of TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA).
2.1.3 Genetic analysis by Polymerase Chain Reaction (PCR) to identify
mice that are homozygous for the perforin mutation
Genomic DNA was subjected to amplification by PCR and analyzed for the 
perforin mutation, as described in Ebnet et al, (1995).
Perf-/-xg/c/ mice had to be obtained by crossing mice that are homozygous for 
the gld gene and and mice that are heterozygous for the perforin gene, to generate mice 
that are homozygous for both nonfunctional genes. Because the breeders I used were
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confirmed to be homozygous for the girl point mutation, I did not need to do further 
DNA testing for that mutation in the offspring.
For detection of the perforin mutations in the double-deficient mice, I amplified 
DNA by PCR, using the following primers: JT98 (sense direction) 5-CCA CTC CAC 
CTT GAC TTC AAA AAG GCG-3, JT272 (antisense direction) 5'-TGG GCA GCA 
GTC CTG GTT GGT GAC CTT-3'; and 01neo2A (antisense direction) 5’-CGG AGA 
ACC TGC GTG CAA TC-3’.
PCR amplifications were performed in reactions that contained 0.2 pM of the 
JT98 primer, 0.4 pM of JT272 primer and 0.2 pM of the 01Neo2A primer. I incubated a 
1 pi sample of genomic DNA with the primers and 2.2 units (U) of Taq DNA 
polymerase (Biotech) in a mixture of 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM 
MgC12, and 50 pM of each deoxynucleoside triphosphate. The reaction mixtures of 
25 pi were overlaid with 20 pi of mineral oil (Sigma). I carried out the PCR 
amplifications in an automated thermal cycler (Perkin-Elmer-Cetus, Emeryville, CA) by 
using one denaturation cycle at 94°C for 5 min, five amplification cycles at 94°C for 
30 sec, 56°C for 30 sec and 72°C for 2 min 30 sec, followed by 28 cycles at 94°C for 
30 sec, 56°C for 30 sec and 72°C for two minutes, one extension cycle at 72°C for five 
minutes, and then cooled the mixtures at 4°C.
PCR products were analyzed by electrophoresis in 2% agarose gels (Sigma). The 
sizes of the products obtained were 660 bp for the perf+/+ mice (product obtained by 
flanking primers JT272 and JT98) and 975 bp for the perf-/- mice (product obtained by 
flanking primers JT272 and 01Neo2A) (Fig. 2.1). Genomic DNA from mice that are 
heterozygous for the perforin gene (perf+/-) was amplified as double bands of the sizes 
above. I used a lambda DNA/EcoR\+Hind III size marker (Promega).
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2.2 Tissue culture
2.2.1 Tissue culture for virus titration
The cell line I used for virus titration was derived from African green monkey 
kidney (Vero). Vero cell cultures were maintained in Eagle’s minimal essential medium 
plus non-essential amino acids (EMEM; Gibco), 5% heat-inactivated fetal calf serum 
(FCS; CSL limited, Parkfield, Australia), 1 mM L-glutamine (Gibco) and antibiotics 
(PSN: 30 pg/ml penicillin G, 50 pg/ml streptomycin sulphate and 50 pg/ml neomycin 
sulphate, all from Sigma). Cells were kept at 37°C in a humidified atmosphere of 5% 
CO2 in air.
2.2.2 Tissue culture for virus propagation
C6/36 cells of Aedes cilbopictus mosquito (Igarashi, 1978) were cultured in 
60 x 15 mm tissue-culture dishes (Falcon). The cells were incubated in a humidified 
atmosphere of 5% CO2 at 28°C in EMEM medium, supplemented with 7% heat- 
inactivated FCS for growth and maintenance.
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Fig. 2.1 PCR screening for the perforin mutation. DNA for PCR was 
prepared from tail biopsies of the offspring from backcrossed perforin 
heterozygous -  gld homozygous mice, as described in Ebnet et al. (1995) 
The PCR product from the wild-type allele is 660 base pairs (bp) and the 
PCR product from the perforin mutation is 975 bp. The positions of ladder 
DNA size standards are shown on the left and are measured in bp. One 
heterozygous (+/-), shown as a double band, three wt (+/+), and one 
homozygous for the perforin knock out (-/-) are shown.
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2.2.3 Tissue culture for assays of cytotoxicity
Mouse B10A.2R cells (fibrosarcoma; H-2KkDb) (abbreviated as 2R) and 
B10A.5R cells (fibrosarcoma; H-2KbDd) (abbreviated as 5R) were maintained in 
EMEM, supplemented with 5% heat inactivated FCS at 37°C in a humidified 
atmosphere of 5% CO2 in air, and used as targets during cytotoxic assays. I infected 
cells with virus or left them uninfected, and then labeled them with slCr as described in 
Hill et al. (1992) and Kesson et al. (1988).
2.3 Viruses used and methods of preparation
2.3.1 Viruses
Working stocks of MVE (prototype strain MVE-1-51; French (1952) were 
prepared by either infecting suckling mice intracerebrally (ic) or by infecting a 
C6/36 cell culture. The MVE stock I used had previously been passed 15 times through 
suckling mouse brains, which did not reduce virulence in mice infections (Lobigs et al., 
1986).
Vaccinia (VV) recombinant viruses (VV-STR, VV-prM/E, VV-E, VV-NS, 
VV-NS1-NS3 and VV-TK ) have been described previously in Lobigs et al. (1994), and I used 
these viruses accordingly. Dr Mario Lobigs provided all the recombinant viruses.
2.3.2 Preparation of virus stocks from mouse brains
One- to two-day-old (newborn) Swiss mice were infected ic with approximately 
3 pi of virus (10s PFU/ml). Brains were collected when the mice started to show signs 
of disease (lack of weight gain, slow motion) at 2-3 days post-infection (pi). I added
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nine volumes of vims diluent (VD, consisting of Hanks’ balanced salt solution [HBSS], 
supplemented with 0.2% of bovine serum albumin [BSA] and 20 mM of Hepes buffer, 
pH 8.0) and homogenized the brains with a 15-ml glass homogenizer and a tight fitting 
plunger. Suckling mouse brain homogenates were clarified by centrifuging for five 
minutes at 4°C at 18,000X g on a high-speed bench-top centrifuge (Heraeus Biofuge 28 
SR).
2.3.3 Preparation of virus stocks from mosquito cell culture
Tissue-culture-grown virus stock was prepared by infecting monolayers of 
C6/36 cells at a multiplicity of infection (MOI) of 0.5. Medium was replaced at day 3 pi 
to avoid nutrient exhaustion. Once approximately 70% of the cells showed cytopathic 
effect (CPE), the supernatant was harvested, and 400 pi of 1 M Hepes (pH 8.0) was 
added to every 20 ml of supernatant. To separate the cells and debris from the virus- 
containing fluid, the mixture was centrifuged (10,000X g) at 4°C. Vims stocks were 
frozen in 0.5 ml aliquots at -70°C until they were used (vims stocks were thawed once 
only). Titration was done by plaque assay in Vero cells as described in section 2.6.
2.4 Parenteral injections
Virus aliquots were removed from -70°C as required, thawed rapidly in a 37°C 
water-bath and diluted in VD. I carried out the inoculations with specified vims 
dilutions that were kept in an ice bath.
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2.4.1 Intravenous injections
Mice were inoculated with 0.1 ml of virus intravenously (iv) by the tail vein 
route, using a 26-G needle and a 1-ml tuberculin syringe.
2.4.2 Intraperitoneal injections
For cytotoxic assays or antibody, respectively and in vivo NK-cell depletion 
studies, I inoculated mice intraperitoneally (ip) with virus using a 26-G needle and a 
1-ml tuberculin syringe.
2.4.3 Intracranial injections
Intracranial (ic) inoculations with a 30-G needle and a 1-ml tuberculin syringe 
were carried out under light ether (Sigma) anesthesia in adult mice for mortality studies 
and in newborn mice for preparation of virus stocks. For mortality studies, mice 
received a volume of 30 pi ic.
2.5 Tissue collection
At indicated times after inoculation, I anesthetized mice with ether and killed 
them by cervical dislocation. With the mice lying on their dorsal surface, I opened the 
thorax and collected the blood from the heart. I transferred the blood to an Eppendorf 
tube to separate the serum from the blood cells by centrifugation (18,000X g for five 
minutes at 4°C), and stored it at -70°C. Next, I opened the peritoneal cavity and
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aseptically collected spleen, kidneys, lymph nodes (mesenteric and inguinal) and liver. I 
then dissected muscle of the hind limb (rectus femoris) and, finally, removed the brain. I 
divided tissues in three aliquots: one for plaque assay, another for RNA extraction and a 
third, fixed in 10% neutral buffered formalin, for histology studies. The tissues that 
were collected for plaque assay and RNA extraction were snap frozen in dry ice or 
liquid nitrogen and stored at -70°C. I obtained blood samples from live mice by 
paraorbital or tail bleeding and separated serum from blood cells by centrifugation at 
18,000X g at room temperature for five minutes. I then stored it at -20°C until it was 
used for analysis in ELISA.
2.6 Determination of MVE titers in virus stocks and tissues
2.6.1 Tissue processing
Organs were weighed and homogenized for plaque assay in VD to obtain a 10% 
(w/v) suspension. Homogenization was achieved by passing the tissues (muscle, spleen 
and lymph nodes) through a metal strainer or, in the case of soft tissues (brain and 
liver), through gradually smaller sized needles (from 18 to 25 G). I centrifuged the 
homogenates (at 18,000X g for five minutes at 4°C) to remove cell debris. Aliquots 
were taken from the supernatants and stored at -70°C. I titrated tissues for content of 
virus by plaque assay in Vero cells.
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2.6.2 Plaque assay for MVE-stock titration and determination of virus
titers in tissues
Vero cells in 6-well plates (Linbro) were grown to 70% confluence. I removed 
approximately three fourths of the culture medium and infected the cells (in duplicate 
wells) with 0.1 ml of tissue homogenate that was serially diluted in VD on ice. 
Adsorption was allowed for one hour, while the samples were rocked every 15 min. I 
did not remove the inoculum prior to adding the overlay (4 ml/well), which consisted of 
1% agar (Bacto), EMEM, 2% FCS, antibiotics (PSN as in section 2.2) and 0.25 pg/ml 
of fungizone (Life Technologies, Rockville, Maryland, USA). Ninety-six hours later, I 
added neutral red (BDH Chemicals, Poole, England) in Hanks’ (0.03% w/v) for 
staining. The day after, I removed the stain and the overlay and counted the plaques. 
Virus titers were expressed as the number of plaque forming units (PFU) per gram 
(PFU/g) of tissue, or per milliliter (PFU/ml) of serum. The limit of detection was set at 
103 PFU/g of wet tissue or at 102 PFU/ml of serum.
2.7 Reverse transcription/PCR for detection of MVE RNA
2.7.1 Preparation of total RNA from tissue samples
Total RNA was prepared from different tissues of infected mice using a 
procedure that was modified from Promega (Technical bulletin 087). Initially, I 
homogenized the frozen tissue samples in 10% w/v PBS, but this process frequently 
caused RNA degradation in hematopoietic organs (spleen and lymph nodes). To reduce 
the risk of RNA degradation, I then employed a second extraction method. For this 
method, I added a small portion of tissue (approx. 3 mm ) directly to 0.5 ml of 
guanidine thiocyanate (Promega) for five minutes on ice, and subsequently
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homogenized the tissue samples with a syringe by passing it through needles of 
gradually smaller size (18 to 25 G). I then added 50 pi of 2 M sodium acetate (pH 4.0) 
and vortexed the samples. After adding an equal volume of acid-equilibrated 
phcnolxhloroform (5:1; Sigma), I vortexed the samples for one minute, held them at 
4°C for 15 min, and then centrifuged them at 18,000X g for 20 min at 4°C. I transferred 
the upper aqueous phase to a tube that contained an equal volume of isopropanol, mixed 
it, and it held at -20°C for 20-30 min. Subsequently, I pelleted the RNA by centrifuging 
it at 18,000X g for 15 min at 4°C. 1 removed the supernatant and washed the pellet 
twice with 1 ml of 75% ethanol. The RNA samples were dried in a Savant SpeedVac 
concentrator (model SVC-100H) and were resuspended in 20 pi of nuclease-free water 
(Sigma), before being stored at -70°C.
2.7.2 Agarose gel electrophoresis of total RNA samples
Total RNA (1 pi) that was obtained from tissues of MVE-infected mice was 
mixed with 5X loading buffer (20% ficoll 400, 25 mM EDTA pH 8.0, 2.5% SDS,
0.05% bromophenol blue, 0.03% xylene cyanol) and was electrophoresed in 1% agarose 
gels which contained IX TBE, 0.1% SDS and 1 pg/pl ethidium bromide (Sigma). I 
observed two bands, corresponding to the 26S and 18S ribosomal RNA. Degradation of 
RNA was indicated by a smear. Viral RNA was not visible in these samples, but the 
clarity of the ribosomal bands gave an indication of the quality of the preparation. I used 
a lambda DNA/EcoRI+Z/md III size marker (Promega).
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2.7.3 Preparation of a positive control for detection of MVE RNA
The MVE RNA positive control, a T7 RNA polymerase transcript, was 
produced from a cDNA clone of M V E -1-51 (the prototype virus) that encompassed 
nucleotide 1 to 5010 of the MVE genome, with an internal deletion between nucleotides 
1450 and 2050 (Hurrelbrink et al., 1999). The reverse transcription/PCR amplification 
of the RNA positive control was 616 bp long, while the product obtained from MVE 
was 717 bp long. The different sizes of the PCR products reduced the risk of a false­
positive interpretation. The MVE RNA was generated using T7 RNA polymerase in a 
reaction that contained transcription buffer (Promega), 1 mM of rNTP, DTT (10 mM), 
RNase inhibitor (1 U/pl; RNA guard, Pharmacia), T7 RNA polymerase (0.5 U/pl; 
Promega) and nuclease-free water (Sigma), in a final volume of 20 pi. I incubated the 
reaction for one hour at 37°C.
For purification, I treated the sample with one U of DNase 1-RNase free 
(Pharmacia, FPLC pure) at 37°C for 15 min. I then inactivated the DNase by incubating 
it at 70°C for 15 min. I extracted RNA twice with equal volumes of phenol and 
chloroform (1:1) that was precipitated by adding one-tenth volume of 3 M sodium 
acetate (pH 5.6) and 2.5 volumes of ethanol. I collected RNA pellets by centrifuging the 
mixture at 18,000X g, washing it once in 70% ethanol, drying it and resuspending it in 
20 jil of nuclease-free water. I then loaded the undiluted samples and the dilutions of 
1:5, 1:25 and 1:2 in a 1% agarose gel (Sigma). Given that a minimal amount of 
approximately 10 ng of RNA can be visually detected in an agarose gel, the 
concentration of the product can be roughly estimated. I diluted the RNA to a final 
concentration of 10 ng/pl (6.02x10“ molecules per mole resuspended at 10 copies/pl) 
and stored aliquots of 2 pi at -70°C.
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2.7.4 Oligonucleotide primer preparation
The JCSMR Biomolecular Resource Facility made the oligonucleotide primers 
and supplied them in ammonium hydroxide. I transferred aliquots of the oligonucleotide 
primer (100 pi) to Eppendorf tubes and added 10 volumes of n-butan-l-ol to each tube.
I vortexed the samples and then centrifuged them at room temperature at 18,000X g for 
two to three minutes in an Eppendorf microfuge (model 5415C). All the top (organic) 
phase was carefully aspirated and the aqueous bottom phase, which contained the 
oligonucleotide, was dried for 10 min in a Savant SpeedVac concentrator (model 
SVC-100H). I resuspended the pellet in 100 pi nuclease-free water.
2.7.5 RT/PCR
An RNA sample (1 pi) was transcribed by combining 2.6 U of expand-reverse 
transcriptase (Boehringer-Mannheim), 25 pM of random hexamer primers (Promega), 
0.8 mM dNTP mix in a IX reverse transcriptase buffer (Boehringer-Mannheim), and 
10 mM DTT (Promega), in a total reaction volume of 10 pi. I incubated the reactions 
for 10 min at room temperature, and subsequently for 30 min at 42°C. The cDNA that 
was generated from the reactions was stored at -20°C.
The cDNA was then amplified with two MVE-specific oligonucleotide primers: 
the sense-direction 23mer primer 5’ ACG AAA CAC TTT CTA GTG CAT CG 
(nucleotides 1547 to 1612 in the MVE genome) and the antisense-direction 23mer 
primer 5’ GGA GGA GCA TTT AGA ACC CCT CC. These primers amplify cDNA 
that corresponds to the positions 1615 and 2332 in the MVE genome (Dalgamo et al., 
1986), with respect to the 5’ terminus in the MVE genome. The product obtained was 
717 bp long. Two pi of cDNA template were added to a PCR amplification mix that
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combined 0.5 pM of each primer, 0.2 mM of dNTPs, IX reaction buffer and 1 U Taq 
DNA polymerase (Advance Biotechnologies) in a total reaction volume of 25 pi, using 
a PCR thermocycler (Perkin Elmer GeneAmp PCR system 2400). The negative control 
contained water instead of cDNA. Thermal cycling consisted of a denaturation cycle at 
94°C for 2 min, 35 amplification cycles at 94°C for 1 min, 51°C for 1 min, and 70°C for 
40 sec, followed by one cycle at 68°C for 7 min.
RT-PCR products were analyzed by agarose gel electrophoresis. For this 
procedure, I dissolved molecular biology grade agarose (Promega) (1% w/v) in TBE 
buffer with ethidium bromide (1 pg/pl) though boiling it; mixed a PCR sample of 10 pi 
with 5X loading buffer; and used a Bio-Rad tank for electrophoresis. I used a lambda 
DNA/£c<9RI+//md III marker (Promega).
The quality of the RNA samples was assessed by RT-PCR using a pair of 
ß-actin mRNA specific primers (Clonotech), 5’-GTG GGC CGC TCT AGG CAC 
CAA-3' (sense direction) and 5’-CTC TTT GAT GTC ACG CAC GAT TTC-3’ (anti- 
sense direction). This produced a product of 540 bp. The PCR mix and electrophoresis 
conditions were the same as for the above reaction. I added water to the negative 
control. I used a DNA size marker with a low molecular weight (DNA molecular weight 
marker VI; Boehringer-Mannheim). The cycling temperatures were as follows: 94°C for 
2 min; 30 cycles at 94°C for 45 sec; 60°C for 45 sec; 73°C for 1 min; 72°C for seven 
minutes and a soak cycle at 8°C.
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2.8 Detection of total MVE-specific antibody (Ab) by enzyme- 
linked immunoabsorbent assay (ELISA)
2.8.1 Production of ELISA antigen
The MVE antigen (Ag) was produced as described in Colombage et al. (1998).
' I  o
Vero cell monolayer cultures were grown in 850 cm' roller bottles (~10 cells) that were 
infected with MVE (moi~10) at 37°C. I over-layered cells with EMEM, which 
contained 5% fetal calf serum (FCS), and incubated them at 37°C while rolling the 
bottles continuously. At 24 hours post-infection, I replaced the medium with 50 ml of 
EMEM, which contained 2% FCS and 20 mM of Hepes buffer (pH 8.0). At 48 hours pi, 
I harvested the culture fluid, replaced the medium with the same mixture as above, and 
subsequently conducted a second harvest at about 60 h pi. Cell debris was removed by 
centrifugation at 18,000X g for 10 min at 4°C in a Sorval centrifuge. I concentrated the 
virus in several steps. I firstly added 40% w/v polyethylene glycol 8,000 (Sigma) in 
NTE buffer (0.12 M Na2Cl, 0.012 M Tris-HCl, 0.001 M Na2 EDTA; pH 8.0) to a final 
concentration of 8%; it was then stirred for two hours at 4°C. I then recovered virus by 
centrifuging the mixture at 18,000X g for 30 min at 4°C. Subsequently, I drained the 
pellets and dissolved them in 4 ml borate saline (0.05 M borate, 0.12 M Na2Cl; pH 9.0), 
to make a 50-fold concentration. I added NTE buffer to the suspension until it totaled 
10 ml, layered it on 2 ml of sucrose cushion (30%) and centrifuged for 3 h in a SW41 
rotor at 35,000 rpm at 4°C in a Beckman ultracentrifuge. I then drained, resuspended, 
aliquoted and stored the pellets at -20°C.
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2.8.2 Plate coating with MVE Ag
U-bottom 96-well assay plates (Titertek) were coated with 50 pi of MVE 
antigen that was diluted to 1/1000 in borate saline (pH 9.0). The plates were then 
incubated overnight at 4°C. I flicked the virus in to bleach and washed the plates once 
with PBS-Tween (0.05%). The plates were then ready to be used immediately or were 
stored for a maximum of one month at -20°C.
2.8.3 Ab titration by ELISA
The 2.2'-azino-di[3-ethyl-benzthiazoline sulphonate] (ABTS) microwell 
peroxidase substrate system (Kirkegaard & Perry Laboratories, Gaithersburg, Maryland, 
USA) was used according to the manufacturer’s instructions, with minor modifications. 
Samples and controls that were initially diluted to 1:100 were further serially diluted by 
two until 1:102,400 (10 times more) in 1% BSA-PBS-Tween (Sigma). They were then 
incubated at room temperature for two hours. I washed the plates four times with wash 
buffer (0.05% PBS-Tween) and blot-dried them. I detected mouse antibodies using 
affinity-purified goat anti-mouse immunoglobulin, conjugated with horseradish 
peroxidase (50 pl/well) that was diluted to 1:1000 in 1% BSA-PBS-Tween. The plates 
were incubated at room temperature for one hour and then washed (as described above). 
I added freshly prepared ABTS substrate solution (50 pl/well) to the plates and 
incubated them at room temperature until color developed (approx. 20 min). I stopped 
the color reaction with 1% SDS and read the color immediately, using a Molecular 
Dynamics microplate reader at 405 nm.
The specific activity of each test serum was established as the cut-off values of 
the mean optical density (OD) of eight negative control wells containing sera from
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naive mice plus 3 standard deviations. The OD values of the tested sera were considered 
positive if they were equal or greater than the OD cut-off values and end points were 
calculated as the reciprocal value of the last dilution that gave a positive OD value.
2.9 Histology
Formalin-fixed tissues were taken to the Histology Unit of the JCSMR for 
routine paraffin-embedding, cutting, mounting on slides and staining with Hematoxylin- 
Eosin. I sent slides to the Max-Plank Institute, Freiburg, Germany, to be interpreted by 
Mr Thomas Steele.
2.10 Passive transfer of immune B and T cells
2.10.1 Generation of anti-MVE effectors
C57B1/6 wt donor mice (12) were infected iv with lxlO2 PFU of MVE. I then 
aseptically collected groups of four spleens at day 6 pi in 50-ml tubes, that contained 
20 ml of EMEM medium at room temperature. Subsequently, I made a single-cell 
suspension by gently pressing the spleens through a stainless steel mesh with syringe 
plungers. I depleted erythrocytes by hypotonic-shock treatment (I added 4.5 ml of 
distilled water to cell pellets for 30-45 s) and added 0.5 ml of 10X HBSS to bring the 
solution back to isotonicity. I then centrifuged the splenocytes at 200X g for five 
minutes at room temperature, washed the pellets twice with EMEM and resuspended 
them in 2 ml of EMEM containing 5% FCS, supplemented with 10 mM of Hepes pH 8.
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2.10.2 Nylon wool cell separation
Ten-ml nylon-column syringes were prepared by loosely packing 0.6 g of 
sterilized and scrubbed nylon wool (Robbins Scientific). I then affixed a three-way 
plastic stopcock (Beckton Dickinson) and added EMEM 5% FCS until the wool was 
covered. I incubated the columns at 37°C overnight. Subsequently, I took the warmed 
columns from the incubator and let the top portion of the medium/5% heat inactivated- 
FCS run off. I then added the cell suspension to the columns, allowed it to enter the 
nylon wool bed, and stopped it just before the fluid with cells could escape. The 
columns were then topped with more warm medium EMEM 5% FCS, and incubated at 
37°C for two hours.
Preparation of the T-cell enriched fraction
The columns were carefully removed from the incubator. I attached an 18 G 
needle to the cock to control the flow of the medium through the syringe. To recover the 
T lymphocytes, 10-20 ml of warm medium/5 % heat inactivated-FCS was allowed to 
slowly drip (~10 min) through the syringe that was held vertically into the tube. I 
recovered the effluent containing the T cells (non-adherent to the nylon-wool) from 
each syringe, pooled it, and centrifuged it at 200X g for five minutes at room 
temperature. I then resuspended the enriched cells in medium that was supplemented 
with 0.2% BSA at 2 x 108 cell/ml.
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Preparation of the B-cell enriched fraction
To recover the adherent B cells, I used cold medium (10°C) without FCS (FCS 
enhances the adherence of the B cells to the nylon) for elution. While I added medium, I 
detached cells by poking the nylon with a pipette and then collected the effluent, pooled 
it and centrifuged it at 200X g for five minutes at room temperature. I then resuspended 
the cells as described above.
2.10.3 Flow cytometry
To assess the phenotype(s) of the transferred splenocytes, I stained samples of 
106 cells with anti-mouse fluorescent antibodies (Pharmingen, San Diego, CA, USA). I 
labeled the cells with rat anti-mouse CD8a (Ly-2) (R-phycoerythrin [R-PE] PBS diluted 
1/100) monoclonal Ab, rat anti-mouse CD4 (L3T4) (fluorescein isothiocyanate [FITC] 
PBS diluted 1/50) monoclonal Ab, rat anti-mouse B (CD45R/B220) [R-PE] PBS diluted 
1/100) monoclonal Ab, and mouse anti-NK cells/2B4 (PE, PBS diluted 1/6) monoclonal 
antibodies. I added 20 pi of the labeling monoclonal Ab (diluted according to the 
manufacturer’s instructions) to each tube of cells and incubated the tubes for 20 min at 
4°C. I centrifuged the tubes at 200X g for five minutes, and subsequently washed them 
twice with 1 ml of PBS. I then resuspended the cells in 200 pi of PBS. I did the analysis 
of the surface fluorescence of cells on a FACScan flow cytometer (Beckton Dickinson, 
Franklin Lakes, NJ, USA).
2.10.4 Adoptive transfer of anti-MVE effectors
Nylon-wool-purified anti-MVE effector B or T cells were injected iv in six mice
7 2that received 4x1 0  cells in a volume of 0.2 ml, after they had received 10“ PFU iv of
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MVE three days previously. Controls were: 1) six uninfected mice that received anti- 
MVE T or B cells; and 2) six non-transferred mice that were infected with 10" PFU iv 
three days previously. I recorded mortality for each group.
The risk of virus carry-over in the transferred nylon-wool-purified B and T cells 
from infected mice was tested by plaque assay. In all cases the cells from the infected 
donors were found to be free of any detectable virus.
2.11 Assays of cytotoxicity
Secondary in vitro, MVE- and VV-immune Tc cells were generated according to 
the methods described in other research papers (Kesson et al., 1988; Mullbacher et al., 
1991; Hill et al., 1992; Regner et al., 2001).
2.11.1 Generation of effector cells
Spleens from MVE- or VV-primed mice (ip injection with 5 x 106 PFU) were 
harvested 10 days pi. By gently pressing the spleens through stainless steel mesh with 
syringe plungers, I obtained single-cell suspensions of the spleens. I then washed the 
cells twice in EMEM, supplemented with 10 mM Hepes. Subsequently, I washed the 
cells twice with EMEM, supplemented with 5% FCS, 2 mM L-glutamine, 10 mM 
Hepes, 0.2% NaHC03 and antibiotics (PSN).
To restimulate these cells with virus, I infected one fifth of the spleen cell 
suspensions for one hour with 5 PFU/cell of MVE or with 0.5 PFU/cell of VV-TK, 
washed these suspensions three times with EMEM/5% FCS, and cultured them with the
Chapter 2: Materials and Methods 86
rest of the splenocytes for five days in EMEM, supplemented with 10% FCS and 
10 4 2M-mercaptoethanol (culture medium).
2.11.2 51Cr-release cytotoxicity assay
The 2R and 5R target cells (2 x 106) were infected with MVE at an MOI of 
50 PFU/cell 24 h prior to being slCr-labeled for one hour. Another batch of 2R and 5R 
cells was infected with VV at an MOI of 10 for one hour, in presence of 51Cr. I washed 
the target cells three times with culture medium and co-cultured them with titrated 
numbers of effector Tc cells for six hours. I performed all assays in triplicate in 96-well 
plates; the SEM was never greater than 5% and medium release was never greater than 
22%. I infected target cells for mapping experiments with VV recombinants encoding 
MVE polyprotein fragments (VV-STR, VV-PrM-E, VV-pr-M, VV-E, VV-NS, or 
VV-NS1-NS3) as described in Hill et al. (1992) and Lobigs et al. (1994).
2.12 Statistical analyses
The mortality ratios after virus challenge were assessed using Fisher's exact test. 
Data in this thesis are expressed as means ± standard error of the mean (SEM). I used 
the student’s t-test to determine the significance of the differences between the 
experimental and the control groups, and I used the Mann-Whitney test to determine the 
significance of the differences in time to death.
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3.1 Summary
In this chapter, the sensitivity of virus detection by reverse 
transcription/polymerase chain reaction (RT/PCR) is compared with the sensitivity of 
virus detection by plaque assay (PA), using tissues from MVE-infected mice. The 
results show that the RT/PCR and PA methods are equally sensitive to detect virus in 
most of the tissue samples that were tested. I selected PA as the preferred method for 
my subsequent studies because it is a simple and quantitative method for the detection 
of infectious viruses.
3.2 Introduction
Flaviviruses are defined as primarily neurotropic in mice. Some researchers 
(Murphy et al., 1968; Hase et ah, 1990; McMinn et al., 1996; Andrews et al., 1999) 
consider that tissues other than the CNS are refractory to flavivirus replication, while 
other researchers (MacDonald, 1952; Huang, 1963; Monath, 1996) have shown that 
virus grows in extraneural organs, albeit at low levels.
Several techniques have been developed to detect encephalitic flavivirus 
infections: by detection of specific Abs, or by detection of viral particles via RT/PCR, 
quantitative real-time PCR (TaqMan) and PA. In humans, because of the short viremic 
phase, flaviviruses are most commonly diagnosed by detection of IgM in serum or 
cerebrospinal fluid (CSF) (Pinto et al., 1988; Harrington et ah, 2003; Hiatt et ah, 2003); 
however, the assay cannot differentiate between WNV, SLE, JEV and other members of 
the JEV serocomplex (Lanciotti et ah, 2000). The RT/PCR assay on the other hand has 
been used for diagnosis of JEV (Meiyu et ah, 1997), MVE (McMinn et ah, 2000) and
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WNV (Porter et al., 1993; Huang et al., 2002; Harrington et al., 2003). The RT/PCR 
technique is particularly important as it can provide a rapid and specific detection.
TaqMan RT/PCR has been recently developed and is also available for specific 
and rapid diagnosis of viruses (Mackay et al., 2002). TaqMan RT/PCR uses fluorescent 
DNA probes in a 5’ exonuclease assay, which has been used for testing brains of 
autopsied humans (Lanciotti et al., 2000), serum (Bae et al., 2003; Harrington et al., 
2003; Hiatt et al., 2003) and mosquito pools (Ritchie et al., 2003). TaqMan RT/PCR 
offers the advantage over traditional RT/PCR of increased sensitivity, increased 
reproducibility and better quantitation (Morris et al., 1996; Martell et al., 1999). In 
general, RT/PCR assays are considered to be rapid and sensitive, although they require 
several steps that can increase the risk of inter-tube contamination and are difficult if 
quantitative results are required (Wang et al., 2000). Additionally, whilst RT/PCR 
assays can detect virus-specific nucleic acids, they do not provide information about the 
infectious capability of the virion. On the other hand, the conventional method of virus 
titration by PA does provide quantitative assay of infective virus (important during 
vaccine production and control), but it is time consuming and laborious (Wang et al., 
2000; Bae et al., 2003).
The fact that encephalitic flaviviruses in peripheral organs are either 
undetectable or at the threshold of the detection limit could, when using standard 
methods of virus detection such as RT/PCR or PA, be due to two factors: 1) the 
limitation of the method used, and 2) the poor virus growth in extraneural organs. It was 
important to this project to investigate if the failure to detect virus in the peripheral 
tissues was due to the release of virus inactivating factors, e.g. proteases and RNAses, 
during tissue processing and not just due to poor virus replication in those tissues. Thus, 
I undertook a comparison of the two different methods of virus detection, RT/PCR for
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the detection of viral RNA, and PA for the detection of infective virions, and tested 
them on aliquots of the same tissue samples obtained from infected adult mice. I 
evaluated advantages and disadvantages of the RT/PCR and PA approaches in order to 
select the best method to investigate the kinetics of MVE replication in mouse tissues.
3.3 Results
3.3.1 Comparison of the RT/PCR and PA methods for virus detection
To determine which technique was more suitable for virus detection in particular 
types of tissues, the RT/PCR method was compared to the PA method. I obtained 
samples of brain, spleen, lymph nodes and muscle from MVE-infected mice that 
showed either low virus titers by PA or faint DNA bands by PCR and tested the same 
samples using both techniques. Six samples from each organ are shown in Figs 3.1 to 
3.4. I used aliquots of each tissue sample to: 1) prepare RNA for RT/PCR, and 2) 
produce a 10% w/v homogenate, which is required for serial dilutions during plaque 
assay.
Initially, I took aliquots from homogenized tissues in PBS and used these for 
RNA extraction and for plaque assay. However, I observed that tissue homogenization 
resulted in significant RNA degradation, particularly in lymph nodes and spleen.
' j
Therefore, I reduced the extent of RNA degradation by adding approximately 3 mm of 
frozen tissue (kept on dry ice) directly into the ice-cold guanadinium thiocyanate (the 
first step for RNA extraction). After an incubation period of 15 min on ice, the tissue 
was homogenized by passing it through gradually smaller needles (18 to 25 G). I 
homogenized the tissues for PA in ice-cold HBSS-BSA (pH 8.0) to reduce the loss of 
vims infectivity. The quality of RNA was not compromised to an extent that prevented
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amplification, since the B-actin control PCR was positive for all the samples and the 
same samples that were positive by PA were also positive by RT/PCR (Figs 3.1 to 
3.4 B). This indicates that these primers were of adequate quality for effective RT/PCR.
RT/PCR was performed on total RNA extracts of tissue samples using a pair of 
E protein gene-specific primers. The cDNA product from RT/PCR was 717 bp in size.
In assays performed on a positive control-RNA (cloned MVE cDNA and 
T7 polymerase-mediated transcription that gives rise to a 616 bp cDNA product due to 
nucleotide deletion), the threshold for RT/PCR amplification under the conditions used 
was 10“ copies of target-RNA.
For the infectivity-based approach, I assayed the different dilutions of tissue 
homogenates for plaque formation, as described in section 2.6.1 then compared virus 
titers from each tissue with the intensity of the PCR bands.
The comparison of the results of the RT/PCR and PA methods for brain tissue 
showed that the three samples that were positive using the PA method had MVE titers 
that were marginally above the detection limit of 103 PFU/g, while the equivalent 
samples, investigated with the RT/PCR method, showed clearly positive results 
(Fig. 3.1). Additionally, there was a direct correlation between the values of the virus 
titers and the intensity of the bands in the PCR results of the brain samples. The sample 
that had the highest titer by plaque assay (1.5 x 104 PFU) also produced the greatest 
yield of cDNA in RT/PCR (Fig. 3.1, sample 3).
The comparison of the results of the RT/PCR and PA methods for infected spleen is 
shown in Fig. 3.2.1 obtained positive results by both methods for samples 1, 2, 3 and 5, 
despite some degradation to the RNA extracts (smeary appearance in agarose gel 
electrophoresis; data not shown).
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The results of RT/PCR amplification and virus titration by plaque assay for lymph 
node samples are shown in Fig. 3.3. I obtained positive results for samples 1 and 3 by 
RT/PCR but not by PA, although the cDNA products of PCR bands were barely 
detectable. There was a direct correlation between the results of RT/PCR and PA for 
samples 2 and 4 (negative) and sample 5 (positive), the latter showing a titer of 
103 PFU/g and a clear band in the RT/PCR result.
In general, I obtained few MVE-positive muscle samples by RT/PCR or plaque 
assay. Six samples are shown in Fig. 3.4. Only sample 3 produced a clearly positive 
result by both RT/PCR and by PA with a titer of 1.3 x 103 PFU.
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Fig. 3.1 A comparison of the results of RT/PCR and PA of brain samples 
taken from mice that were infected iv with 102 PFU of MVE
Brain samples (1-6), controls (a-c) and DNA molecular weight marker (M).
A, MVE-specific RT/PCR. Controls: a, reagents control (water); b, PCR amplification of 
105 RNA copies; c, PCR amplification of 102 RNA copies. Products of 717 bp from infected 
tissues and 616 bp from the positive control were amplified by MVE-specific RT/PCR.
B, B-actin specific RT/PCR (540 bp). Controls: a, reagents control (water); b, positive 
control; c, blank.
C, virus titers obtained from infection of Vero cell monolayers, in PFU/g of wet tissue.
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Fig. 3.2 A comparison of the results of RT/PCR and PA of spleens taken from 
mice that were infected iv with 102 PFU of MVE
Spleen samples (1-6), controls (a-c) and DNA molecular weight marker (M).
A, MVE-specific RT/PCR. Controls: a, reagents control (water); b, PCR amplification of 105 
RNA copies; c, PCR amplification of 102 RNA copies. Products of 717 bp from infected 
tissues and 616 bp from the positive control were amplified by MVE-specific RT/PCR.
B, B-actin specific RT/PCR (540 bp). Controls: a, reagents control (water); b, positive 
control; c, blank.
C, virus titers obtained from infection of Vero cell monolayers, in PFU/g of wet tissue.
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Fig. 3.3 A comparison of the results ot RT/PCR and PA ot lymph nodes taken 
from mice that were infected iv with 102 PFU of MVE were infected iv with 102 PFU 
of MVE
Lymph node samples (1-6), controls (a-c) and DNA molecular weight marker (M).
A, MVE-specific RT/PCR. Controls: a, reagents control (water); b, PCR amplification of 105 
RNA copies; c, PCR amplification of 102 RNA copies. Products of 717 bp from infected 
tissues and 616 bp from the positive control were amplified by MVE-specific RT/PCR.
B, B-actin specific RT/PCR (540 bp). Controls: a, reagents control (water); b, positive 
control; c, blank.
C, virus titers obtained from infection of Vero cell monolayers, in PFU/g of wet tissue.
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Fig. 3.4 A comparison of the results of RT/PCR and PA of muscle from mice 
that were infected iv with 102 PFU of MVE
Muscle samples (1-6), controls (a-c) and DNA molecular weight marker (M).
A, MVE-specific RT/PCR. Controls: a, reagents control (water); b, PCR amplification of 105 
RNA copies; c, PCR amplification of 102 RNA copies. Products of 717 bp from infected 
tissues and 616 bp from the positive control were amplified by MVE-specific RT/PCR.
B, B-actin specific RT/PCR (540 bp). Controls: a, reagents control (water); b, positive 
control; c, blank.
C, virus titers obtained from infection of Vero cell monolayers, in PFU/g of wet tissue.
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3.3.2 Effect of tissue homogenization on virus infectivity detection
To examine the effect of homogenization of brain, spleen, muscle and liver 
tissues of uninfected mice on the detection of virus infectivity during plaque titration, 
several assays were performed. Given the low virus titers detected in most tissues 
(except in brain), it was important to determine if the difficulty in detecting virus in 
peripheral organs was because the virus was absent, or because it was present in only 
small amounts in those organs. Inactivating factors that are released during tissue 
homogenization could have further reduced such a low presence of virus.
Fifty PFU of virus were mixed with tissue homogenates of brain, muscle, liver 
and spleen that had been serially diluted by 10-fold (from 10% to 0.01%), and were 
incubated on ice for an hour prior to plaquing in Vero cell monolayers. I determined to 
what extent the detection of infectivity was reduced, by comparing the number of 
plaques that resulted from the combined homogenate-virus inoculum to the number of 
plaques that were formed by the virus inoculum alone (Table 3.1).
A concentration of 10% of brain homogenate produced an almost complete 
(94%) inhibition of plaque formation (low numbers and small sizes). Tissue 
homogenates of 1% and 0.1% reduced the plaques by 70% and 14%, respectively; 
however, a concentration of 0.01% of brain homogenate had no effect on the number of 
plaques obtained.
A concentration of 10% (w/v) of spleen homogenate resulted in a 94% inhibition 
of plaque numbers, while concentrations of 1% and 0.1% reduced plaque numbers by 
82% to 18%, respectively. A concentration of 0.01% had no effect on plaque numbers.
Concentrations of 10% and 1% muscle homogenate reduced plaque numbers by
90% and 38%, respectively.
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Table 3.1 The percentage of reduction of MVE-infectivity in various 
concentrations of tissue homogenates* tested by PA
Tissue sample0 Concentration of 
homogenate (%)c
% reduction
Brain 10 94
1 70
0.1 14
0.01 0
S pleen 10 94
1 82
0.1 18
0.01 0
M uscle 10 90
1 38
0.1 22
0.01 0
L ive r 10 100
1 86
0.1 24
0.01 2
a Serially diluted tissue suspensions in HBSS-BSA were incubated for 1 h with 50 PFU of virus. 
^Tissues from non-infected mice were 10% w/v in HBSS-BSA. 
c Clarified tissue homogenate. 
d Reduction in % of plaques was:
1- /  Number of plaques in presence of tissue homogenate \  100%
\  Number of plaques in absence of tissue homogenate /
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Liver homogenates produced a significant reduction in plaque numbers on Vero 
cells. The 10% liver homogenate produced a total inhibition (greater than 99%) of 
plaque formation, while dilutions of 1%, 0.1% and 0.01% produced a reduction of 
plaque formation by 86%, 24% and 2%, respectively. The potent effect of liver 
homogenate on virus infectivity may explain why the results in liver samples are 
negative when they are tested by plaque assay.
In summary, homogenates of brain, spleen and liver showed a significant 
inhibition of plaque formation at concentrations greater than 0.1% w/v, and muscle 
homogenates had the least inhibitory effect on MVE infectivity of the four tissues 
tested.
3.4 Discussion
In this chapter, I compare two commonly used methods of virus detection in 
tissues: PA detects infectious virus in tissue culture, whereas RT/PCR amplifies viral 
RNA. It is important to test aliquots from the same samples using both methods, since 
different organs may contain factors, such as the amount of RNAse (relevant during 
RT/PCR, since RNA is the starting material), or infectivity-inhibiting substances 
(important during PA), that could affect the detection of viral genetic material or 
infectious virus, respectively. Overall, the results from the RT/PCR and PA methods for 
tissues such as brain, spleen, and muscle are similar (positive or negative). These results 
correspond to the ones obtained by Bae et al. (2003), who compared the precision of the 
plaque assay and real-time PCR in the detection of YF.
There is evidence that flaviviruses have preferential sites of replication in the 
brain at different stages of the infection. In neuroinvasion experiments of 3-week-old
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mice, the olfactory lobe has a higher viral content than the other parts of the brain in the 
initial stage of invasion. Later in the infection, the structures of the hippocampus have a 
higher viral content. Virus spreads to most of the brain immediately before death 
(Monath et al., 1983; Matthews et ah, 2000). Thus, given that the virus can be present in 
different locations within the brain at different stages of the infection, a small sample of 
the brain may not be representative of the organ. Consequently, to ensure that all the 
areas of the brain that support virus replication are included, at least one hemisphere of 
the brain should be homogenized. Therefore, plaque assay seems to be an ideal method 
for detecting virus in the brain, because a representative sample from the 
homogenization of half a brain can be processed for tissue titration. Thus, the standard 
3 mm of tissue taken for RNA extraction and PCR testing used for other extraneural 
organs may not be suitable for brain tissue, as such a sample would not be 
representative for virus replication in all areas of the brain.
Lymph nodes more often gave positive results when they were analyzed by 
RT/PCR than by PA. The small size of lymph nodes and the adherent characteristics of 
the tissue were a problem during the PA test because most of the tissue remains on the 
wire mesh during tissue homogenization, probably along with the virus. Thus, the 
difficulty in detecting virus in lymph nodes by plaque assay may have been due to 
technical problems. To avoid this problem and to increase the amount of lymph node 
tissue, I collected lymph nodes from the axillary, inguinal and cervical areas for my 
subsequent experiments (see Chapters 4-7). Because MVE was inoculated iv, I was able 
to use any lymph node, since there were no specific virus-draining lymph nodes.
From the above experiments, one could conclude that the RT/PCR method is 
more sensitive in detecting virus than the PA method. However, the RT/PCR method’s 
higher detection rate may be because it detects RNA from inactivated virus, as was
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previously shown for the human T-lymphotropic virus 1 (Morozov and Weiss, 1999). 
This would mean that RT/PCR results are not suitable for drawing conclusions about 
the infectious potential of the virus (Bae et al., 2003). Besides the latter deficiency, the 
RT/PCR method has several other known limitations (Piatak et al., 1993; Souaze et al., 
1996; Deubel, 1997). Firstly, the amount of product obtained by the RT/PCR method 
does not consistently reflect the amount that is present in the initial target. This is 
probably because PCR and/or RT have different efficiencies and kinetics that depend 
upon the abundance of the target, and the presence of various inhibitors (Piatak et al., 
1993; Deubel, 1997). Secondly, the comparison of the amount of viral RNA that is 
amplified from the specimen, to the amount that is amplified from a titrated standard (in 
separate reactions) is not ideal for quantification (Wang et al., 2000). Thirdly, the 
process of normalization by co-amplifying a heterologous target (such as actin or 
B-globulin) cannot provide a good internal control because there are differences in the 
abundance of the heterologous target and its priming efficiency (Piatak et al., 1993; 
Deubel, 1997). Additionally, the RT/PCR method has a higher risk of cross­
contamination than the PA method, as its molecular techniques require a number of 
different steps where contamination can occur, e.g. RNA purification, reverse 
transcription and PCR. In my study, contamination during the RT/PCR process was 
only detectable if the reagent control and the positive control had a smaller size than the 
testing samples. Consequently, because cross contamination between the tissue samples 
in the RT/PCR process cannot be identified, the possibility of false positive results is 
increased. Compared to the limitations of RT/PCR, quantification by PA is simple and 
reliable.
Another factor that needs to be considered when deciding which method is better 
is the reduction of infectivity that occurs through the release of inhibitory factors during
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tissue processing for the PA method. The tissue homogenates that are used during 
plaque assay drastically reduce virus infectivity when 10% to 1% tissue suspensions are 
used. If virus titers in the tissues are low, virus detection could become masked by the 
inactivating reaction that is caused by the factors that are present in the tissues. The 
content of the MVE in the organs is not affected by these factors when less than 0.01 of 
homogenates are used (my observations), or 0.5%, as shown by Lee and Lobigs (2002), 
so virus titers obtained at these dilutions are considered reliable.
The results I present in this study confirm that there is poor MVE replication in 
peripheral organs tested in 6-week-old mice. This, together with the technical 
difficulties such as viral RNA degradation and the reduction of virus infectivity by 
factors that are present in the tissue homogenates, make virus detection in peripheral 
organs even more difficult. Most of the results given by the two techniques coincide 
when the same samples are tested. For the purpose of the work in my thesis, I selected 
the traditional PA as the technique to use in further experiments, as it is a simple 
method that obtains quantitative results and detects infective virus.
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4.1 Summary
This chapter presents the establishment of a mouse model of encephalitic 
flavivirus infection that parallels infection in humans. In particular, only a subset of the 
mice used develops disease. The virus is administered by the intravenous route, which is 
analogous to the portal of entry in natural infections, and the mice are given a virus dose 
in the range that would be experienced following the bite of an infectious mosquito.
The results show that mice of 6 weeks of age were susceptible to doses of MVE 
in the range of 0.1 to 10s PFU, which resulted in close to 50% mortality, and that 10- 
week-old mice were mostly resistant to similar doses of virus. Mice of all ages were 
susceptible, even to low doses, after ic flaviviral infections. Susceptibility in 6-week-old 
mice after iv infection was higher than after ip infection. Because females did not show 
a significant difference in susceptibility compared with males, both genders were 
suitable for further studies. After iv infections with 102, 103 and 105 PFU, MVE titers in 
extraneural organs were low or undetectable, despite 100% seroconversion, which
o
confirmed infection. After infection with a high dose of 10 PFU that produced 100% 
mortality, titers in extraneural organs were relatively low, but titers in the brain showed 
that virus had already reached the target organ at day 2 pi. Titers in the brain further 
increased to 109 PFU/g on day 3 and 4 pi. The rapid neuroinvasion after infection with a 
high dose indicated that the virus crossed the blood-brain barrier (BBB) and did not 
need peripheral replication. Histopathology correlated in most of the cases with the 
level of infection: foci of inflammation and tissue destruction were rare or undetectable 
in extraneural organs but prominent in brains of moribund mice. In vitro studies showed 
that MVE-specific Tc-cell (H-2b-restricted) responses were induced.
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4.2 Introduction
Mice are relatively good laboratory animals to model flaviviral encephalitis in 
humans. All members of the JE serocomplex are neurotropic in mice, with clinical and 
histopathological features of young mice infected with encephalitic flaviviruses similar 
to those that appear in humans (Monath, 1986). However, the lack of a fully mature 
immune system in the young mouse model is a limitation to the study of immune 
responses against flaviviruses. In most of the cases, adult immunocompetent mice are 
susceptible to flaviviruses only after ic inoculation, a route of infection that does not 
mimic the natural route of infection via mosquitoes.
Macaques are susceptible to encephalitic flavivirus infection and would 
probably represent the disease in humans better, but their high costs make them an 
impractical host model (Markoff, 2000; Monath et al., 2002). In order to fulfill the 
requirements of an ideal animal model, small adult laboratory animals should present 
morbidity and mortality after systemic infection (Leyssen et al., 2000). The role of the 
immune responses in the protection against flavivirus-induced disease has been difficult 
to demonstrate in vivo due to the above limitations.
Previous studies on encephalitic flaviviruses show that humoral immunity is the 
key to prevent the spread of virus from the blood to the brain (Camenga et al., 1974; 
Kimura-Kuroda and Yasui, 1988; Schlesinger et al., 1993). Passive transfer of 
antibodies can protect animals against a lethal flavivirus challenge, including an 
infection via the ic route, while neutralizing antibodies to the E protein protect them 
against a homologous flavivirus challenge (Gould et al., 1986; Hawkes et al., 1988; 
Kimura-Kuroda and Yasui, 1988). However, the kinetics of induction of humoral 
immunity in a primary flavivirus infection may not be sufficiently rapid to prevent 
neuroinvasion and encephalitis after peripheral virus growth. Cell-mediated immunity
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(CMI) develops with a kinetics that is consistent with the requirement for rapid virus 
elimination (Gajdosova et al., 1981; Kesson et ah, 1987). Flavivirus-immune cytotoxic 
T (Tc) cells are generally apparent at day 5 pi, and their numbers peak on day 7 pi. The 
flavivirus NS3 protein contains Tc-cell determinants presented by a number of mouse 
and human MHC class I restriction elements (Kurane et al., 1989; Kurane et al., 1991; 
Parrish et al., 1991; Rothman et al., 1993; Lobigs et al., 1994). The role of the Tc cells 
in recovery from encephalitic flavivirus infection may depend on whether they can 
prevent virus from spreading into the CNS while their function is directed against virus- 
infected cells in the periphery. Although virus-specific immune Tc and NK cells have 
been isolated from brains of flavivirus-infected mice, it is still unclear whether they arc 
necessary for the recovery from encephalitic flavivirus infection, or whether they induce 
immunopathology, as has been observed in some viral models (Doherty and 
Zinkernagel, 1974; Moskophidis and Kioussis, 1998), including flaviviral models 
(Camenga and Nathanson, 1975; Semenov et al., 1975). Thus, the relative contribution 
of cytotoxic lymphocytes to neuronal destruction remains ambiguous (Nathanson and 
Cole, 1970; Lad et al., 1993; Andrews et al., 1999).
The work described in this chapter concerns pathogenesis studies of MVE 
infection of C57B1/6 wild-type (wt) mice. This study covers the dual aspect of the 
pathogenesis, namely the ability of the virus to invade the host and inflict pathogenesis, 
and the ability of the host to clear the infection, given that both death and survival of the
hosts are obtained under similar conditions of infection.
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4.3 Results
4.3.1 Mortality after MVE infection of C57BI/6 mice according to age and 
gender of mice, and infection route and dose of virus
Flaviviruses induce an age-dependent disease in mice. Because it was of interest 
to establish at which maximum age mice are still susceptible to MVE infection, I tested 
mice of 6 and 10 weeks of age (Table 4.1 A). I also tested if the mice showed a gender 
difference in susceptibility (Table 4.1 B), and tested which route of infection leads to a 
higher susceptibility when the virus is inoculated systemically (the ip or iv route). I used 
the ic route of inoculation to find out what the mortality time would be once the virus is 
present in the brain (Table 4.1 C). Once I established the maximum age for 
susceptibility with no apparent gender difference, and the route of the infection, I tested
o
different iv doses — ranging from 0.1 to 10 PFU — in 6-week-old mice (Table 4.1 D). 
I recorded morbidity and mortality daily until day 21 pi, when mice either had 
asymptomatic infection, recovered from a mild clinical disease, or died.
Age-dependent susceptibility of C57BI/6 mice to infection with MVE
Mice of 6 and 10 weeks of age received MVE via the iv route. Each group was 
injected with doses of either 102 or 108 PFU. A dose of 102 PFU killed 46% of the 6-
o
week-old mice, but did not kill any of the 10-week-old mice. The higher dose of 10 
PFU killed all the 6-week-old mice (P = 0.11) at day 5.5 pi and 80% of the 10-week-old 
mice at day 6.8 pi (Table 4.1 A). I chose to continue with 6-week-old mice for further 
work, since they were optimally susceptible to MVE and had a mortality of 50% after 
infection with the low dose (although they had a fully developed immune system).
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Effect of gender on mortality of 6-week-old C57BI/6 mice after MVE
infection
The effect of gender was tested to investigate whether possible behavioral 
differences, including stress (e.g. males showing a fighting tendency) and weight 
differences (males were on average three grams heavier than females of the same age), 
contributed to mortality when the conditions of infection were similar (Table 4.1 B). 
After I infected a group of 14 males and 15 females with a dose of 102 PFU iv, I 
observed a mortality of 43% and 40%, respectively, a difference that was not 
statistically significant (P = 1.0). The higher average weight of males, and the lower 
amount of virus per unit of body weight in males relative to females did not lead to an 
increased resistance to infection or a statistical difference in the ATD (P = 0.40).
Effect of route of infection on mortality of 6-week-old C57BI/6 mice
The ip, iv and ic routes of infection were compared to determine their influence 
on the pathogenicity of MVE (Table 4.1 C). I compared the ip with the iv route of 
infection after injecting mice with doses of 103, 105 and 108 PFU of virus. Of those mice
o  c  #
that were injected with doses of 10' and 10 PFU, the mice that were injected iv 
consistently showed higher fatalities than the mice that were injected ip, although there 
was no statistically significant difference. Of those mice that were infected with a dose 
of 108 PFU of MVE, the mice that were injected ip showed 70% mortality, but the mice 
that were injected iv yielded no survivors; a difference which was statistically 
significant (P = 0.03). Intracerebral inoculation of a low dose of 10 PFU of virus 
produced an acute disease that was similar to the disease after iv injection of 108 PFU, 
resulting in both cases in a 100% mortality between days 5 to 7 pi. Mice injected ic with
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10 PFU of virus died after an average of 6.4 days pi, i.e. slightly later than mice injected 
iv with 108 PFU, which died after an average of 5.5 days pi. Thus, it would appear that 
once virus enters the CNS, either by direct injection into the brain or after iv 
administration of 108 PFU, death is rapid and inevitable.
Dose-response of MVE in C57BI/6 mice
Peripheral inoculation with viral doses in the range of 0.1 to 103 PFU of MVE 
by the ip or iv route killed approximately 50% of the animals, but characteristically 
failed to produce a significant dose-dependent increase in mortality, whereas a high 
virus dose of 108 PFU by the iv route consistently resulted in 100% death (Table 4.1 D). 
An iv-injected virus dose of 0.1 PFU resulted in 59% mortality, while an iv injection of 
102 PFU resulted in 46% mortality (P = 0.26). This slight inverse correlation between 
virus dose and percentage of mortality was also observed in MVE-infected mice by 
Boyle (1979). I observed two distinct mechanisms for the average time to death (ATD): 
mice injected with 108 PFU of MVE died at 5-6 days pi, whereas mice injected with the 
lower doses died from day 9 to 13 pi (Table 4.1 D). This pattern has been also observed 
for the encephalitic flavivirus WNV (Wang et al., 2003).
Animals that succumbed to MVE infections showed similar clinical symptoms 
at one to two days prior to death. This observation, in addition to observing similar virus 
titers in the brains of moribund mice from groups that were peripherally infected with 
the high or lower doses, suggests that in both cases viral encephalitis was the cause of
death.
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Table 4.1 Mortality of MVE-infected C57BI/6 wt mice according to mouse age 
and gender, infection route and dose
A. Age response
Age (w) Dose(PFU) Na % Mortality ATD ±S E M b
10 102 10 0 -
10 108 10 80 6.8 ± 0.5
6 102
oo
46 11.6 ± 0.4
6 108 19c 100 5.5 ± 0.2
B. Gender response
Gender Average 
weight (g)
Na % Mortality ATD ± SEM6
male 20.2 14 43 11.9 ± 0.8
female 17.0 15 40 10.7 ± 1.2
C. Route of infection
Route Dose(PFU) Na % Mortality ATD ± SEMb
iv 103 9C 56 12.0 ± 0.8
iv 105 12c 50 10.3 ± 0.7
iv 108 19c 100 5.5 ± 0.2
ipd 103 58 40 13.7 na
ipd 105 32 38 11.8 na
ipd 108 10 70 8.6 na
ic 10 5 100 6.4 ± 0.5
D. Dose response
Dose (PFU) Na % Mortality ATD ± SEMb
0.1 27 59 10.2 ± 0.7
102 -vj o o 46 11.6 ± 0.4
103 9C 56 12.0 ± 0.8
105 12c 50 10.3 ± 0.7
108 19c 100 5.5 ± 0.2
aTotal number of mice infected per group. Morbidity and mortality were recorded daily. 
Surviving mice were monitored for 21 days. All mice were 6 weeks old, except in A. Mixed 
groups of males and females, except in B. Infection of mice by the iv route, unless otherwise 
specified (C).
bThe average time to death (ATD) in days ± standard error of the mean (±SEM). 
cThe groups of mice in D are repeated in A and C.
d Mortality studies after ip infection, performed by Ms G. Colombage (personal communication); 
no statistics available (na).
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4.3.2 Kinetics of replication of MVE in tissues from infected 6-week-old
C57BI/6 mice
MVE growth in extraneural tissues
The virus load in tissue homogenates was studied by plaque assay to determine 
which extraneural organs (ovaries, serum, blood cells, kidneys, spleen, muscle, lymph 
nodes and liver) supported virus replication, and to define the kinetics of virus growth 
before the virus reaches the CNS. Liver, kidneys, ovaries and blood cells did not show 
detectable virus titers even after infection with a high dose of 108 PFU (tested by both 
plaque assay and RT/PCR, data not shown) and were not further studied. Using plaque 
assay, I tested spleen, muscle and lymph node samples from mice infected iv with 
10 PFU (Fig. 4.1) and 10 PFU (Fig. 4.2) of virus, for the presence of virus at two-day
o
intervals, and I tested samples of mice infected with 10 PFU (Fig. 4.3) of virus at one-
o
day intervals. Serum was also collected after infection with 10 PFU.
Consistent with earlier studies (MacDonald, 1952), I found that MVE grows 
poorly in extraneural tissues of mice of this age. After inoculating mice with 10“ PFU 
iv, I did not detect any virus in their extraneural organs (spleen, lymph nodes and 
muscle) (Fig. 4.1), although the mice all seroconverted (Table 4.2). Infection with 103 
PFU resulted in barely detectable virus titers in the spleen at day 4 pi, clearing of the 
virus by day 6 pi (Fig. 4.2).
o
Intravenous inoculation of 10 PFU of virus resulted in virus replication in the 
spleen, muscle and lymph nodes (Fig. 4.3), although virus titers were low, and virus was 
not detected in liver (data not shown). Virus titers in the spleen were the highest on 
day 2 pi and were absent on day 4 pi in most animals (Fig. 4.3 B). Since virus titers 
seemed to decrease with time in the spleen, there was probably minimal or no detectable 
viral replication in that organ. Growth of MVE in muscle occurred in a few mice on
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days 2, 3, and 4 pi, and virus titers were slightly higher (2xl04 PFU/g), and present in 
more mice, on the later collection days (Fig 4.3 C). This result could be an indication 
that muscle, as well as brain, may support virus replication, instead of only brain, as has 
been reported by other studies with MVE (Murphy et ah, 1968; Hase et ah, 1990; 
McMinn et ah, 1996; Andrews et ah, 1999). I also collected and pooled mesenteric and 
inguinal lymph nodes for virus titration, and found that virus titers were similar to those 
of the spleen (Fig 4.3 E). Low virus titers were detectable in serum at day 1 pi, ranging 
only from 102 to 103 PFU/ml, while the limit of detection was 102 PFU/ml (Fig. 4.3 D). 
The lack of virus detection in serum at later time points was an indication that the virus 
I detected in the tissues collected from day 2 pi was not a carry-over from the blood. 
This indicates that adult mice show no detectable viremia, and that they are therefore 
similar to human cases (Monath, 1996).
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Fig. 4.1 Growth of MVE in tissues of C57BI/6 wt mice. Six-week-old mice 
were infected with 102 PFU of MVE iv. At the indicated times, animals were 
sacrificed, and virus titers in the brain (A), spleen (B), lymph nodes (C) and 
muscle (D) were determined by plaque assay. The lower limit of detection of 
virus titers was 1 x 103 PFU/g of wet tissue and is indicated by the interrupted 
line. The different symbols represent tissues of individual mice (mouse 1-8).
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Kinetics of neuroinvasion and growth of MVE in the brain of wt mice
The time to neuroinvasion and the level of virus growth in the brain were tested
2 5in groups of mice that were infected iv with low (10“ PFU), medium (10' PFU), or high
o
(10 PFU) doses of MVE. Brains from most of the mice (six out of eight) infected with 
the low dose only showed detectable virus titers on day 8, with values that ranged from 
103 to 108 PFU/g (Fig 4.1 A). The increase of 3 logs (from 102 to 105 PFU/g) in the viral 
inoculum did not result in an increase in titer values (i.e. an earlier detection) in the 
brain. On the contrary, none of the brains from the mice that were infected with the 
medium dose had detectable virus titers at any of the collection time points (Fig. 4.2 A). 
However, an average of 50% mortality at day 10, after infection with 105 PFU (which
'y
was similar to mortality after infection with 10“ PFU), indicated that neuroinvasion 
occurred, but probably after the last brain sample was collected (day 8 pi). Mice
o
infected with a high virus dose of 10 PFU had detectable virus titers in the brain, which 
ranged from 103 to 105 PFU/g on day 2 pi, and increased to a range of 107 to 109 PFU/g
on day 4 pi (Fig. 4.3 A).
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Fig. 4.2 Growth of MVE in tissues of C57BI/6 wt mice. Six-week-old mice 
were infected with 105 PFU of MVE iv. At the indicated times, animals were 
sacrificed, and virus titers in the brain (A), spleen (B), muscle (C) and lymph 
nodes (D) were determined by plaque assay. The lower limit of detection of 
virus titers was 1 x 103 PFU/g of wet tissue, and is indicated by the interrupted 
line.
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Fig. 4.3 Growth of MVE in tissues of C57BI/6 wt mice. Six-week-old mice 
were infected with 108 PFU of MVE iv. At the indicated times, animals were 
sacrificed, and virus titers in the brain (A), spleen (B), muscle (C) serum (D) and 
lymph nodes (E) were determined by plaque assay. The lower limit of detection 
of virus titers was 1 x 103 PFU/g of wet tissue and 102 PFU/ml for serum, and is 
indicated by the interrupted line. The different symbols represent tissues of 
individual mice (mouse 1-6).
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4.3.3 MVE-specific antibody response
The Ab response was measured using ELISA. Serum from 6-week-old mice that 
were iv infected with 0.1 PFU of virus were tested at day 10 and 22 pi; mice infected
9  c
with 10“ PFU were tested at day 10, 22, and 27 pi; and mice infected with 10 PFU were 
tested at day 5, 10, 15 and 21 pi. I also tested older mice of 10 weeks of age for Ab 
production at day 25 pi, after infection with 105 PFU. Antibody titers and the incidence 
of seroconversion were important because they allowed me: 1) to verify that infection of 
mice with the doses of MVE used in the pathogenesis and virulence assays resulted in 
infection of extraneural tissues, and 2) to test whether differences in the magnitude of 
the humoral response against different doses of MVE were detectable. The sera from all 
infected animals were reactive against MVE antigen (Table 4.2). Because a single 
vaccination of mice with 10 PFU of UV-inactivated MVE does not induce MVE- 
specific antibodies detectable by ELISA (data not shown), the 100% seroconversion 
indicates that all the mice had been effectively infected and that virus growth in 
peripheral tissues had occurred.
Mice infected with the low dose showed considerable Ab levels, with mean 
values of 3.7 Logio and 4.3 Logio on day 10 and 22 pi, respectively. This indicates that 
despite the low dose of 0.1 PFU of virus, the dose was high enough to induce 100% 
seroconversion. Sera from mice, infected with 10“ PFU of virus iv, collected on days 10, 
22 and 27 pi, showed similar levels of Ab (Logio of 3.7, 3.9 and 4.3, respectively). Mice 
infected with 10s PFU showed Ab titers from early on (day 5 pi) — in accordance with 
studies made by McMinn et al. (1996) — and gradually increased to Logio of 4.0 by day 
21 pi. The increase in injected virus from 0.1 to 102 PFU, and even 10̂  PFU, did not 
cause a significant difference in Ab production. In general, antibody titers increased
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gradually until day 21 pi, when antibody production is considered to be at a plateau 
level (Monath, 1986).
Ab levels from 10-week-old mice infected with 105 PFU ranged from 3.5 to 
4.4 Logio, at day 25 pi, with a mean value of 3.9 Logio(data not shown). This result 
suggests that the increase in age from six to ten weeks does not necessarily bring about 
an increase in the capacity for Ab production (although, I did not measure the level of 
neutralizing Ab). Six-week-old mice had a mean Ab production of 4.5 Logio on day 21 
pi, and this value was not statistically different from the levels produced by 10-week-old 
mice.
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Table 4.2 MVE-specific Ab production in 6-week-old C57BI/6 wt mice
Dose
(PFU)a
No./
group0
% Seroconversion Day pi Mean Ab titer, 
Log10 (range)c
0.1 6 100 10 3.7 (2.6-4.1)
0.1 4 100 22 4.3 (3.8-4.7)
102 6 100 10 3.7 (2.6-4.1)
102 6 100 22 3.9 (2.9-4.7)
102 5 100 27 4.3 (3.8-4.7)
105 6 100 5 2.5 (2.0-2.9)
105 7 100 10 3.4 (3.2-3.5)
105 7 100 15 3.7 (3.5-3.8)
105 12 100 21 4.0 (3.5-4.7)
a Intravenous MVE inoculation.
b Number of mice tested for MVE-specific antibody titers determined by ELISA. 
cThe endpoints were calculated as described in Materials and Methods, Chapter 2.
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4.3.4 MVE-immune Tc-cell response in C57BI/6 mice
To verify that MVE-specific Tc-cell responses are induced in C57B1/6 mice 
(Fig. 4.4), splenocytes were obtained from groups of four mice that had been infected ip 
with 106 PFU of MVE 10 days previously. I tested secondary, in vitro stimulated, MVE 
immune splenocytes against MVE-infected and uninfected 2R (Kk, Db) and 5R (Kb, Dd) 
target cells using 5lCr release assays. Figure 4.4 A shows that Db- and Kb -restricted 
anti-MVE Tc-cell responses are elicited in MVE-infected C57B1/6 mice, with the 
former having the stronger response. Given that specific killing of H-2-mismatched 
MVE-infected target cells (L929, H-2K) by the MVE-immune effector cells from 
C57B1/6 mice was not observed, the Db- and Kb-restricted lysis was Tc-cell mediated 
(data not shown).
To identify the MVE-specific antigenic determinant(s) that are recognized by H-2b- 
restricted Tc cells, I infected 2R (Kk, Db) and 5R (Kb, Dd) target cells with the VV 
recombinant viruses (VV-STR, VV-prM-E, VV-prM, VV-E, VV-NS, VV-NS1-NS3, 
and control VV-TK) encoding overlapping regions of the MVE polyprotein 
(Fig. 4.4 C). The 2R target cells infected with recombinants VV-STR, VVprM-E, or 
VV-prM, were lysed by MVE-immune Tc cells, whereas the target cells infected with 
the constructs VV-E, VV-NS, or VV-NS 1-NS3 or with the control virus, VV-TK', were 
not recognized.
Accordingly, the Derestricted response was directed against a determinant that was 
derived from the viral prM protein (Fig. 4.4 B). The VV-immune Tc cells recognized all 
the VV-infected target cells, but not the uninfected cells (Fig. 4.4 B). The Kb-restricted 
anti-MVE Tc-cell response was directed against a determinant(s) that was derived from 
the non-structural polyprotein region down-stream from NS2B (data not shown).
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Fig. 4.4 MVE-infection of C57BI/6 wt mice elicits H-2b-restricted anti-viral 
Tc-cell responses. A. Lysis of 51Cr-labelled 2R (K\ Db) and 5R (Kb, Dd) cells 
infected with MVE, VV-TK- or left uninfected by secondary /n-wYro-stimulated 
MVE-immune Tc cells from wt mice. B. Lysis of 51Cr-labelled 2R (Kk, Db) and 5R 
(Kb, Dd) cells from mice that were infected with constructs VV-MVE; mock 
infected mice and VV-TK- as controls. C. Schematic representation of MVE 
polyprotein fragments expressed via VV recombinants. The MVE polyprotein is 
shown at the top. Regions encoded by the VV recombinants used in this study 
are shown below.
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4.3.5 Histopathology
2
To further analyze the disease progression of mice infected iv with 10“ to
o
10 PFU, I did kinetic studies to follow the virus load and histopathology. Pathology 
and virus titer studies of brain, spleen, muscle, lymph nodes, kidney and liver of mice 
infected iv with 10 and 10 PFU of virus showed that hardly any virus could be 
detected in the different tissues, and that cell infiltration or histopathology were rare 
(data not shown). Results that were obtained from mice that had been infected iv with a 
higher dose of 10x PFU are shown in Table 4.3. Between days 2 and 4 pi, I daily 
collected brains and spleens from three individual mice in each group. From day 2 pi, 
virus titers in all the brains were above the detection limit (>1CF PFU/g), and increased 
to up to 109 PFU/g on day four. Mr Thomas Steele (Max Plank Institute, Freiburg, 
Germany) observed perivascular infiltration (pvi) in brain samples only on the last days 
of collection (in one brain on day 3 and in all three brains on day 4) (Fig. 4.3). This 
early manifestation of pathology on day 3 and 4 pi, visible as cell infiltration in the 
brain (the type of the cells that infiltrated was not identified), suggests that innate 
immunity was involved in the defense against acute MVE infection. Contrary to the 
results of virus load in the brain, titers in the spleen reduced with time pi. This 
correlated with splenic histology studies, which showed a gradual reduction in 
pathology. At day 2 pi spleens showed reactivity with the development of secondary 
follicles, and an enlarged red pulp and a white pulp. From day three to day four, spleens 
showed only reactivity, consistent with the reduction observed in the virus titers.
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Table 4.3 Histopathology of brain and spleen from wt mice infected iv with 
108 PFU of virus
Brain Spleen
Day
pi
Histology Plaque assay Histology Plaque assay
2 normal 1.5x104 reactive , red pu lp  en la rged , 
w h ite  pu lp  w ith  seconda ry  
fo llic les
5x103
2 normal 2x104 reactive , red pu lp  en la rged , 
w h ite  pu lp  w ith  secon da ry  
fo llic les
2x103
2 normal 4.5x103 red pulp enlarged 5x103
3 normal 2.2x106 reactive 1.5x103
3 normal 9.5x103 reactive 4x103
3 extensive pvi 2.2x107 reactive 3x103
4 extensive pvi 2.7x109 reactive 1.5x103
4 extensive pvi 6x108 reactive <103
4 mainly pvi 5.4x108 reactive <103
normal: no histological lesions, similar to mock-infected mice (data not shown), 
pvi: perivascular infiltration.
reactive: reaction to antigens with the development of secondary follicles.
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4.4 Discussion
The lack of an effective immunocompetent animal model has been a major 
obstacle in attempts to define the role of humoral and cellular immune responses during 
flaviviral infections (Hall et al., 1996). The typical animal model for flaviviruses has 
been the 3-week-old mouse, which shows nearly 100% of disease incidence. This model 
is poorly suitable to reproduce the disease of humans, in the sense that interpretation of 
the level of immune protection or the level of immunopathology during infection is 
difficult because young mice have an underdeveloped immune system. Additionally, the 
BBB in those mice is not yet fully mature. Thus, a detailed study of the pathogenesis of 
flaviviruses in immunologically mature adult mice is warranted. In this chapter, I have 
described a model for the study of the pathogenesis of encephalitic flaviviruses using 6- 
week-old C57B1/6 wt mice.
Pathogenesis studies involve a pathogen-host relationship under controlled 
environmental conditions (Oldstone, 1990). In my MVE pathogenesis study, I 
considered the following aims with regard to the pathogen: 1) to identify how the 
virulence patterns change according to mouse age and gender, and infection dose and 
route, and 2) to establish the tissues in which MVE amplification occurs before the virus 
reaches the target organ (brain). The host factors that are important in defining the 
mechanisms of protection are: 1) the humoral immune response, which I studied by 
determining Ab titers at different doses and times pi; and 2) the T-cell immune 
response, which I measured by testing for the level of in vitro cytotoxicity of immune 
splenocytes to MVE-infected target cells and defining the viral epitopes for Tc cells. 
Histopathology of brain and spleen was also recorded.
Immunocompetent mice of 6 and 10 weeks old were used for MVE pathogenesis 
experiments. The 10-week-old mice have an increased resistance over the 6-week-old
Chapter 4: MVE pathogenesis in wt mice 125
mice. Thus, the 6-week-old mice were used for further experiments because they are 
fully immunocompetent and still susceptible to MVE infection after inoculation with the 
various doses of virus. I did not find gender differences in susceptibility to MVE 
infection. This finding corresponds to that of Wang et al. (2003), who did studies in 6- 
week-old mice infected with WNV.
A similar dose of virus, but inoculated by a different route, may result in a 
different manifestation of the clinical disease (Grossberg and Scherer, 1966). In the case 
of MVE, infection by the iv route slightly increased the level of susceptibility, 
compared with infection by the ip route (when a similar dose of virus is used). I 
therefore used the iv route in most of the subsequent studies. Additionally, the iv 
injection is also comparable to the portal entry in natural infections, which occurs via 
the bite of infected hematophagous insects. Although the ic route of infection does not 
represent the natural way of infection, I used it to define the onset of clinical signs once 
the virus is in the CNS.
Mortality did not occur in a dose-dependent manner after iv inoculation of virus 
doses that ranged from 0.1 to 105 PFU (all of which produced close to 50% mortality 
around day 11 pi). The susceptibility of mice to a small dose of virus, such as 0.1 PFU, 
can help to explain how a small amount of virus that is carried by a mosquito can be 
enough to produce disease and mortality in a vertebrate host. It is not unusual to find 
that the highest dilution of virus (0.1 PFU) produced a slightly higher mortality than the 
higher doses of 102, 103 and 105 PFU. A similar phenomenon has been observed for 
MVE by Boyle (1979) and for WNV, another encephalitic flavivirus (Wang et al.,
2003), and for LCMV (Lehmann-Grube, 1969). This inverse correlation between dose 
and mortality may be due to the fact that a low dose may not trigger a sufficiently strong 
immune response to reduce viral replication before there is neuroinvasion and death.
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2The fact that it was more common to find virus in tissues after infection with 10“ PFU 
than after infection with 10̂  PFU, supports this interpretation, although lower levels of 
immune response were not revealed under the assay conditions of this study.
A dose of 108 PFU iv and 10 PFU ic both produced 100% mortality around day
o
six. The fact that the mice injected iv with 10 PFU died at a similar time as mice 
injected ic, combined with the fact that virus was detected from day two onward (first 
day of collection) in the brain, suggests that the virus enters directly from the blood 
stream into the CNS, and probably without the need of peripheral replication.
The fact that a balance can develop between the resistance and the mortality in 
the mouse groups infected with low to medium doses — which resulted in close to 50% 
mortality — permits the study of the two aspects of pathogenesis: 1) the capacity of the 
host to defend itself from infection, and 2) the ability of viruses to produce disease. 
Infection with a high dose of 10c PFU caused an acute pattern of disease where, despite 
full immunocompetence, all the mice succumbed to MVE infection. Animals that were 
given high or low doses of MVE show similar clinical symptoms at 1-2 days prior to 
death and have, in addition, similar virus titers in the brains when moribund. This 
suggests that viral encephalitis is the cause of death, whether by direct infection of the 
brain or by peripheral infection.
Mice that were peripherally inoculated with doses of 0.1 to 105 PFU of MVE 
had a time to death of 11 days pi on average, while mice that were peripherally 
inoculated with a high dose had a mean survival time of 5.5 days pi and mice that were 
ic inoculated survived 6.4 days. The longer time to death in mice infected iv with the 
lower virus doses suggests that peripheral virus replication may be required prior to 
neuroinvasion. However, a 106-fold difference (from 0.1 to 105 PFU) in the amount of 
initial virus inoculum did not result in any significant change to the time to death. This
Chapter 4: MVE pathogenesis in wt mice 127
suggests that viral growth in the periphery may not be the only factor that determines 
the time to death following infection.
In addition to mortality, another important aspect for the study of the 
pathogenesis of a neurotropic virus is its distribution in the tissues. Extraneural organs 
from 6-week-old mice were found to be largely refractory to MVE replication (virus 
was hard to find by plaque assay and by RT/PCR), which is consistent with other 
studies (MacDonald, 1952; Huang, 1963; Monath et al., 1983; McMinn et al., 1996) 
where MVE was found to grow poorly in tissues of mice that are older than 3 weeks. 
After infection of 10“ PFU iv, and close to the time when clinical signs start to appear 
(day 8 pi), virus growth was only detected in the brain tissues of approximately half the 
mice. When mice were inoculated with 10̂  PFU, virus was barely detectable in the 
spleen at day four, and was not detectable in any of the other organs, although all mice 
had seroconverted. This indicates that a productive infection took place.
The viremia that was detected in mice only one day after infection with 108 PFU 
could be caused by a remnant from the inoculated virus the day before, and not a result 
of virus replication, because the virus is rapidly removed from the circulation by the 
reticuloendothelial system (Lee and Lobigs, 2002). Solid organs such as spleen, muscle 
and lymph nodes showed virus titers that were marginally above the detection limit of 
10 PFU/g, despite inoculation with a high virus dose. Virus titers in the spleen were 
higher at early time pi, which may be explained by the fact that the spleen is the organ 
that collects the antigen from the circulation (Janeway, 1999). The fact that the virus 
was injected iv presumably facilitated the presence of MVE in the spleen at early times 
pi. In contrast to the gradual decrease of virus load in the spleen, I observed a moderate 
increase of MVE in the muscle over time. It is of interest to note that MVE is 
considered to replicate only in nerve tissue (McMinn et al., 1996). One possible
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explanation for the gradual increase of titer values in the muscle could be that, since 
MVE is a primarily neurotropic virus, it replicates in the peripheral nerve tissue of the 
leg muscle sample. Because I did not attempt to separate nerve and muscle, the question 
of whether the virus had replicated in muscle or nerve tissue, remains unanswered.
Histopathology was present in most of the tissues of MVE-infected mice that 
showed virus titers. Histopathological results indicated that the levels of inflammation, 
necrosis and perivascular infiltration associated with neurological and splenic infection
o
were more evident in tissues of mice that are infected with the high dose of 10 PFU.
The increase in brain titers correlated with an increase in the level of histopathology.
The inverse situation occurred in spleen tissues, where a decrease in histopathology was 
found, consistent with virus distribution.
It has been observed that ic inoculation of JEV results in few inflammatory 
changes, and that there is a rapidly fatal infection in which mice may die before any 
appreciable host immunological response can take place in the brain (Hase et al., 1990). 
In contrast, my experiments showed that when a high dose of MVE is injected iv, it is 
accompanied by the recruitment of inflammatory-immunological elements from the 
periphery to the brain. This result is phenotypically very different from the results of the 
localized ic route of infection. The inflammatory reaction I observed in the brain after
o
peripheral infection of 10 PFU may have had a deleterious effect, and could have 
accounted for the reduced AMT of approximately one day in comparison to mortality 
after ic inoculation (days 5.5 and 6.4 respectively). Similar levels of virus (~109 PFU/g) 
were detected near the time of death, irrespective of whether mice were injected iv or ic.
The MVE-specific antibody response showed no significant dose-dependent 
difference in the magnitude of the Ab response within the dose range of 0.1 to 103 PFU. 
As little as 0.1 PFU induces Ab production from as early as day 5 pi (the earliest testing
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time), consistent with studies by McMinn et al. (1996) where anti-MVE antibody is 
found as early as day 4 pi, and as late as day 31 pi. The 100% seroconversion found in 
my experiments indicates that there was an effective infection and possibly a partial Ab 
protection.
Age was not a significant factor in the Ab production as occurs for mortality. 
Mice of 10 weeks of age did not show increased Ab levels compared to the 6-week-old 
mice. The similarity in seroconversion between 6- and 10-week-old mice indicates that 
the factor that leads to an increase in resistance to MVE infection in the older mice 
could be caused by something different than Ab protection. However, because I did not 
use Ab in neutralization studies, I could not establish the level of protection that 
antibodies may have offered.
My initial in vitro studies of the T-cell-mediated immunity by assays of 
cytotoxicity on spleens from MVE-primed mice (to measure the level of target-cell 
killing of MVE-infected cells) confirm that wt mice mount an H-2b-restricted Tc-cell 
response against MVE. Additionally, the mapping experiments indicate that the 
Kb-restricted response is directed against a determinant that is derived from the viral 
prM protein. The strong Db-restricted anti-MVE Tc-cell response, directed against 
determinants derived from the non-structural polyprotein region downstream of NS2B 
(data not shown), raises the question whether it is responsible for the lethal encephalitis 
in MVE-infected mice, as is the case in the well-studied LCMV mouse-model.
To conclude, in this chapter, general parameters of MVE pathogenesis, such as 
mortality, virus distribution in mouse tissues, serology, Tc-cell reactivity and histology 
have been clarified for mice that are still susceptible to MVE infection but are already 
immunologically mature. Therefore, this immunocompetent mouse model can be used
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to study the role of specific immune mechanisms involved in the pathogenesis of MVE 
infection.
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5.1 Summary
In this chapter, subtractive (MVE infection of mice with a deficiency in effector 
cells) and additive (passive transfer of MVE-immune effector T and B cells to MVE- 
infected wt mice) studies were performed in 6-week-old animals to provide information 
on the role of B and T cells during the pathogenesis of encephalitic flaviviral disease. 
The RAG-1-/- mice (B- and T-cell deficient) showed increased susceptibility to MVE 
infection, compared with wt mice, probably due to the lack of antibody-mediated 
protection. Conversely, ß2-M-/- mice (that lack expression of MHC class I and hence 
are CD8+ T-cell deficient) showed increased resistance to the MVE infection, 
suggesting a deleterious role of Tc cells. Passive transfer of MVE-primed B cells to 
MVE-infected wt mice resulted in complete protection from the encephalitic disease. In 
contrast, mortality was slightly higher in infected wt mice that received MVE-primed 
T cells, indicating that these cells do not play a protective role during MVE infection 
and that they may even contribute to pathogenesis.
5.2 Introduction
The immune response plays an important role in the production of lesions in the 
host. Such lesions are characteristic of the disease during infection with certain viruses. 
For instance they occur for infections with hepatitis B virus (Ando et al., 1993), LCMV 
(Buchmeier et ah, 1980; Bosma et ah, 1983; Custer et ah, 1985), Sindbis virus (Levine 
et ah, 1991; Levine and Griffin, 1993) and Semliki Forest virus (Levine et ah, 1991; 
Fazakerley and Buchmeier, 1993). These viruses, normally pathogenic in 
immunocompetent mice, are avirulent or produce reduced pathology in animals that are 
unable to mount an effective immune response.
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There are currently a few reports where B- and T-cell-deficient mice with a 
defect in the recombinase-activation gene function-1 (RAG-1-/-) have been used in the 
study of encephalitic falaviviruses (Mombaerts et al., 1992; Diamond et ah, 2003;
Hebeis et ah, 2004), and there are some reports where mice with the severe combined 
immune deficiency mutation (SCID) (Bosma et ah, 1983; Halevy et ah, 1994; Campbell 
and Pletnev, 2000; Pletnev et ah, 2000; Leyssen et ah, 2001; Pletnev, 2001; Charlier et 
ah, 2002; Leyssen et ah, 2003) have been used. The use of these immunodeficient mice 
has helped to understand the pathogenesis of WNV (Halevy et ah, 1994; Diamond et ah, 
2003). However, some aspects of the WNV pathogenesis differ from MVE/JEV 
pathogenesis, as discussed in section 1.4 of this thesis. Thus, the use of RAG-1-/- mice 
for the study of MVE pathogenesis is warranted.
Studies of flaviviruses in SCID mice are useful to elucidate some of the 
mechanisms of flavivirus neuroinvasiveness (Halevy et ah, 1994; Chambers and 
Nickells, 2001), tissue tropism (Mathur et ah, 1981; Wu et ah, 1995; An et ah, 1999; 
Chambers and Nickells, 2001) and for therapeutic purposes against flavivirus infections 
(Leyssen et ah, 2001; Charlier et ah, 2002). Nude mice that lack functional T cells 
(Nakamura et ah, 1985) and immunocompetent mice have been used for infection with 
the encephalitic flavivirus JEV, but disease only occurred in the former (Lad et ah, 
1993). The interpretation of these results remains ambiguous. T-cell help is required to 
switch B-cell immunoglobulin synthesis to the IgG isotype, which has a virus­
neutralizing property (Uren, 1987; Mathews et ah, 1991; Mathews et ah, 1992). Thus, 
the lack of protection of nude mice from JEV challenge could be due to the lack of a 
direct protective T-cell response, or to the lack of T help for the proper Ab response. 
Clear cases of flavivirus-induced T-cell immunopathology exist (Hirsch and Murphy, 
1968; Camenga and Nathanson, 1975; Semenov, 1975; Semenov et ah, 1975); however,
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there are many contradicting studies and the role of the cellular immune response in the 
protection or in the enhancement of flavivirus pathogenesis is unclear (for reviews see 
(Monath, 1986; Hill, 1993; Mullbacher et ah, 2003)).
An additional in vivo approach, which addresses the specific role of CD8+ T 
cells during flavivirus infections, is the use of mice with a knockout mutation in the 
ß2-microglobulin (ß2-M-/-) gene. The ß2-M-/- mice lack cell-surface expression of MHC 
class I antigen, which is necessary during positive selection of CD8+ T cells, and 
consequently these mice are deficient in CD8+T cells (Koller et al., 1990; Zijlstra et al., 
1990). Thus, the mouse model allows assessment of the role of CD8+ T lymphocytes in 
viral infection.
In this chapter, I use RAG-1-/- and ß2-M-/- mice to investigate if MVE-induced 
CNS disease is the result of viral infection per se, and/or if it is due to pathology 
mediated by lymphocytes. I also discuss complementary studies on MVE-immune T- 
and B-cells following passive transfer to MVE-infected wt mice, and investigate what 
their role is in the recovery from an infection, or if they contribute to disease.
5.3 Results
5.3.1 Mortality of RAG-1-/-, ß2-M-/- and wt mice after infection with 102 and
108 PFU of MVE, iv
I injected RAG-1-/-, ß2-M-/- and wt mice iv with an MVE dose of 102 PFU, to 
compare their susceptibility to the infection. Mortality in RAG-1-/- mice was 
significantly higher (91.3% versus 47% in the wt controls; P = 0.003), but delayed (17.1 
versus 11.5 days pi in the wt controls; P = 0.04) in comparison with wt mice (Table 
5.1). Contrary to the increase in mortality of RAG-1-/- mice, the mortality in ß2-M-/-
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mice was significantly reduced (13.7%: P = 0.03), and the ATD (13.7 days pi) delayed 
in comparison to wt mice (Table 5.1). The latter suggests that Tc cells played a 
detrimental role in wt mice infected with MVE.
Infection of B2-M-/- mice with 108 PFU of MVE, iv, resulted in 100% mortality. 
However, the ATD was delayed by ~1 day relative to wt mice (Table 5.1). I also 
infected three RAG-1-/- and three wt mice of 11 weeks of age with 10 PFU of virus iv 
(data not shown). One of the RAG-1-/- mice died at day 7 pi, while the other two died at 
day 11 pi. Two of the wt mice died at day 6 and one survived. Although there were only 
very small groups of 11-week-old mice available, the experiment revealed that there 
was a similar trend in the development of the disease as in the 6-week-old mice: RAG- 
1-/- mice died in higher numbers but with a delayed time to death.
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Table 5.1 Mortality of 6-week-old C57BI/6 mice after infection with 102 or 108 
PFU of MVE, iva
D ose
(P F U )
M ouse  stra in N * %  m o rta lity A TD  ± SEM
102 wt 17 47.0 11.5 ± 0 .6
RAG-1-/- 23 91.3 17.1 ± 2 .2
ß2-M-/- 22 13.7 13.7 ±1 .2
108 wt 19 100.0 5.5 ± 0 .2
ß2-M-/- 9 100.0 6.7 ± 0 .4
Mortality ratios are given for wt and mutant mice. 
b Number of infected mice per group.
c Average time to death (ATD), calculated in days ± standard error of the mean (±SEM).
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5.3.2 Kinetics of MVE growth in extraneural organs and brains of 
RAG-1-/- and ß2-M-/- mice
To assess the role of B and T cells in the clearance of MVE, I used 6-week-old 
mice that are deficient in both effector cells (RAG-1-/-), and mice that lack effector Tc 
cells (B2-M-/-); I used immunocompetent wt mice as controls. All mice received doses 
of 10“ or 10 PFU of virus iv to compare the kinetics of virus growth in organs such as 
spleen, lymph nodes (lymph nodes were not collected from RAG-1-/- mice due to their 
minute size), muscle and brain. The virus titers for wt mice infected with 10 PFU were 
taken from chapter 4 .1 collected extraneural tissues of the mice infected with 102 PFU
o
at days 6 and 8, brains at days 6, 8,12 and 14, and tissues of the mice infected with 10 
PFU at days 2, 3 and 4 pi. To test for viremia, I collected sera samples at days 1 and 2 
after infection with 10“ PFU of virus iv.
Virus growth in extraneural organs
I expected that the chance to detect virus in RAG-1-/- mice would be higher than 
in wt mice because the former would lack T- and B-cells. However, virus titers were 
below the limit of detection (103 PFU/g for spleen and muscle and 102 PFU/ml for 
serum; data not shown) after infection with 10 PFU. For ß2-M-/- and wt mice, spleen, 
muscle and lymph nodes were tested in parallel. Results of virus load in ß2-M-/- mice 
were also below the detection limit (data not shown). I also compared virus distribution 
in spleen and muscle of two moribund RAG-1-/- and wt mice infected with 10 PFU iv 
of MVE and sacrificed on days 12 and 14 pi. The spleen virus titers in RAG-1-/- and wt 
mice at day 14 pi were both low (~ 10 PFU/g). The virus content in muscle of a
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RAG-1-/- mouse at day 12 pi was slightly higher (1.5 x 104 PFU/g) than the 4 x 103 
PFU/g found in the wt mouse (data not shown).
When mice were infected iv with 108 PFU, virus titers in spleen of wt and 
B2-M-/- mice marginally decreased between days 2 and 4 pi. The opposite occurred in 
spleen of RAG-1-/- mice, where virus titers started to appear a day later than in the 
other mouse strains and were all positive on day 4 pi. Most of the spleens from wt and 
B2-M-/- mice showed no detectable titers by that day (Fig. 5.1 A).
Q
The results from virus titration in lymph nodes after infection with 10 PFU, iv, 
are shown in Fig. 5.1 B. Lymph nodes of B2-M-/- mice had comparable titers to those of 
wt mice, and showed a similar decline between days 2 and 4 pi.
o
Of the muscle tissues from mice that were infected with 10 PFU, iv, only 
samples from wt and RAG-1-/- mice had increased titers from day 2 to day 4 pi, while a 
muscle sample from a B2-M-/- mouse showed marginal virus titers of 103 PFU/g only at 
day 2 pi (Fig. 5.1 C).
In general, spleen and muscle from RAG-1-/- mice after infection with 108 PFU 
appear to support slightly higher (although delayed in the spleen) virus replication than 
tissues from B2-M-/- and wt mice. Results obtained from the infection of wt and B2.M-/- 
mice were comparable. They indicate that CD8+ lymphocytes do not appear to reduce 
virus growth.
Kinetics of neuroinvasion and growth of MVE in brains of infected
RAG-1-/- and B2-M-/- mice
Groups of RAG-1-/-, B2-M-/- and wt mice, infected with a dose of 102 PFU of 
MVE, iv, showed no detectable virus titers in the brain at days 6 and 8 pi (Fig. 5.2 A;
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only small groups of mice were available for this experiment). When I collected brain 
tissues from moribund RAG-1-/- mice at later times (days 12 and 14 pi), I not only 
observed positive titers, but also titer values of at least two logs higher than for the wt 
mice that were injected in parallel (Fig. 5.2 A). At day 12 pi, brain virus titers were as 
high as 6.2 x 10 PFU/g in the moribund RAG-1-/- mouse, compared with 1.6 x 10 
PFU/g in the moribund wt mouse. At day 14 pi, MVE titers in brain tissue were 
4.4 x 109 PFU/g in the RAG-1-/- mouse, versus 1.3 x 106 PFU/g in the wt mouse. I also 
tested the brains of two B2-M-/- asymptomatic mice that were infected at the same time 
as the wt and RAG-1-/- mice with the same dose of 102 PFU of MVE iv, at days 12 and 
14 pi. These tests were negative (Fig. 5.2 A), which is consistent with the significant 
reduction in mortality that occurred in wt and RAG-1-/- mice (Table 5.1).
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Fig. 5.1 Growth of MVE in extraneural tissues of RAG-1-/- ( a ), ß2-M-/- (•) 
and wt mice (■). Six-week-old mice were infected with 108 PFU of MVE iv. At 
the indicated times, animals were sacrificed and virus titers in the spleen (A), 
lymph nodes (B) and muscle (C) were determined by plaque assay. The limit of 
detection of virus titers was 1 x 103 PFU/g of wet tissue and is indicated by the 
interrupted line.
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Figure 5.2 B shows a comparison of virus titers in brain tissue from RAG-1-/- 
and ß2-M-/- mice, relative to those from wt mice infected with 10 PFU of MVE. Virus 
titers increased in all the mouse strains between days 2 and 4 pi. At day 2 pi, virus 
content in the brains of wt and B2-M-/- mice was in the range of <103 to >106 PFU/g, but 
did not exceed 104 PFU/g for the RAG-1-/- mice. At day 3 pi, one out of six wt brains 
tested negative, but all the RAG-1-/- and B2-M-/- brains showed positive titers. The
Q C
lowest virus titers in the brain were in the range of 10 PFU/g in wt mice, 10 PFU/g in 
RAG-1-/- mice, and 106 PFU/g in B2-M-/- mice, but all three strains had comparable 
maximum titers of 2x l08 PFU/g. All brains from the RAG-1-/- and B2-M-/- mice at day 
4 pi had virus titers in the range of 109 PFU/g. In contrast, three out of six wt mice 
showed a virus content in brain that was 4 logs lower. It is of interest that, despite 100% 
mortality found in the groups of 6-week-old wt and B2-M-/- mice that were inoculated 
with 108 PFU of MVE, iv, (mortality of RAG-1-/- mice was not tested at this dose), a 
significant number of wt — but not B2JM-/- mice — had low or undetectable titers in the 
brain on days 3 and 4 pi.
5.3.3 Anti-MVE Ab response in ß2-M-/- mice
Because B2-M-/- mice still retain their CD4+ T-cell function, T-cell help is 
available for induction and isotype switching in anti-viral humoral immunity. I 
compared antibody levels in B2-M-/- and wt mice in parallel, after they were infected 
with 10s PFU of virus, iv. Serum samples were tested at days 5, 10, 15 and 21 pi. Mice 
of both strains showed 100% seroconversion at all time points. Ab titers ranged from 
2.0 to 4.1 Logio, with no marked difference between groups of B2-M-/- and wt mice 
(Table 5.2). I also confirmed that sera from MVE-infected RAG-1-/- mice did not show 
virus-reactive Ab detectable by ELISA.
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Fig. 5.2 Growth of MVE in brains of RAG-1-/- ( a ), ß2-M-/- (•) and wt mice 
(■). Six-week-old mice were infected with 102 (A) and 108 (B) PFU of MVE iv.
At the indicated times, animals were sacrificed and virus titers were determined 
by plaque assay. Control wt mice were not infected in parallel with the 
immunodeficient mice for the dose of 108 PFU. The lower limit of detection of 
virus titers was 1 x 103 PFU/g of wet tissue and is indicated by the interrupted 
line.
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T ab le  5.2 M V E -specific  Ab production  in 6 -w eek-o ld  C 57B I/6  w t and in
ß2.M -/- knockout m ice after in fection  w ith  105 PFU, iv
M ouse
stra in
N o ./
group
D ay %  S ero co n vers io n  
Pi
M ean Ab titer, 
logio (ran g e )3
w t 3 5 100 2.3 (2.0-2.6)
ß2“M -/- 3 5 100 2.2 (2.0-2.6)
w t 3 10 100 3.4 (3.2-3.5)
b 2-m -/- 3 10 100 3.5 (3.2-3.8)
w t 3 15 100 3.6 (3.5-3.8)
ß2-M-/- 3 15 100 3.7 (3.5-3.8)
w t 3 21 100 3.8 (3.5-4.1)
b 2-m -/- 3 21 100 4.0 (3.8-4.1)
a MVE-specific antibody titers were determined by ELISA, and end points were calculated as 
described in Materials and Methods, Chapter 2.
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5.3.4 Histopathology in brain and spleen of RAG-1-/- and ß2-M-/- mice
Table 5.3 shows a summary of histopathological manifestations and vims load 
for corresponding spleen and brain samples of RAG-1-/-, B2-M-/- and wt mice infected 
with 108 PFU of MVE, iv. The data from wt mice are taken from Table 4.3 for 
comparison. None of the samples from the two immunodeficient mouse strains showed 
histopathology (except one brain sample of a RAG-1-/- mouse at day 4 pi), despite 
frequently showing high vims titers. This result is distinct from that for wt mice, which 
generally had a histopathology that corresponded with the presence of vims in brain on 
day 4 pi.
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Table 5.3 Histopathology results of ß2-M-/-, RAG-1-/- and control wt mice 
infected with 108 PFU of MVE iv
B rain  S p leen
M ouse
stra in
D ay
pi
H is to lo g y P laq u e
ass ay
H is to lo g y P laqu e
assay
ß2-M -/- 2 norm al 1 .5x10s norm a l 4 x1 0 3
2 norm al 8x104 norm al 1 .5x103
2 norm a l < 103 norm a l 2 x1 03
3 norm a l 2 .7 x1 08 norm a l < 103
3 norm al 3.5x10® norm al 4 x 1 03
3 norm a l 1.3x10® norm al < 103
4 norm a l 2 .7 x 1 09 norm a l < 103
4 norm a l 4 .3 x 1 09 norm a l < 103
4 norm a l 7 .2 x1 0 9 norm a l < 103
R A G -1-/- 2 norm a l 1x104 norm a l <10®
2 norm al 1 .5x103 norm a l < 10 3
2 norm a l < 103 norm a l < 10 3
3 norm a l 1.8x10® norm al < 10 3
3 norm a l 4.5x10® norm al 4 x 1 03
3 norm a l 3 .6 x1 0 7 norm a l 4 x1 03
4 norm a l 1x10® norm al 6 x1 03
4 extens ive  pvi 9 x1 09 norm a l 3 x1 03
4 norm a l 4 .9 x 1 09 norm a l 1 .7x104
wt 2 norm al 1 .5x104 reactive , red pulp 
en la rged , w h ite  pu lp  
w ith se co nd a ry  fo llic les
5x10®
2 norm al 2 x1 04 reactive , red pu lp  
en la rged , w h ite  pu lp  
w ith se co nd a ry  fo llic les
2x103
2 norm a l 4 .5 x 1 03 red pu lp  en la rged 5x103
3 norm a l 2.2x10® reactive 1.5x10®
3 norm al 9 .5 x1 0 3 reactive 4x10®
3 extens ive  pvi 2 .2 x 1 07 reactive 3x10®
4 extens ive  pvi 2 .7 x1 09 reactive 1.5x10®
4 extens ive  pvi 6x10® reactive <10®
4 m a in ly  pvi 5.4x10® reactive <10®
normal: no histological lesions, similar to mock-infected mice (data not shown), 
pvi: perivascular infiltration.
reactive: reaction of the spleen to antigens with the development of secondary follicles.
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5.3.5 Passive transfer of MVE-primed B and T cells to MVE-infected wt
mice
The results in this chapter show, somewhat paradoxically, that mice that lack 
effector Tc cells (B2-M-/- mutation) are significantly more resistant to MVE infection 
than wt mice. Thus, it was of interest to know if passive transfer of anti-MVE B or T 
cells to wt recipient mice would give rise to immunopathology.
I generated anti-MVE effector cells by infecting wt donor mice withlO2 PFU of 
MVE, iv, and collected spleens 6 days pi. I separated CD4+ and CD8+ T cells from B
n
cells with nylon wool and injected 4 x 1 0  anti-MVE effector B or T cells into wt mice 
that had three days previously received 10 PFU of MVE, iv. The controls were six 
mock-infected mice that received anti-MVE T or B cells, and six mice that were iv 
infected with 10“ PFU of MVE only. The possibility of virus contamination in 
transferred splenocytes was tested by plaque assay: the assays were all negative. The 
fact that mock-infected recipient mice did not show signs of infection also suggests that 
no infective virus was contaminating the transferred cells.
All five mice that received MVE-immune B cells (78% pure) survived MVE 
infection, whilst 50% died in the control group of six mice that received the virus but 
not the immune B cells (Fig. 5.3 A).
Passive transfer of MVE-primed T splenocytes (73% pure) into MVE-infected 
mice resulted in 66% mortality in a group of six MVE-infected recipients. Of the seven 
infected non-recipients, 42.8% died, and none of the mock-infected recipients died (Fig. 
5.3 B). It is not known if contaminating B cells among transferred T splenocytes 
contributed to survival. Thus, due to difficulties in obtaining pure B- and T-cell 
populations, the transfer experiments have to be interpreted with some reservation. 
Nevertheless, they show interesting trends, particularly in the T-cell transfers. In
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summary, passive transfer of MVE-immune B cells offers protection, while transfer of 
T cells to MVE-infected wt mice does not offer protection to the infected recipients, but 
shows a slight (although statistically not significant) increase in mortality compared 
with the non-recipient infected mice.
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Fig. 5.3 Mortality in groups of wt mice infected iv with 102 PFU of 
MVE, after passive transfer of MVE-immune B cells (A) and MVE- 
immune T cells (B).
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5.4 Discussion
Due to their B- and T-cell deficiencies, respectively, RAG-1-/- and B2-M-/- 
animals provide unique mouse models to assess the role of the two lymphocyte 
populations in recovery from, or exacerbation of, MVE infection. To complement the 
two mouse models, passive transfer of MVE-immune B and T cells to MVE-infected wt 
recipients was performed.
Mortality of RAG-1-/- mice after infection with a low MVE dose was 
significantly increased (P = 0.003), but accompanied by a delay in ATD of 6 days (P = 
0.04) compared to wt mice. The high mortality of MVE-infected RAG-1-/- mice was 
most likely due to the lack of an Ab response. This lack probably occurred because 
there was protection provided by transfer of MVE-immune B cells. Such a lack was also 
shown in numerous studies by others that studied the importance of Ab in survival of 
flaviviras infection (Mathur et al., 1982; Heinz et al., 1983; Mathews and Roehrig,
1984; Monath, 1986; Schlesinger et al., 1986; Kimura-Kuroda and Yasui, 1988; 
Kaufman et al., 1989; Mason et al., 1989; Schlesinger and Chapman, 1995; Kreil and 
Eibl, 1997; Broom et al., 2000; Roehrig et al., 2001; Ben-Nathan et al., 2003; Diamond 
et al., 2003). The small number of RAG-1-/- mice that survived infection with a low 
MVE dose in my experiments could be due to protection conferred by their unimpaired 
innate immunity. The fact that the immunodeficiency in RAG-1-/- mice could prolong 
survival, but at the cost of increased mortality, strongly indicates that the T-cell immune 
response may have a pathogenic role in MVE infection. Consistent with the delayed 
ATD in rag mice infected with a low dose of MVE, clinical signs of disease and virus in 
the brain were detectable ~4 days later than in wt mice. However, virus content in the 
brain of RAG-1-/- mice at late times pi was very high (>109 PFU/g). This probably
reflects that there was a reduced virus clearance in the brain due to the loss of B- and T-
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cell function, and/or that the longer time interval allowed virus to grow in the brain prior 
to the death of the animals.
o
Results on MVE load in tissues of RAG-1-/- mice after infection with 10 PFU 
showed that these mice had a delayed, but more efficient, vims replication than B2 -M-/- 
and wt mice. At the early time pi, virus load in the brains of RAG-1-/- mice was lower 
than vims load in the brains of wt and B2 -M-/- mice. However, at later times, vims titers 
in brains of RAG-1-/- mice were as high as for wt and B2-M-/- mice. The delayed but 
increased mortality and detection of vims in RAG-1-/- mice suggests both a negative 
and positive input of the adaptive immune response: negative, in the sense that lack of 
adaptive immunity seems to delay vims entry into the brain and mortality; and positive, 
in the sense that the immune responses are required to prevent massive virus replication 
and increased mortality.
Contrary to the results obtained in RAG-1-/- mice, the mortality of B2 -M-/- mice 
after infection with a low dose of MVE iv, was significantly reduced (P  =  0.03) relative 
to wt mice. This suggests that CD8+ T cells are detrimental in recovery from MVE 
infection in mice. Alternatively, cell surface MHC class I could have played a role in 
MVE infection, for instance as a receptor for the vims. However, this latter notion was 
refuted by the experiments discussed in Chapters 6 and 7. A more efficient humoral 
immune response is unlikely to have contributed to the increased resistance of B2 -M-/- 
mice to MVE (relative to wt mice). This result is similar to results found with other 
virus models such as vaccinia and vascular stomatitis (Spriggs et al., 1992). Virus- 
specific Ab titers in semm of MVE-infected B2 -M-/- and wt mice did not differ 
significantly. Chapters 6 and 7 further explore and discuss a putative CD8+ T cell- 
mediated mechanism for vims entry into the brain that may have accounted for the
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increased survival of B2 -M-/- mice from infection with MVE in the absence of CD8T+ 
cells.
In the absence of CD8+ T cells, growth of MVE in extraneural tissues was not 
significantly augmented relative to wt mice. Accordingly, the poor growth of MVE in 
extraneural tissues of adult mice, in general, is not the result of an anti-viral function of 
MVE-immune CD8+ T cells but more likely due to innate immunity, in particular type I 
interferon, as shown in Lobigs et al. (2003). It is possibly an early antiviral Ab response. 
The fact that MVE-infected B2 -M-/- mice did not show more virus replication in the 
brain than wt mice has been observed in other virus models. For example, infection of 
B2 -M-/- mice with Sindbis virus (SV) (Kimura and Griffin, 2000) or reovirus (Major and 
Cuff, 1997) resulted in virus clearance. In the case of SV, there was no difference in 
virus load compared with to wt mice (Kimura and Griffin, 2000). It has been postulated 
that CD4+ T cells may play a more prominent role in control of virus infection when 
CD8+ T cells are absent, by increasing their cytotoxicity and numbers. For example, 
phenotypic analysis of splenic lymphoid cells of ß2 -M-/- mice showed that there was an 
increase in CD4+ cell subsets (Spriggs et al., 1992).
Histological analyses of brains from MVE-infected B2-M-/- and RAG-1-/- mice 
show that there is less inflammatory cell infiltration than in the brains of infected wt 
mice. This is consistent with their respective lack of splenocyte subpopulation, and with 
studies that show that most of the inflammatory cells in the brains of 6-week-old WNV- 
infected wt mice are CD8+ T cells (Liu et al., 1989; Wang et al., 2003). Wang et al. also 
showed that B2 -M-/- mice infected with WNV had reduced histopathology and a 
prolonged survival time (Wang et al., 2003).
Experiments on the passive transfer of MVE-immune T or B cells into MVE- 
infected wt mice give some indication on the role of these cells in the recovery from, or
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exacerbation of, infection. Transfer of T cells to MVE-infected wt mice does not 
contribute to protection; on the contrary, it appears to give rise to a slight increase in 
mortality. Given that no death occurred in any of the recipient mice, passively 
transferred MVE-immune B cells clearly have a protective function,.
In summary, the results in this chapter indicate that B cells are vitally important 
for protection from MVE infection, a finding which is consistent with previous studies 
(Mathur et al., 1982; Heinz et al., 1983; Mathews and Roehrig, 1984; Monath, 1986; 
Schlesinger et al., 1986; Kimura-Kuroda and Yasui, 1988; Kaufman et al., 1989; Mason 
et al., 1989; Roehrig et al., 1989; Schlesinger and Chapman, 1995; Kreil and Eibl, 1997; 
Broom et al., 2000; Libraty et al., 2002; Ben-Nathan et al., 2003; Diamond et al., 2003). 
Contrarily, the lack of CD8+ T cells has a positive effect on the recovery from MVE 
infection. The main mechanisms of cytotoxicity of T cells, namely the degranulation 
and Fas pathways, could be responsible for the increased pathology mediated by CD8+
T cells in MVE infection, and are studied in Chapters 6 and 7.
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6.1 Summary
In this chapter, I describe MVE pathogenesis in mice with a deficiency in 
different subsets of the effector functions of cytotoxic (NK/Tc) cells. I used C57B1/6 
mice with knockout (ko) mutations in the perforin gene (perf-/-), the granzymes A and 
B genes (gzmAxB-/-), and the perfxgzmAxB-/- genes to evaluate the role of the 
degranulation pathway of cytotoxicity during MVE challenge. Fas ligand mutant (gld) 
mice, and Fas receptor mutant (Ipr) mice allowed the investigation of the role of the Fas 
pathway of cytotoxicity in recovery or disease following MVE infection. Mice with a 
deficiency in the gamma interferon receptor (IFN-yR-/-) were also tested. I used 
syngeneic wild-type (wt) mice as controls. Most of the immunodeficient mice (except 
the Ipr and IFN-yR-/- mice) showed a reduction in mortality and morbidity, compared 
with the wt controls. However, the virus load in tissues of mice with a deficiency in 
cell-contact-mediated cytotoxicity (perforin/granzymes and Fas) was slightly increased, 
relative to that of controls. Additionally, these mice showed earlier neuroinvasion of the 
virus, in comparison with wt mice. These data confirm the importance of cell-mediated 
cytotoxicity in virus clearance, but also suggest that it can contribute to increased 
disease.
6.2 Introduction
The humoral immune response is the main mechanism of protection during 
flaviviral infections (Heinz et al., 1983; Mathews and Roehrig, 1984; Schlesinger et al., 
1986; Kimura-Kuroda and Yasui, 1988; Kaufman et ah, 1989; Mason et ah, 1989; 
Schlesinger and Chapman, 1995; Kreil and Eibl, 1997; Broom et ah, 2000; Roehrig et
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al., 2001; Libraty et al., 2002; Ben-Nathan et al., 2003; Diamond et al., 2003a; Diamond 
et al., 2003b). However, humoral immunity in primary flavivirus infections is not 
always sufficient to prevent fatal encephalitis.
Cytotoxic NK and Tc cells exert their effector function by two different 
mechanisms: 1) by cellular cytotoxicity, through the degranulation pathway 
(perforin/granzymes) or the Fas pathway (Kagi et al., 1994) and 2) by cytokines such as 
gamma interferon (IFN-y) (Boehm et al., 1997) and tumor necrosis factor alpha (TNF-a) 
(Vassalli, 1992). The cytotoxic functions of NK and Tc cells are critical for immunity 
against some virus infections, and also contribute to the pathogenesis of other viral 
diseases (Harty et al., 2000). IFN-y is crucial to control a number of neurotropic viral 
infections (Finke et al., 1995; Geiger et al., 1997). The importance of IFNs in the 
recovery from encephalitic flavivirus infections has been shown in vivo through the 
administration of IFN inducers (Haahr, 1971; Vargin et al., 1977; Taylor et al., 1980) 
and through the administration of recombinant IFNs (Pinto et al., 1988; Brooks and 
Phillpotts, 1999). The presence of IFN-y in vitro studies has shown inhibition of JE 
virus production by infected monocytes (Hasegawa et al., 1990).
Mice used in this study — perf-/- single ko mice, gzmAxB-/- double ko mice, 
and perfxgzmAxB-/- triple ko mice — are viable, fertile and display normal numbers of 
CD8+ and NK cells (Blink et al., 1999), in which the Fas pathway of cytotoxicity is still 
functional. On the other hand, a deficiency in either Fas (Ipr mutation) or Fas ligand 
(gld mutation) results in accumulation of aberrant T cells, which leads to 
lymphoadenopathy and splenomegaly (Igney et al., 2000). Thus, Fas-deficient mice die 
of lymphoproliferative disease around 25 weeks of age (Kagi et al., 1999). Mice with a 
targeted disruption of the IFN-yR-/- gene help to investigate the role of that cytokine
(made exclusively by NK and T cells) during MVE pathogenesis. The IFN-yR-/- mice
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have an impaired production of nitric oxide by monocytes and a reduced expression of 
MHC classes I (Chou et ah, 2000) and II (Dalton et al., 1993). The IFN-yR-/- mice have 
been used during infection with dengue (Johnson and Roehrig, 1999) and yellow fever 
(Liu and Chambers, 2001) viruses in mice. The IFN-yR-/- mice have been recently used 
in the infection of MVE by Lobigs et al. (Lobigs et al., 2003).
The specific aims of the work described in this chapter were therefore: a) to 
characterize the role of perforin, granzymes A and B, Fas and IFN-yin MVE 
pathogenesis and recovery, by using mice with a deficiency in those effector molecules, 
and b) to assess the role of cytotoxicity versus other effector mechanisms of antiviral 
immunity (e.g. the antibody response) during in vivo MVE infection.
6.3 Results
6.3.1 Mortality caused by MVE in mice with a deficiency in degranulation, 
Fas, and IFN-y receptor
In the experiments described in this chapter, I infected 6-week-old perf-/-, 
gzmAxB-/-, perfxgzmAxB-/-, gld and Ipr mice with doses ranging from 0.1 to 108 PFU 
of MVE iv, and one group of IFN-yR-/- mice of matching age with 10“ PFU of MVE iv. 
Subsequently, I observed the mice for three weeks after infection, and recorded the 
percentage mortality and average time to death (ATD) (Table 6.1).
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Role of the degranulation pathway (perforin and granzymes) of 
cytotoxicity in MVE pathogenesis
The groups of perfgzmAxB-/- ,  and perfxgzmAxB-/- ko mice that were 
inoculated with virus doses of 0.1, 10“, 10 and 10 had reduced mortality in comparison 
to wt mice. There was no dose-dependent increase in mortality. All ko mice infected 
with 0.1 PFU of virus showed a slightly reduced and delayed mortality rate, when 
compared with wt mice. Mortality in perf-/- mice was 33% (P = 0.18), in gzmAxB-/- 
mice 28% (P =  0.07) and in perfxgzmAxB-/- mice 33% (P  =  0.37), in contrast to 59% 
mortality in wt mice (Table 6.1). After infection with 102 PFU of MVE, mice showed 
the following percentages of mortality: perf-/- mice 20% (P = 0.09), gzmAxB-/- mice 
25% (P = 0.12), perfxgzmAxB-/- mice 32% (P = 0.86), and wt mice (46%). Of the ko 
mice, I only infected a group of perf-/- mice with a dose of 103 PFU of MVE. These, 
consistent with the 0.1 and 10“ PFU doses, produced a reduced mortality of 38% (P = 
0.43), in comparison with a mortality of 56% in wt mice. The mortality after infection 
with a dose of 105 PFU of MVE was 33% (P = 0.09) in perf-/- mice, compared with 
40% in the wt mice. When the mortality data, obtained from the doses that gave rise to 
close to 50% mortality (0.1 to 103 PFU) for the perf-/- and gzmAxB-/- mice are 
summed up, a statistically significant increase in resistance to MVE infection is found 
for the two strains (P = 0.022 and 0.014, respectively; Fisher’s exact test). Given the 
relatively small number of perfxgzmAxB-/- mice that were available for this study, the 
difference in combined mortality between these ko mice (8 dead, 17 alive) and the wt 
mice (59 dead, 59 alive) is not statistically significant (P = 0.125).
o
All mouse strains infected with 10 PFU of virus showed 100% mortality after 5 
to 6 days pi. However, the ATD was marginally delayed, in comparison with the wt 
mice, in mice that lacked subsets of the cytotoxic pathways (Table 6.1). On average, wt
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mice died at day 5.5, perf-/- mice at day 6.6, gzmAxB-/- mice at day 6.4, and 
perfxgzmAxB-/- mice at day 9.4 pi, showing a significant increase in ATD relative to 
wt mice (P = 0.009; Mann-Whitney test). Clinical signs appeared a day earlier in the wt 
mice (day 4) than in most of the mutant mice (data not shown). Additionally, the 
majority of the mutant mice showed clinical disease (i.e., encephalitis and hind leg 
paralysis) for a shorter period (2-3 days) than the wt mice, which developed severe 
clinical signs of disease early, and died within 24 h of disease onset (data not shown).
In summary, the data in Table 6.1 indicate that the granule exocytosis-mediated 
cytotoxicity of NK/Tc cells has no protective value in MVE infection, and that it 
appears to accelerate the fatal outcome of viral growth in the CNS, and increase the 
mortality rate.
Role of the Fas-mediated pathway of cytotoxicity in MVE pathogenesis
When I infected groups of Ipr and gld mice with 0.1 PFU of MVE, they had a 
mortality of 40% and 33% respectively; this is a reduced mortality compared with wt 
mice (59%), although not statistically significant, with P-values of 0.46 for Ipr mice and 
0.37 for gld mice in comparison with wt mice (Table 6.1). After MVE infection with 
102 PFU, gld mice showed a slightly reduced mortality, of 27% (P = 0.33), compared 
with 46% in the wt mice, but Ipr mice showed a slightly increased mortality of 55%, an 
increase that was not statistically significant (P = 0.74). A viral dose of 105 PFU 
resulted in a similar situation: a slightly reduced mortality for the gld mice (36%; P = 
0.69) and an increased mortality in the Ipr mice (80%; P = 0.20) in comparison with the 
wt mice (40%). The mortality after infection with 108 PFU of MVE was 100% in the
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gld, Ipr and wt mice. After inoculation of this high dose, clinical signs started to appear 
at day 4 in the wt and Ipr mice, and at day 6 in gld mice. The average time to death was 
similar in the wt and Ipr mice (days 5.5 and 5.8 pi, respectively), but was significantly 
delayed to day 6.8 pi (P = 0.014) in the gld mice. The similar pattern in the mortality 
rate of the Ipr and wt mice may be due to the Ipr mutation being ‘leaky’, whereby small 
amounts of functional Fas are expressed in those mutant mice (Booker et al., 1998).
To conclude, this part of the study indicates that the Fas pathway of cytotoxicity 
has no protective role in MVE infection.
Role of IFN-y in recovery from MVE infection
NK/Tc cells also exert an antiviral function via a nonlytic pathway that involves 
cytokines (Ruby and Ramshaw, 1991; Biron, 1994). IFN-yis secreted by T and NK 
cells and plays an important role in many antiviral immune responses (Ruby and 
Ramshaw, 1991; Young and Hardy, 1995). When I gave 6-week-old IFN-yR-/- mice a 
peripheral infection with a small dose of MVE iv (102 PFU), they showed a similar time 
to death of 11.6 days as the wt mice (comparative data for wt mice taken from Table 
4.1), but displayed an increase in mortality (73%; P = 0.44) from encephalitis compared 
with the 46% of wt mice. This result suggests that the lack of the cytokine receptor 
enhances the susceptibility of mice to MVE.
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6.3.2 Virus growth in tissues of wt mice and mice with a deficiency in either the 
granule exocytosis or the Fas pathway of cytotoxicity
I infected groups of perf-/-, gzmAxB-/-, perfxgzmAxB-/-, gld, Ipr and wt mice 
with 102 PFU of MVE and groups of perf-/-, gld, Ipr and wt mice with 10s or 108 PFU 
of MVE. The data for virus titers in organs of wt mice infected with 108 PFU were taken 
from chapter 4. I collected spleen, lymph nodes, muscle and brain on days 4, 6 and 8 
after infection with 102 PFU, on days 2, 4, 6 and 8 after infection with 10s PFU, and on 
days 2, 3 and 4 pi after infection with 108 PFU of MVE.
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Table 6.1 Mortality of 6-week-old C57BI/6 mutant and wt mice that are 
defective in the NK/Tc-cell granule exocytosis-mediated  
cytotoxicity, in the Fas-mediated cytotoxicity, or in IFN-y receptor, 
following iv infection of MVE
Dose(PFU) Mouse strain Na % mortality0 ATD ± S E M C
0.1 wt 27 59 10.3 ± 0.6
perf-/- 12 33 11.0 ± 0.7
gzmAxB-/- 18 28 11.6 ± 0.6
perfxgzmAxB-/- 6 33 11.0 ± 1.0
g ld 10 40 12.3 ± 1.5
Ipr 6 33 14.0 ± 0.0
102 wt 70 46 11.6 ± 0.4
perf-/- 15 20 12.3 ± 2.2
gzmAxB-/- 20 25 10.8 ± 1.5
perfxgzmAxB-/- 19 32 12.5 ± 0.3
g ld 11 27 11.7 ± 0.7
Ipr 11 55 11.3 ± 1.1
IFN-yR-/-d 22 73 11.6 ± 0.4
103 wt 9 56 12.0 ± 0.8
perf-/- 16 38 12.0 ± 0.7
105 wt 20 40 10.9 ± 0.8
perf-/- 12 33 13.3 ± 1.0
g ld 14 36 12.8 ± 1.0
Ipr 10 80 10.8 ± 0.6
108 wt 19 100 5.5 ± 0.2
perf-/- 10 100 6.6 ± 0.2
gzmAxB-/- 6 100 6.2 ± 0.4
perfxgzmAxB-/- 5 100 9.4 ± 1.4
g ld 10 100 6.6 ± 0.3
Ipr 5 100 5.8 ± 0.2
a Number of mice infected.
b Mortality percentages are given for wt and mutant mice.
c The average time to death (ATD) was calculated in days ± standard error of the mean 
(±SEM).
d Mouse strain representing the cytokine effector mechanism of NK/Tc cells.
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Kinetics of MVE replication in extraneural tissues of mice with a 
deficiency in the cytotoxicity pathways
Virus was not detectable (<10 PFU/g of wet tissue) in kidney or liver samples, 
or in blood (<10 PFU/ml) at any time, after infection with the low or medium doses in 
any of the mouse strains (data not shown), even though all the mice had seroconverted
o
(Table 6.2). I only observed low levels of viremia at day 1 pi, after infection with 10 
PFU of virus in all the mice tested (wt, gld and Ipr); titers ranged from 102 to 
101 PFU/ml. Virus detected in blood at this time might have been the remainder of high 
dose inocula, and disappeared at day 2 pi (data not shown).
When I tested spleen (Fig. 6.1), lymph nodes (Fig. 6.2), muscle (Fig. 6.3), 
serum, liver and kidneys (data not shown) by plaque assay, the results showed no 
significant differences between the different mouse strains. I detected spleen virus titers
' i
just above the limit of detection (10 PFU/g) when ko, mutant and wt mice were 
inoculated with the low (Fig. 6.1 A) or medium (Fig. 6.1 B) doses of MVE, but only in
o
a few samples. After infection with 10 PFU of MVE, the virus titers in the spleen 
declined with time in all the mouse strains: virus load in all the mouse strains increased 
to 104 PFU/g at day 2 pi, and only half of the mouse groups tested positive (with 
103 PFU/g) at day 4 pi (Fig. 6.1 C). MVE was detected in the lymph nodes in only two 
of 61 samples taken from the different strains (one in a gld and the other in an Ipr 
mouse) after infection with 102 and 105 PFU of MVE (Fig. 6.2 A and B). After infection 
with 108 PFU of virus, titers gradually declined with time in lymph node samples of wt 
mice, but remained positive in most of the immunodeficient mice (Fig. 6.2 C). Virus 
titers in muscle were hardly detectable after infection with low to medium doses: only 
one perfxgzmAxB-/- and one gzmAxB-/- mouse had detectable virus titers at day 8 pi 
(after infection with 10 PFU), but none of the other 82 mutant or wt mice had
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detectable virus titers. I detected virus in muscle mainly after infection with 10 PFU. 
Titers increased from 10 to 10 PFU/g from day 2 to 4 (Fig. 6.3 C). I did not observe a 
consistent difference in the growth kinetics, or in the values of the virus titers, in 
extraneural tissues, between the mice that are defective in NK/Tc-cell cytotoxic effector 
mechanisms and the wt mice. Given the apparent inability of extraneural tissues to 
support efficient growth of MVE, it is not possible to say whether: 1) NK/Tc-cell- 
mediated cytotoxicity contributes to the control of virus infection in these tissues, or 2) 
the level of virus titers in extraneural tissues is a factor that determines the incidence of 
neuroinvasion, and can thus account for the variability between individuals in the 
susceptibility to infection with MVE.
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Fig. 6.1 Growth of MVE in spleen of mice with a deficiency in either the 
degranulation or Fas pathway of cytotoxicity. Mice were infected with 102 (A), 
1Cr (B) and 108 (C) PFU of MVE iv. At the indicated times, animals were 
sacrificed and virus titers were determined by plaque assay. The lower limit of 
detection of virus titers was 1 x 103 PFU/g of wet tissue and is indicated by the 
interrupted line.
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Fig. 6.2 Growth of MVE in lymph nodes of mice with a deficiency in either 
the degranulation or Fas pathway of cytotoxicity. Mice were infected with 102 
(A), 105 (B) and 108 (C) PFU of MVE iv. At the indicated times, animals were 
sacrificed and virus titers were determined by plaque assay. The lower limit of 
detection of virus titers was 1 x 103 PFU/g of wet tissue and is indicated by the 
interrupted line.
Chapter 6: MVE pathogenesis in mice deficient in cytotoxic pathways
166
A 102 PFU
• o
O
•  O
•  O
«
<
ooo••
□□□
■ ■
■
■ ■■
■
□
□
□
••
•
o
o
o
o
o
►►
►
»
»
4 6 8
■ wt 
□  perf-/-
•  perfxgzmAxB-/- 
O gzmAxB-/- 
A g ld  
A  Ipr
—  lim it of detection
2 4 6 8
C
3
T -
U)
o
3
Li.
CL
108 PFU
▲
I D  4 Ä
A
a
■
■ A A
---
---
---
---
---
---
---
---
---
-1
□ ►
►
►
►
►
>
> <
□
□
■
■
■
■
<
<□
■
■
■
2 3 4
day post-infection
Fig. 6.3 Growth of MVE in muscle of mice with a deficiency in either the 
degranulation or Fas pathway of cytotoxicity. Mice were infected with 102 (A), 
1(r (B) and 108 (C) PFU of MVE iv. At the indicated times, animals were 
sacrificed and virus titers were determined by plaque assay. The lower limit of 
detection of virus titers was 1 x 103 PFU/g of wet tissue and is indicated by the 
interrupted line.
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Kinetics of MVE replication in brains of mice with a deficiency in the
cytotoxic pathways
To determine whether the reduced severity of the disease in the deficient mice 
was due to a reduced viral load in the brain, groups of 6-week-old perf-/-, gzmAxB-/-, 
perfxgzmAxB-/-, gld, Ipr and wt mice were infected iv with 10“ PFU of MVE, and a 
second group of perf-/-, gld, Ipr and wt mice were infected with 10' or 10 PFU of 
MVE. I collected mouse brains at the same pi times as the extraneural tissues described 
above.
After inoculation of 10 PFU of MVE, I found low titers of virus from day 6 pi 
in brains of a few deficient mice of the gld, Ipr and perfxgzmAxB-/- groups, but I did 
not detect virus in the brains of wt, perf-/- or gzmAxB-/- mice at this stage. By day 8 pi,
I found virus in six out of eight wt mice, with titers that ranged from 10 to 10 PFU/g; 
in two out of six perf-/- mice, with titers of 107 PFU/g; in two out of four perfxgzmAxB- 
/- mice, with titers of close to 109 PFU/g; in four out of six gzmAxB-/- mice, with 
variable virus titers that ranged from 104 to 109 PFU/g; and in two out of six gld mice, 
with 107 to 108 PFU/g MVE titers (Fig. 6.4 A).
After inoculation of 10s PFU of MVE, none of the wt mice and only a few 
deficient mice showed detectable virus titers in the brain: on day 6 pi, one gld mouse 
showed a virus titer of 104 PFU/g; and on day 8, two perf-/- mice, all three gld mice and 
two out of three Ipr mice showed virus titers that ranged from 10 to 10 PFU/g 
(Fig. 6.4 B). These results indicate that, after infection with low or medium doses of 
virus, the wt mouse brains show a delayed detection of virus and/or a reduction in virus 
titers compared with mutant mice. This happens despite the higher mortality of groups 
of wt mice, relative to mutant mice. This observation is valid until the last day of testing
(day 8 pi).
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o
Infection with 10 PFU of virus iv gave detectable virus titers at day 2 pi in 
brains of most animals: ranging from 103 to 106 PFU/g, and increasing to a value of 108 
PFU/g on day 3 pi, and 109 PFU/g on day 4 pi in all the deficient mice, and in some of 
the wt mice. The mean titers of MVE in the brains of the four strains of mice were 
similar, although titers of wt mice showed more variation on days 3 and 4 pi, compared 
with the other groups (Fig. 6.4 C).
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Fig. 6.4 Growth of MVE in brains of mice with a deficiency in either the 
degranulation or Fas pathway of cytotoxicity. Mice were infected with 102 (A), 
10° (B) and 108 (C) PFU of MVE iv. At the indicated times, animals were 
sacrificed and virus titers were determined by plaque assay. The lower limit of 
detection of virus titers was 1 x 103 PFU/g of wet tissue and is indicated by the 
interrupted line.
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6.3.3 MVE-specific antibody responses in wt mice and mutants with a
deficiency in either the granule exocytosis or the Fas pathway of 
cytotoxicity
The humoral immune response against MVE in mice that are defective in either the 
granule exocytosis- or the Fas-mediated pathway of cytotoxicity was investigated to 
determine if the responses in these mice would differ (as had been reported for perf-/- 
mice by Sambhara et al. (1998)), and to verify if the mice had been productively 
infected. Given that vaccination of wt mice with 102 PFU (my results) or 106 PFU (Dr 
M. Lobigs) of UV-inactivated MVE does not induce MVE-specific Abs that are 
detectable by ELISA (data not shown), seroconversion of mice inoculated with live 
virus (0.1 to 105 PFU) was consistent with a productive infection (Table 6.2). Compared 
with the wt mice, there was a significant increase in the magnitude of the humoral 
immune response against MVE in some groups of gld mice, but not in the perf-/-, 
gzmAxB-/-, and Ipr mice (Table 6.2).
The Ab levels in 9-week-old perf-/- and wt mice, after infection with 102 PFU of 
MVE iv, were also investigated. Sera collected at day 25 pi did not show a significant 
difference between the two mouse strains. The 9-week-old mice did not show an 
increase in anti-MVE Ab levels compared with the 6-week-old mice (data not shown); 
thus, the increase of resistance of the older mice may not be due to an enhanced Ab
response.
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Table 6.2 MVE-specific Ab production in 6-week-old C57BI/6 wt mice and
mutant mice with a deficiency in either the granular exocytosis or 
the Fas pathway of cytotoxicity
Mouse strain Dose
(PFU)
No./
group
Day pi %
Seroconversion
Mean Ab titer 
Log10 (range)3
w t 0.1 6 10 100 3 .7  (2 .6 -4 .1 )
p e rf-/- 0.1 3 10 100 4 .0  (3 .8 -4 .1 )
g z m A x B -/- 0.1 4 10 100 4 .2  (4 .1 -4 .4 )
g ld 0.1 3 10 100 3 .7  (2 .6 -4 .4 )
w t 0.1 4 2 1 -2 5 100 4 .3  (3 .8 -4 .7 )
p e rf-/- 0.1 3 2 1 -2 5 100 4 .6  (4 .1 -5 .0 )
g ld 0.1 1 2 1 -25 100 5 .0  (5 .0)
w t 102 11 2 1 -32 100 4 .0  (2 .9 -4 .7 )
p e rf-/- 102 4 2 1 -32 100 4 .3  (4 .1 -4 .4 )
g z m A x B -/- 102 5 2 1 -32 100 3 .8  (3 .5 -4 .1 )
p e rfx g z m A x B -/- 102 8 2 1 -32 100 4 .0  (3 .8 -4 .1 )
g ld 102 8 2 1 -32 100 4 .5  (3 .5 -5 .0 ) b
Ip r 102 4 2 1 -32 100 4 .3  (3 .8 -4 .7 )
w t 105 3 21 100 3 .8  (3 .5 -4 .1 )
p e rf-/- 105 3 21 100 4 .0  (3 .8 -4 .1 )
g ld 105 3 21 100 4 .5  (4 .4 -4 .7 ) b
a MVE-specific antibody titers were determined by ELISA, and end points were calculated as 
described in Materials and Methods, Chapter 2.
b Statistically significant difference (P< 0.05; Mann-Whitney test) relative to values found in the 
groups of wild-type mice.
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6.3.4 Histopathology
The results of histopathology and virus load determinations for brain and spleen 
samples of wt, perf-/-, gld and Ipr mice, after infection with Iff PFU iv, are shown in 
Table 6.3.
Although histopathological changes and/or virus load in extraneural organs were 
rarely detected in the deficient mice after infection with 105 PFU of MVE, these were 
found more often in the mutant mice than in the organs of the wt mice. This corresponds 
with the observation that virus is more often present in tissues of the deficient strains 
(Table 6.3). Brains of the wt mice that were infected with 105 PFU of MVE yielded no 
virus when collected from day 2 to day 8 pi, which corresponds with the absence of 
histopathology. In contrast, the brains of perf-/-, gld and Ipr mice yielded virus at day 6 
and 8 pi, and showed histopathological lesions such as perivascular infiltration (pvi), 
meningitis and necrosis. Two of three brains from Ipr mice showed meningitis on day 2 
pi, and samples that gave rise to detectable virus at day 8 pi showed pvi in addition to
meningitis (Table 6.3).
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Table 6.3 Histopathology results of perf-/-, gld, Ipr, and control wt mice 
infected with 105 PFU of MVE iv
Brain Spleen
Mouse
strain
Days pi Histology Plaque assay Histology Plaque
assay
wt 2 normal <103 reactive <103
2 normal <103 normal <103
2 normal <103 normal <103
4 normal <103 normal 1x103
4 normal <103 normal <103
4 normal <103 normal 2x103
6 normal <103 normal nt
6 normal <103 normal nt
6 normal <103 normal <103
8 normal <103 normal nt
8 normal <103 normal nt
8 normal <103 normal nt
Perf-/- 2 normal <103 normal <103
2 normal <103 normal <103
2 normal <103 reactive <103
4 normal <103 reactive <103
4 normal <103 normal <103
4 normal <103 normal <103
6 normal <103 normal n t '
6 normal <103 normal nt
6 normal <103 normal nt
8 extensive pvi, meningitis 2.1x108 reactive nt
8 extensive pvi, meningitis, 
necrosis
3.4x107 very reactive nt
8 pvi, meningitis <103 reactive nt
gld 2 normal <103 reactive <103
2 normal <103 normal <103
2 normal <103 reactive <103
4 normal <103 reactive <103
4 normal <103 reactive <103
4 normal <103 very reactive <103
6 normal <103 normal nt
6 normal <103 normal nt
6 normal <103 normal nt
8 extensive pvi, meningitis 7x107 reactive <103
8 extensive pvi, meningitis 2.5x103 reactive <103
8 extensive pvi, meningitis 1.8x105 very reactive <103
Ipr 2 meningitis <103 very reactive <103
2 meningitis <103 reactive <103
2 normal <103 normal <103
4 normal <103 normal 5x103
4 normal <103 reactive 5x103
4 normal <103 normal <103
8 pvi, meningitis 1.6x109 reactive nt
8 normal <103 reactive nt
8 extensive pvi, meningitis 5x103 slightly reactive nt
normal: no histological lesions, similar to mock-infected mice (data not shown), 
pvi: perivascular infiltration, 
nt: not tested.
reactive: spleen reaction to antigens with the development of secondary follicles.
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6.4 Discussion
In general, the mortality patterns in the mutant mice showed a similar trend as in 
the wt mice. There were two kinetically distinct processes that lead to fatal encephalitis 
depending on: 1) a high virus dose with 100% mortality and, 2) a low to medium dose, 
with close to 50% mortality (as discussed in Chapter 4). Although there was no 
statistically significant difference in the mortality rate from different doses between the 
different mouse strains, a general and surprising trend of reduced and delayed mortality 
was observed in the immunodeficient mice. Consequently, either the lack of expression 
of the main constituents of the cytolytic vesicles (perforin, granzymes A and B), or the 
deficiency in Fas ligand (gld) causes the enhancment of survival rates in mice that are 
infected with MVE.
Contrary to the above mutant mice, the FasR-deficient (Ipr) mice and gamma 
interferon receptor knockout (IFN-yR-/-) mice mostly showed a higher mortality than 
the wt mice. For the Ipr mice this may have two explanations. The first explanation is 
that Ipr mice are ‘leaky’, which means that some functional Fas is still expressed 
(Booker et al., 1998). The second explanation is that Ipr mice show infiltration of 
lymphoid cells, not only in lymphoid organs (which is more often evident in mice that 
are older than 6 weeks), but also into the choroids plexus. The latter may be a 
consequence of increased BBB permeability in this site (Vogelweid et al., 1991). The 
presence of a functional Fas receptor is also required for Fas-FasL-dependent 
suppression of inflammation (Griffith et al., 1995; Okuda et al., 1998; Park et al., 1998). 
Thus, in the Ipr mice there may be an additional increase in the invasion of 
inflammatory elements, together with the virus, into the CNS. IFN-yand NO have been 
reported as being important in the protection against YF encephalitis (Liu and 
Chambers, 2001) and JEV infection (Liu and Chambers, 2001; Saxena et al., 2001) in
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animal models. However, there are also reports that suggest that depletion of 
macrophages (major producer cells of NO) may exacerbate WNV infection (Ben- 
Nathan et ah, 1996). Recent studies of the role of IFN-y and NO during infection with 
MVE suggest that their potentially deleterious inflammatory response is more than 
compensated by their antiviral effect (Lobigs et al., 2003). In my study, IFN-yR-/- mice 
succumbed in higher numbers than wt mice, when inoculated with 10“ PFU of MVE. 
This suggests that the IFN-y-receptor is important for the antiviral effect of the cytokine. 
Such effect may involve NO production, class-switching of immunoglobulin isotypes, 
and/or direct antiviral function in the CNS (Kundig et al., 1993; Binder and Griffin, 
2001).
To determine if the absence of cell-mediated cytotoxicity alters the kinetics and 
the load of virions in the tissues, I assayed extraneural organs and brain virus load in 
groups of mutant and wt mice that had been injected with low to high doses of MVE. I 
found that the infection of mice with low (10 PFU) to medium (10 PFU) doses of 
MVE rarely gave rise to detectable virus in the extraneural tissues, that it never 
produced a detectable secondary viremia, and that all infected animals seroconvered. 
This confirms that there is productive vims infection present. In general, I recovered 
infectious vims from the tissues (predominantly spleen and brain) of immunodeficient 
mice at earlier times, and more frequently, than from the tissues of wt mice. This 
indicates that when the cytotoxic mechanisms are absent, neuroinvasion happens earlier. 
However, in general, wt mice still die earlier of typical viral encephalitis, and have 
higher numbers of dead mice, than the deficient mice.
The gld and granule exocytosis knockout animals used in this study showed, 
despite having earlier neuroinvasion and more (albeit slight) vims-positive tissue 
samples, a reduced mortality and a prolonged survival compared with the control wt
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mice; which suggests that the presence of virus in the brain is not the only factor that 
contributes to disease. This suggests not only that cell-mediated cytolysis is important 
for the clearance of MVE, but also that it can contribute to clinical neuronal disease. 
These observations suggest that CD8+T, and possibly CD4+T and NK cells, contribute 
directly to the morbidity and mortality of mice that have been infected with MVE. The 
lower mortality of mice with a deficiency in one of the two cytolytic pathways suggests 
that there is immunopathology after infection with MVE. It could be that lethal 
pathology is, at least in part, due to cytotoxic T cells that may induce a breakdown of 
the BBB. This, possibly MVE-triggered immunopathology, is, of course, hard to 
observe in earlier studies that mostly use younger mice of 3 weeks of age, because the 
immune Tc-cell response at that age is not mature enough to protect the animals. 
Consequently, the likelihood that an exaggerated pathological reaction is induced at that 
age is much less.
Contrary to the expectation, based upon established research in other virus 
models (Mullbacher and Flynn, 1996; Topham et al., 1997; Moskophidis and Kioussis, 
1998; Mullbacher et ah, 1999; Topham et ah, 2001), that NK cells, Tc cells, and their 
cytotoxic mechanism are important in the control and clearance of infection, it may be 
that both the granule exocytosis and the Fas pathway of cytotoxicity can contribute to 
disease progression in MVE infection. However, a potentially over-compensatory 
function of the present cytotoxic mechanism, for the defective one cannot be discarded. 
Thus, in the next chapter, I continue this investigation with mice that are deficient in 
cytotoxicity of NK cells (beige mutation), or in both NK- and Tc-cell cytotoxicity
(perforin and FasL mutations).
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7.1 Summary
This chapter deals with disease outcome in the absence of NK- and Tc-cell 
cytotoxicity during an encephalitic flavivirus infection. I infected mice with a deficiency 
in NK-cell cytotoxicity (beige mutation) and mice that are simultaneously deficient in 
NK- and Tc-cell cytotoxicity (perf-/-xg/c/ mutations) with MVE. Beige mice had a 
similar susceptibility to MVE infection like wt mice. This result confirms that NK cells 
have a limited role in encephalitic flavivirus infections, an observation that has been 
made by others. Mice that were simultaneously deficient in both pathways of NK/Tc- 
cell cytotoxicity — the granule exocytosis and the FasL/Fas (perf-t-\gld\ Chapter 6) 
pathway — showed a higher resistance to MVE than syngeneic wt mice and mice with a 
single mutation (perf-/- or gld). This increased resistance of the double-deficient mice 
suggests that the cytotoxic mechanisms play a deleterious role in MVE infection.
7.2 Introduction
The role of antiviral cellular cytotoxicity in conferring protective or deleterious 
immunity during encephalitic flavivirus infections remains elusive. Mice that are 
deficient in both the degranulation and the Fas (perf-/-xgld mice) pathway are a unique 
tool to investigate cytotoxicity during infection. A limitation of the perf-/-xg/d mouse 
model is that these mice develop a severe autoimmune syndrome. The Fas pathway 
plays a critical role in lymphocyte homeostasis, which accounts for the autoimmune 
syndrome observed in Fas-receptor (Ipr) and Fas-ligand (gld) deficient mice. This 
disease is exacerbated in the absence of functional perforin (Nagata, 1999). Doubly- 
deficient mice are generated from the offspring of heterozygous perf+/-xg/d progenitors, 
because homozygous perf-/-xgld mice cannot be established as a strain due to
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lymphoproliferation in the female reproductive organs, and consequent infertility 
(Spielman et al., 1998). Additional to female infertility, male and female perf-/-xg/d 
mice die of lymphoproliferation between 4 and 16 weeks of age, due to excessive 
mononuclear infiltrates in the pancreas, liver and kidneys (Kagi et al., 1999).
Up to now, perf-/-xgld mice have been used for the study of graft-versus-host 
disease (Braun et al., 1996; Martin et al., 1998; Jiang et al., 2001; Taylor et al., 2002), 
contact hypersensitivity (Kehren et al., 1999), inflammatory bowel disease (Simpson et 
al., 1998), vascular leak syndrome (Rafi et al., 1998), diabetes mellitus (Kreuwel et al., 
1999), and chlamydiasis (Perry et al., 1999), but not as a model for flaviviral diseases.
NK cells are part of the innate immune system and are important for the early 
protective response against numerous virus infections (Kiessling and Wigzell, 1979; 
Herberman and Ortaldo, 1981; Hercend and Schmidt, 1988; Scott and Trinchieri, 1995; 
Biron et al., 1999). Only a limited number of studies have addressed the role played by 
NK cells in flavivirus infections (Vargin and Semenov, 1986; Kopecky et al., 1991; 
Lobigs et al., 1996; Momburg, 2001). In order to discriminate between the roles of 
cytotoxic and cytokine secretory functions of NK cells, in the recovery from 
encephalitic flavivirus infection, beige mice — which lack only the cytotoxic 
function — were used. Thus, in both beige and perf-/-xgld mice, cytokine secretion by
lymphocytes is not deficient.
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7.3 Results
7.3.1 Pathogenesis of MVE in mice with a deficiency in NK-cell 
cytotoxicity (beige mutation)
To assess the role of NK-cell cytotoxicity in the in vivo control of MVE 
infection, I used beige and wt mice of 6 weeks of age. The mice received a dose of 
102 PFU of MVE iv, primarily for mortality studies. Groups of beige mice did not show 
significant difference in percent mortality compared with wt mice (60% and 45.5% 
respectively, P = 0.69) and ATD (10.5 and 11 days pi respectively; Table 7.1). I used 
three moribund beige mice (out of the 10 used for mortality studies) to assay virus load 
in the brain. Brains of beige mice, collected at day 11 pi, had titers between 107 and
o
10 PFU/g (data not shown). These values were similar to those obtained from brains of 
moribund wt mice that were collected at a similar time pi after infection with 10“ PFU 
of MVE iv.
7.3.2 Perf-/-xg/d mice die early due to lymphoproliferative disease
I observed mortality in a group of 21 non-infected doubly-deficient mice over a 
period of four months. The moribund mice had acute lymphoproliferation, especially in 
spleen and lymph nodes, as shown in Fig. 7.1, and died from as early as 4 weeks of age. 
Between 6 and 9 weeks, about one third of the doubly-deficient mice had died and by 
13 to 14 weeks most of them had died of the lymphoproliferative disease (Fig. 7.2). At 
the start of the experiment, the six-week-old doubly-deficient mice had an average 
weight of 16.4 g, compared to 18.6 g for the syngeneic wt mice. At an age of 10 weeks, 
doubly-deficient mice had an average weight of 15 g, while the wt mice had increased 
their weight to 24 g (data not shown). Thus, the 10-week-old doubly-deficient mice
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weighed on average 9 g less than the wt mice. Such a weight difference could make the 
doubly-deficient mice more susceptible to the MVE infection, because they would have 
more virus per body weight after inoculation with a similar dose. During the course of 
this experiment some perf-/-xgld mice showed signs of illness, such as a hunched back, 
ruffled fur and gradually increased emaciation.
It was important to know if mortality due to lymphoproliferative disease could 
be distinguished from mortality due to MVE infection. Ruffled fur and a hunched back 
are signs that are also present during MVE infection of mice. However, the clinical 
signs of MVE infection can still be distinguished from those of lymphoproliferative 
disease. One of the signs that characterize MVE infection is hind-leg paralysis, which 
never appears in the mice affected by lymphoadenopathy. Additionally, moribund 
MVE-infected mice mostly die approximately 24 h after the onset of the clinical signs. 
This is different to mice that suffer from lymphoadenopathy, which can survive with 
signs of lethargy, reduction in feeding and consecutive emaciation for weeks. Another 
difference is that mice affected by the autoimmune syndrome have lymph nodes and 
spleen that are up to 10 times bigger than the respective organs in mice that show 
symptoms of MVE infection (Fig. 7.2). Enlargement of lymph nodes and spleens in the 
double-deficient mice that die, following infection with MVE, could also be observed, 
although to a lesser extent. Finally, testing for MVE in brains of doubly-deficient mice 
is a further criterion to define if mortality was due to lymphoproliferative disease or to
viral encephalitis.
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time (weeks)
Fig. 7.1 Time to death of animals in a cohort of perf-/-xgld mice.
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7.3.3 Resistance of mice that are doubly-deficient in granule exocytosis-
and Fas-mediated cytotoxic pathways, to infection with MVE
A comparative study on the susceptibility of perf-/-xg/c/ and wt mice to infection 
with MVE was of interest, to try to explain the apparent increase in resistance of mice 
that are deficient in the degranulation or Fas pathways of cytotoxicity to MVE (Chapter 
6), as well as to investigate the possibility of redundancy between the two major 
pathways of cytotoxicity (Topham et al., 1997; Parra et ah, 2000; Topham et ah, 2001). 
The latter could have resulted in underestimation of the detrimental role of NK/Tc cells 
in encephalitic flaviviral disease.
Initially, I infected 9-week-old perf-/-xgld mice with 102 PFU of MVE iv and 
observed daily for 21 days. At 9 weeks, similar to wt mice, the double-deficient mice 
survived the MVE infection (Table 7.1).
'y
Next, I infected the following mice with 10 PFU of MVE iv: 6-week-old mice 
that were homozygous for gld and heterozygous for perforin (perf+/-xgld), mice that 
were homozygous for perforin and Fas ligand deficiencies (perf-/-xgld), and wt mice. 
Surprisingly, the group of homozygous (perf-/-xgld) double-deficient mice did not 
show any cases of fatal viral encephalitis. The group of heterozygous mice (perf+/- 
xgld) had a marginally lower mortality than the wt mice: 33.3% and 45.5% respectively 
(P = 0.42) (Table 7.1). Four out of twelve doubly-deficient (perf-/-xgld) mice died 
without displaying the characteristic clinical signs of viral encephalitis. This mortality 
rate was consistent with that of an uninfected perf-I-xgld control group (Fig. 7.1).
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Fig. 7.2 Acute lymphoproliferative disease. Lymph nodes and spleen in a 
wt mouse (A), compared with a perf-/-xg/c/ mouse (B); both mice are 10 weeks 
of age.
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Because I could not recover MVE from the brains of the perf-/-.xglcl cadavers 
within a period of 16 h after death had occurred (data not shown), and because these 
mice showed greatly enlarged lymph nodes and spleens (Fig. 7.2), death was most 
likely due to lymphoproliferative disease.
After increasing the dose of MVE to 105 PFU, results confirmed the increased 
resistance in the perf-/-jcgld mice. All eight perf-/-jcgld mice survived without showing 
clinical signs of encephalitis; in contrast to 40% mortality in the wt group (Table 7.1).
o
After a high-dose infection with 10 PFU of MVE by the iv route, the 6-week- 
old perf-/-jcgld and wt mice showed 100% mortality. The 10-week-old perf-/-xgld mice 
and wt mice had mortality values of 75% and 80%, respectively (Table 7.1). In these 
experiments, the mortality values for the doubly-deficient and wt mice were similar to 
each other, but the ATD was significantly longer in the doubly-deficient animals (7.3 
compared with 5.6 days for 6-week-old mice [P = 0.14], and 9.7 compared with 7.0 
days [P = 0.14] for the 10-week-old mice). After an intracranial injection of 10“ PFU of 
MVE in 6-week-old perf -/-xgld and wt mice, I observed 100% mortality in both groups, 
a result similar to when a peripheral injection of a high dose of MVE was given. This 
result suggests that once the virus is in the brain of the doubly-deficient mice, similar 
percentages of mortality and ATD to those of wt mice occur (Table 7.1).
Results shown in Chapter 6 suggested that mice with functional defects in the 
granule exocytosis- or Fas-mediated pathway of cytotoxicity are less susceptible to a 
lethal infection with MVE than wt mice. Those results, together with the increased 
resistance, shown in this chapter, that occurs in mice that lack both pathways of
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cytotoxicity (perf-/-xgld), give evidence that NK/Tc-cell mediated killing can contribute 
to the pathogenesis of encephalitic flaviviruses in their vertebrate hosts.
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Table 7.1 Mortality as a consequence of iv infection with MVE in mice with a 
deficiency in NK cytotoxicity (beige mutation) and in mice with a 
deficiency in NK/Tc-cell cytotoxicity (perf+/-xg/d and perf-/-xg/d)
Dose
(PFU)
Mouse 
strain a
Age
(w)
Route N“ %
mortality
ATD ± 
SEMd
102 be ige 6 iv 10 60.0 10.5 ± 0 .3
wt 6 iv 11 45 .5 11.0  ±  1.1
perf-/-xg /o f 6 iv 8
oOd
-
pe rf+ /-xg/af 6 iv 15 33 .3 12.8 ±  1.8
102 wt 6 ic 3 100 .0 6 .0  ±  0 .6
p e rf - / -x g ld 6 ic 3 100.0 6 .3  ±  0 .3
102 wt 9 iv 2 0 .0 -
p e rf- /-x g /d 9 iv 5 0.0 -
105 wt 6 iv 20 40 .0 10.9  ± 0 .8
p e rf- /-x g /d 6 iv 8 0.0 -
108 wt 6 iv 5 100 .0 5 .6  ± 0 .2
p e rf- /-x g /d 6 iv 6 100.0 7 .3  ± 0 .9
108 wt 11 iv 10 80 .0 7 .0  ± 0 .5
p e rf - / -x g ld 10 iv 8 7 5 .0 9 .7  ±  1.5
a Morbidity and mortality of mutant and wt mice were recorded daily in all experiments and 
survivors were monitored for 21 days. 
b Number of mice infected.
c Mortality due to lymphoproliferative disease occurred in the group of doubly-deficient mice on 
day 9 (n = 1) and 13 (n = 3), and was excluded from the total. 
d The average time to death (ATD) was calculated in days ± standard error of the mean 
(±SEM).
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7.3.4 Virus growth in tissues of perf-/-xg/dand wt mice after iv MVE 
infection
Kinetics of virus growth in extraneural tissues
To assay for MVE in extraneural organs, I infected groups of double-deficient 
mice of 6 weeks of age with 102 or 10x PFU of MVE iv. Comparative data for the 
control wt mice were taken from Figure 4.3. When I tested spleen, lymph nodes and 
muscle of perf-/-xgld mice that were infected with a low dose of 102 PFU iv of virus at 
4, 6 and 8 days pi, I did not detect virus in any of the tissues (data not shown). However,
o
infection of the perf-/-xg/<i mice with a high dose of 10 PFU of MVE resulted in 
detectable virus titers in lymph nodes and muscle at 3 and 4 days pi. In contrast to wt, 
the perf-/-xg/d mice did not give detectable virus titers in spleens (Fig. 7.3).
In general, virus was detected in less samples from extraneural organs of perf-/- 
xgld mice than wt mice. However, 1 noticed that lymph nodes and muscle titers of the 
doubly-deficient mice from day 4 pi were the highest among all the mutant and wt
o
mouse strains tested, after infection with 10 PFU of virus.
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Fig. 7.3 Growth of MVE in extraneural tissues of mice with a deficiency in 
both subsets of the degranulation and the Fas pathway of cytotoxicity 
(perf-/-xg/d) (•) compared with the wt mice (■). Six-week-old mice were 
infected with 108 PFU of MVE iv. At the indicated times, some animals were 
sacrificed, and virus titers in the spleen (A), lymph nodes (B) and muscle (C) 
were determined by plaque assay. The lower limit of detection of virus titers 
was 1 x 103 PFU/g of wet tissue, and is indicated by the interrupted line.
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Kinetics of virus clearance from blood
The aim of this experiment was to test if the increased resistance to MVE 
infection in the perf-/-xgld mice was due to an improved capacity to clear virus from the 
blood. Spleen is considered to be the main organ that collects antigen from blood 
(Janeway, 1998). Spleen in perf-/-xg/d mice is approximately 10 times enlarged, relative 
to spleen of wt mice, a condition which could facilitate the reduction of viremia in these 
mice relative to their wt counterparts. I infected six-week-old perf-/-xgld mice and wt
o
controls with 10 PFU of MVE iv, and tested the level of viremia at 30 and 60 min pi.
The kinetics of virus reduction from blood was similar in both strains of mice (Fig. 7.4
£
A) . I also infected groups (n = 3) of 9-week-old doubly-deficient and wt mice with 10 
PFU iv and collected serum at 2, 4, 6, and 9 hours pi. Virus titers in sera samples of 
perf-/-xgld mice were slightly higher, compared with those of the wt controls (Fig 7.4
B) . These higher virus titers in the double-deficient mice may be due to their lower 
body weight. The similar levels of viremia found in the two mouse strains of 6 weeks of 
age suggest that there are factors, other than the increased capacity of virus clearance 
from the blood, present in the doubly-deficient mice which may account for the 
increased resistance against MVE infection. At day 2 pi, serum from three 9-week-old 
wt and perf-/-xg/<i mice showed no detectable MVE titers. The lack of detectable 
viremia at two days pi in the 9-week-old wt and doubly-deficient mice is consistent with 
the lack of detectable viremia in the younger 6-week-old mice, and with earlier findings 
of increased resistance to MVE infection in mice that are older than six weeks (as
shown in Chapter 4).
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Kinetics of neuroinvasion
To test if the reduced mortality in the doubly-deficient mice was due to a 
reduction in neuroinvasion, I injected six perf-/-xg/r/ mice with 10" PFU of MVE iv and 
collected their brains at days 4, 6 and 8 pi. None of these brain samples showed 
detectable virus titers, which is consistent with a lack of encephalitic disease, and with 
death due to MVE infection (Fig. 7.5 A).
A higher dose of 108 PFU of MVE iv was also injected into doubly-deficient 
mice and their brains were tested for virus on days 2, 3 and 4 pi. Comparative data for 
the wt mice were taken from Chapter 4. At day 2 pi, brains of five out of six of the perf- 
l-xgld mice did not have detectable virus titers (the one positive sample had a titer of 
1.4 x 103 PFU/g), but five out of six wt mice exhibited detectable virus titers of up to 
2.4xl06 PFU/g. At day 3 pi, all four brain samples of the perf-/-xgld mice showed titers 
that ranged from 3.5 x 106 to 2.5 x 108 PFU/g, while five out of six brains from wt mice
o o
had more variable titers, ranging from 6 x 10 to 1.3 x 10 PFU/g. At day 4 pi, all of five 
samples from the perf-I-xgld mice had titers that ranged from 7.3 x 107 to
5.6 x 109 PFU/g, and 5 out of 6 wt mice had variable titers that ranged from 1 x 103 to
2.7 x 109 PFU/g (Fig. 7.5 B). Thus, after iv inoculation with a high dose of MVE, the 
perf-/-xg/d mice showed a delay in neuroinvasion of MVE, but at days 3 and 4 pi all 
mice showed virus growth in the brain and most of the virus titers were higher than 
those of the wt mice.
To further substantiate that virus growth in the CNS of the doubly-deficient 
mice was not inhibited by unknown factors, I also infected six-week-old perf-/-xg/<i and 
wt mice with 10" PFU of MVE ic. I collected brains at day 4 pi, and assayed these for 
virus load. The titers were similar in both mouse strains (Fig. 7.5 C), consistent with the 
result that the perf-/-xg/c/ mice show a similar mortality than the wt mice when the virus
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is inoculated directly into the brain, although the ATD was delayed by two days in the 
double-deficient mice.
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Fig. 7.4 MVE in serum of mice with a deficiency in both subsets of the 
degranulation and Fas pathway of cytotoxicity (perf-/-xgld) (•), compared to the 
wt mice (■). 6- (A) and 9-week-old (B) mice were infected with 108 PFU of MVE 
iv. At the indicated times, serum was collected and virus titers were determined 
by plaque assay. The lower limit of detection of virus titers was 1 x 102 PFU/ml, 
and is indicated by the interrupted line.
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Fig. 7.5 Growth of MVE in brains of mice with a deficiency in both 
subsets of the degranulation and Fas pathway of cytotoxicity (perf-/-xglcf) (•), 
compared to the wt mice (■). Six-week-old mice were infected with 102 (A), 
108 (B) PFU of MVE iv and 102 PFU of MVE ic (C). At the indicated times, 
animals were sacrificed and virus titers were determined by plaque assay. 
The lower limit of detection of virus titers was 1 x 103 PFU/g of wet tissue and 
is indicated by the interrupted line.
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7.3.5 The anti-MVE Ab response in perf-/-xg/c/mice
Another important factor that could contribute to the increased resistance of 
perf-/-xg/c/ mice to MVE infection is the Ab response. I infected three or four perf-/- 
xgld mice, as well as wt control mice, with 105 PFU of MVE iv to test whether they 
show differences in the magnitude and kinetics of humoral immune response against 
MVE, and in incidence of seroconversion. At days 5, 10, 15 and 21 pi, I collected the 
sera and tested these for anti-MVE-Ab production by ELISA. The sera from all animals 
were reactive against MVE antigen from day 5 pi, and titers increased gradually until 
day 21. At day 5 pi titers were similar in both groups. A significant increase in the 
magnitude of the humoral immune response against MVE in perf-l-xgld mice, relative 
to wt mice, was seen at days 15 and 21 pi (Table 7.2).
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Table 7.2 MVE-specific Ab production in 6-week-old C57BI/6 perf-/-xg/d and 
wt mice, after infection with 105 PFU iv
Mouse strain No./
group
Day
Pi
%
Seroconversion
Mean Ab titer,a 
log10 (range)
wt 3 5 100 2.7 (2.6-2.9)
perf -/-xgld 3 5 100 2.7 (2.6-2.9)
wt 4 10 100 3.3 (3.2-3.5)
perf -/-xgld 4 10 100 4.0 (3.8-4.4)0
wt 4 15 100 3.7 (3.5-3.8)
peri-/-xgld 4 15 100 4.1 (3.5-4.7)
wt 4 21 100 3.8 (3.8-4.1)
perf-/-xgld 4 21 100 4.5 (4.1-4.7)0
a MVE-specific antibody titers were determined by ELISA, and endpoints were calculated as 
described in Materials and Methods, Chapter 2.
ju
Statistically significant difference (P< 0.05; Mann-Whitney test) relative to groups of wt mice.
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7.4 Discussion
The importance of Tc and NK cells in the control and clearance of infection in 
several virus models is well recognized (Blanden, 1971; Zinkernagel, 1993; Kagi et al., 
1994; Mullbacher and Flynn, 1996; Mullbacher et al., 1999). Mice that lack NK 
cytotoxicity (beige mutation) and mice that lack both NK- and Tc-cell cytotoxicity 
(perf-/-xgld) provide an important in vivo model for the study of the role of cytotoxicity 
during viral diseases, which has not been thoroughly investigated in the case of 
encephalitic flaviviruses.
In this study, I found no significant difference in susceptibility to MVE between 
beige mice and wt mice. Previous studies suggested that NK cells play only a minor role 
in the control of flavivirus infection (Ilyinskikh et al., 1990; Hill, 1993; Lobigs et al., 
1996; Momburg, 2001). Hill and Momburg (Hill, 1993; Momburg, 2001) hypothesized 
that the limited NK-cell activity during flavivirus infection is due to flavivirus-mediated 
MHC class I upregulation. In other words, the engagement of the NK-cell receptor with 
MHC class I results in a down-regulatory signal of NK-cell activity. Following this 
hypothesis, flavivirus-infected cells may employ this strategy to escape NK-cell lysis, 
and to produce sufficient viremia, that can be transmitted to an arthropod vector, in the 
natural host (mainly birds) during early infection (Momburg, 2001).
My work on mice that lack either the degranulation or the Fas pathway of 
cytotoxicity (Chapter 6) showed that those cytotoxicity mechanisms do not play an 
essential protective role during MVE infection. Because of the possibility of 
redundancy between the two major pathways of cytotoxicity (Topham et al., 1997;
Parra et al., 2000; Topham et al., 2001), a potentially deleterious role of NK/Tc cells in 
MVE infections cannot be defined when using mice that are only defective in one of the 
two pathways. Thus, mice that lack both cytotoxic mechanisms were generated. Studies
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described in this chapter show that perf-/-xg/r/ mice are significantly less susceptible to 
MVE than both the wt mice, and the mice with a deficiency in only one pathway of 
cytotoxicity. The greatly increased resistance of perf-Axgld mice to MVE infection 
suggests that immunopathology is the cause, since NK/Tc-cell-mediated killing seems 
to contribute to the pathogenesis of encephalitic flaviviruses in their vertebrate hosts.
The cytotoxic mechanisms do not account for the capacity of the mice to clear 
MVE infection from extraneural organs. Most of the extraneural organs from the 
doubly-deficient mice have similar, or even lower, virus titers than those of wt mice. 
However, the possibility that the brains of perf-/-xgld mice are resistant to replication of 
ihe virus can be excluded: when a low dose of MVE is injected directly into the brain, 
or when a high dose is injected iv, all doubly-deficient animals, like the wt controls, 
develop fatal encephalitis, with virus titers in the brains similar to those in wt mice.
The 100% seroconversion in all mutant and wt mice that are MVE-infected 
confirms that infection and extraneural growth of MVE occurs in these animals. The 
humoral immune response against MVE was elevated (relative to wt mice) in mice with 
the gld mutation only (Chapter 6), and also in the doubly-deficient perf-/-xgld mice (this 
chapter), but not in mice with a targeted disruption of the perforin gene (Chapter 6). The 
latter contradicts reports on other viral infections (Sambhara et al., 1998); however, 
given that the perf -/-xgld mice were significantly more resistant to MVE infection than 
the gld mice, it is unlikely that antibody-mediated virus clearance can account for the 
greatly reduced mortality in the former (Table 7.2).
What is the mechanism by which a deficiency in the two main cytotoxic effector 
functions prevents fatal flaviviral encephalitis? It is conceivable that cytotoxic cells 
disrupt the BBB by killing infected endothelial cells that line the brain capillaries, thus 
allowing virus access into the brain parenchyma. When the encephalitic flavivirus WN
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infects human endothelial cells, the expression of leukocyte adhesion molecules is 
induced at the plasma membrane of the infected cells (Shen et ah, 1997), making them 
susceptible to NK/Tc cell-mediated attack. The kinetics of appearance of MVE in the 
brain (at 6 to 8 days pi) following iv infection with a low virus dose, is consistent with 
that of the induction of the anti-viral Tc-cell response (Kesson et ah, 1987) and, in turn, 
with the Tc-cell-induced damage of the cells that line the brain capillaries.
More work has to be done to produce direct experimental evidence to support 
the hypothesis that damage to the integrity of the BBB occurs because the cytotoxic 
effector pathways allow encephalitic flaviviruses to invade the brain. The possibility 
that a third NK/Tc cell antiviral effector pathway, namely cytokines, could account for 
the increased protection that is seen in perf-/-xgld mice also has to be studied in the 
doubly-deficient mice. However, work done by Perry et ah (1999) shows that perf-/- 
xgld mice, infected with Chlamydia, do not show statistically significant differences 
between the levels of IL-6, IL-10 and IFN-yin wt, Ipr, gld, perf-/- and perf-/-xgld mice.
Few studies have been done using the perf-/-xg/d mice, possibly due to the great 
amount of work involved to obtain sufficient numbers (which involves backcrossing of 
heterozygous perf+/-xg/<7 mice, defining the genotype, and high levels of mortality due 
to the lymphoadenopathy when perforin and FasF are missing). Cretney et ah (2002) 
performed studies that show that the inflammatory mediator TNF contributes to the 
immunopathology of perforin/Fas-ligand double deficiency. The Cretney group 
compared disease progression in perf-/-xgld mice that were also deficient in TNF 
(triply-deficient TNFxperf-/-xg/J mice). Unlike the perf-/-xg/d doubly-deficient mice, 
triply-deficient mice were comparatively fertile, with the majority of mice not suffering 
severe pancreatitis or hysterosalphingitis in the first five months of life. However, at 8 
weeks of age, TNFxperf-/-xg/r/ mice developed pancreatitis, which suggests that loss of
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TNF was not completely protective. That study concludes that TNF is necessary for the 
full manifestation of immune deregulation caused by the perforin/FasL-deficiency, and, 
in particular, is responsible for the overwhelming early tissue infiltration and 
destruction caused by inflammatory cells.
Whenever doubly-deficient mice have been used in disease studies (see section 
7.2) they have shown a reduced disease outcome; a result that is likely due to the 
reduction of vascular leak syndrome and inflammation. Inflammation and vascular 
leakage are some of the most widely noted phenomena in a variety of clinical diseases. 
Although the BBB has not been studied in the doubly-deficient mice in combination 
with viral agents, vascular leakage could (at least in the case of encephalitic flavivirus 
infections) be the cause of virus-activated NK/Tc cytotoxic damage to the BBB, and 
lead to encephalitis. Most of the clinical diseases caused by flavivirus (if not all) have 
an inflammatory and sometimes hemorrhagic (e.g. dengue hemorrhagic fever) 
presentation. Could the lack or reduction of perforin and FasL expression reduce the 
severity of other flaviviral diseases? Or could it reduce the severity of other 
inflammatory-hemorrhagic pathologies?
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Chapter 8
Concluding remarks
The major aims of the studies presented in this thesis were two-fold: 1) to 
establish a mouse model for the study of MVE pathogenesis that parallels important 
aspects of the human disease, and 2) to investigate whether cytolytic lymphocytes give 
protection against, or exacerbate, the encephalitic disease.
Mice provide an excellent animal model for flaviviral encephalitis in humans, 
given that infection with members of the encephalitic flaviviruses mimics the low or 
absent viremia, the lack of detectable virus growth in extraneural tissues, and the low 
but mostly lethal incidence of CNS infection found in humans. However, although 
consistent with the human disease, the low incidence of CNS invasion in adult mice that 
are infected by an extraneural route demands the use of large numbers of animals in 
order to undertake studies into the pathogenesis of these viruses. To avoid this problem 
three- to four-week-old mice that are highly susceptible to extraneural flavivirus 
infection have been used in many virulence and pathogenesis studies to date, for 
instance: MacDonald, 1952; Huang, 1963; Cole and Wisseman, 1969; Monath et al., 
1980; Hase et al., 1990; Lobigs et al., 1990; Cecilia and Gould, 1991; Mason et al.,
1991; Hasegawa et al., 1992; McMinn et al., 1996; Guirakhoo et al., 1999; Broom et al., 
2000; Gritsun et al., 2001; Chambers et al., 2003; and Gupta et al., 2003.
The high lethality of encephalitic flavivirus infection in young mice is thought to 
be the result of the immaturity of their immune system and a blood-brain barrier (BBB) 
that is not fully developed. Hence, it is clearly important to use animals with fully 
developed immune systems for the study of immune responses against flavivirus 
infection. To date, few pathogenesis studies of JEV and MVE have used
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immunologically mature adult mice of at least six weeks of age. These include studies 
by MacDonald (1952), Huang (1963), Mathur et al. (1983), Lange and Sedmak (1991), 
Lad et al. (1993), my own work (Licon Luna, 2002), and subsequent work by members 
of our research group (Lee and Lobigs, 2002; Lobigs et al., 2003a; Wang et al., 2004).
In this thesis C57B1/6 adult mice of at least six weeks of age were used to 
establish pathogenesis parameters for the prototype strain of MVE. Parameters included 
mortality, the virus growth in brain and extraneural tissues, the kinetics and magnitude 
of the virus-specific antibody response, the induction of a virus-specific Tc-cell immune 
response, and histopathological manifestations. The C57B1/6 inbred mouse strain was 
chosen because it made a wide range of mice with gene knock-out and null mutations 
available and gave rise to mice with defined defects in humoral and cellular immunity.
The pathogenesis studies showed that the age of the mice and the dose of virus 
were the variables that most influenced susceptibility to MVE infection. Mice of 10 
weeks of age were considerably more resistant than mice of six weeks of age. Thus, 
mice of the latter age-group were used for most of the studies, given that a subset of 
approximately 50% of these mice developed encephalitis and succumbed after infection 
with low to medium doses of MVE. Mice were mostly infected iv, to mimic the natural 
route of infection by hematophagous mosquitoes. An important finding of the studies 
(see Chapter 4) was the lack of a dose response over a wide range of MVE inocula 
ranging from 0.1 to 10s PFU, each dose giving a similar percentage of mortality at 
around day 11 pi. This disease pattern suggests that the virus first replicated in 
extraneural tissues prior to entering the CNS, and that invasion of the brain was a 
stochastic process unrelated to the dose of virus injected over a 106 range of iv virus 
inocula. A similar observation was made subsequently for the Sarafend (Wang et al., 
2003b) and New York isolates of WNV (Diamond et al., 2003b). However, when a high
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dose of 10s PFU of MVE was inoculated iv, 100% of mice died at -day 6 pi. Given that 
the death rate and time to death of mice injected ic with a low dose (10 PFU) were 
virtually identical to those of mice that were injected iv with a high virus dose, it is most 
likely that the latter inoculation allowed virus in the inoculum to breach the BBB 
directly from blood. In contrast to iv infection with 108 PFU, infection with the lower 
doses delayed detectable neuroinvasion of MVE and ATD by approximately five days. 
This strongly supports the view that a period of extraneural virus replication preceded 
the spreading of the virus into the CNS.
Two fundamental questions on encephalitic flavivirus pathogenesis in humans 
and mice remain elusive, i.e.: 1) which extraneural tissue(s) supports virus growth prior 
to CNS invasion; and 2) by which mechanism(s) does virus spread into the CNS take 
place. My earlier findings (Licon Luna, 2002) show that there are two distinct disease 
progressions that depend on the virus dose. These are: an immediate presence of virus in 
the brain and an earlier occurrence of death (day 5-6 pi) in mice that are infected with a
Q
high (<10 PFU) virus dose, and a later occurrence of virus in the brain combined with a 
variable mortality (after day 10 pi) in mice are infected with a low (105 PFU) virus dose. 
This difference in disease pattern strongly supports the view that in the latter scenario 
virus growth in extraneural tissues occurs prior to entry into the brain. It also raises the 
possibility that more than one mechanism may be involved in virus breach of the BBB. 
These candidate routes of neuroinvasion could be: 1) by the neuronal route after 
infection of the peripheral nerves; 2) by infection of highly susceptible olfactory 
neurons, which are unprotected by the BBB (Monath et al., 1983); 3) by virus entry into 
the vascular endothelial cells of capillaries in the brain, transcytosis, and release of virus 
into the brain parenchyma (Lad et ah, 1993); and 4) by diffusion of virus between 
capillary endothelial cells in individuals that display a leakiness of the BBB due to
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factors unrelated or secondary to the viral infection (Kobiler et al., 1989; Hase et al., 
1990; Lustig, 1992).
Attempts to determine extraneural sites and kinetics of MVE growth in adult 
mice after iv infection with low to medium doses gave disappointing results. This may 
be due to technical problems that cause virus degradation during tissue preparation, 
and/or to the notion that flaviviruses only need to be present at concentrations under the 
limit of detection before they reach the brain. The use of two standard techniques 
(plaque assay and RT/PCR) on tissue samples to detect MVE addressed the possibility 
that different organs may contain different factors that affect the infectivity of the virus 
or the integrity of the viral RNA. One could speculate that the RT/PCR method is more 
sensitive because it can also detect the genomes of inactivated virus. However, both 
RT/PCR and plaque assay gave similar low efficiency of virus detection. Whilst 
conventional and even new technology of real-time RT/PCR (Mackay et al., 2002) can 
(in the latter case quantitatively) detect genetic material of the virus, these methods do 
not allow researchers to draw conclusions about the infectivity of the virus detected 
(Bae et al., 2003).
Muscle was the only extraneural tissue tested that harbored gradually increasing 
virus growth pi (Fig. 4.2), albeit at low levels. Since MVE seems to be predominantly 
neurotropic, its occurrence in muscle could have been the result of virus growth in nerve 
tissue (e.g. the large femoral nerve), which was not separated from the muscle tissue. 
Thus, the question whether virus growth occurred in muscle or in peripheral nerve 
tissue remains unresolved.
The 100% seroconversion of the mice infected with doses of MVE as low as 0.1 
PFU is surprising in the light of poor virus growth in extraneural tissues. It suggests that 
either: 1) the two detection methods underestimated the virus content in tissues, or 2)
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that a peripheral tissue that was not included in the screening allowed more efficient 
growth (albeit not reflected in detectable viremia) of MVE than the tested tissues, or 3) 
that a low, mostly undetectable, vims growth in extraneural tissues over a number of 
days is sufficient for CNS invasion to occur (either stochastically or with the additional 
requirement of insult to the integrity of the BBB). It is noteworthy that MVE and other 
encephalitic flaviviruses are rapidly removed from the bloodstream (MacDonald, 1952; 
Huang, 1963; Lee and Lobigs, 2002) and prevent accumulation of vims in the 
circulation (see Chapter 4).
Several researchers have used adult mice to study the pathogenesis of WNV, 
another member of the JEV serocomplex (Diamond et al., 2003b; Diamond et al.,
2003a; Diamond et al., 2003c; Wang et al., 2003a; Wang et al., 2003b). One difference 
between WNV, MVE and JEV is that WNV can be isolated from the blood of human 
patients as well as from mice during the acute phase of infection, MVE and JEV usually 
cannot (MacDonald, 1952; Huang, 1963; Monath, 1996; Lee and Lobigs, 2002; 
Diamond et al., 2003b; Lobigs et al., 2003b). This suggests that there is more efficient 
growth of WNV in extraneural tissues. Furthermore, although WNV can also produce 
encephalitis, its most characteristic symptomatology resembles that of dengue-like fever 
(Hubalek and Halouzka, 1999; Sampson et al., 2000). Of relevance for the studies 
presented in this thesis is the finding that the murine CD8+ Tc-cell response against 
WNV plays an important role in protection from disease (Shrestha et al., 2003; Wang et 
al., 2003b, 2004), whilst its role in MVE is deleterious. Thus, although there are many 
similarities in the pathogenesis of members of the JEV serocomplex flaviviruses, 
caution must be applied when extrapolating findings from one virus to another (Wang et
al., 2004).
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Published work on the role of Tc cell immune responses during encephalitic 
flavivirus infections (JEV, WNV, YFV, TBE) in the past resulted in conflicting 
findings: some researchers showed that the Tc-cell response was protective (Mathur et 
ah, 1983; Murali-Krishna et ah, 1996; Wang et ah, 2003b) or had no apparent effect on 
the outcome of the disease (Pan, 2001), whilst others demonstrated that 
immunosuppression of cellular immunity enhanced the survival of mice from flavivirus 
infection (Hirsch and Murphy, 1968; Camenga and Nathanson, 1975; Semenov, 1975; 
Semenov et ah, 1975). However, given the severity of some of those challenge models 
(ic inoculation of virus or disruption of the BBB), and the fact that the 
immunosuppressant drugs they used did not allow them to discriminate between the role 
of CD4+ and CD8+ T cell responses, the importance of the Tc-cell response in MVE 
infection of mice remained unknown.
This thesis demonstrates and partially characterizes the generation of an MVE- 
specific, H-2b-restricted, CD8+ Tc-cell response. This work will be fundamental for the 
subsequent work that investigates the role of cytolytic effector cells in the recovery 
from, or exacerbation of, MVE in C57B1/6 wt mice. The H-2Db-restricted response is 
mapped to the prM protein, which is somewhat unusual, although not unprecedented 
(Konishi et al., 1998; Co et al., 2002; van der Most et ah, 2002), given that flavivirus­
immune Tc-cell responses in mice and humans predominantly recognize determinants 
derived from the non-structural proteins, in particular NS3 (Hill et ah, 1992; Rothman et 
ah, 1993; Lobigs et ah, 1994; Rothman et ah, 1996; Lobigs, 1997; Spaulding et ah, 
1999).
A most surprising finding in my investigation on the role of cytotoxic effector 
function of NK/Tc cells in MVE infection is that mice which lack both the granule 
exocytosis- and the Fas-mediated cytolytic mechanism show a significantly increased
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resistance relative to wt mice. This was most apparent when a low dose (1CF PFU, iv) of 
MVE was used: 100% of perf-/-xg/<r/ mice survived, compared to 80% of perf-/- mice, 
73% of gld mice, and 54% of wt mice. Two (not necessarily exclusive) interpretations 
can be forwarded to account for the difference: 1) that an anti-viral function is up- 
regulated in the double-deficient mice, preventing extraneural virus growth sufficient 
for neuroinvasion of MVE to occur, or 2) that the cytotoxic function of NK/Tc cells is 
detrimental for the host in MVE infection, for instance by causing leakage of the BBB. 
However, given the lymphoproliferative disease in perf-/-xgld mice, their levels of Ab, 
interferon, and cytokine could have been elevated relative to wt mice. In my 
experiments, the level of MVE-reactive antibodies was indeed higher in most of the 
perf-/-xg/c/ mice than that in the wt and perf-/- mice, but similar to the level in gld mice. 
Given that the perf-/-xgld mice were significantly more resistant than the gld mice, it is 
unlikely that the higher level of antibodies accounted for the great increase in resistance 
of the double-deficient mice. In the absence of a systematic quantitation of interferon 
and cytokine production in perf-/-xgld mice, a contribution of these factors to the 
resistance of the mice to MVE infection cannot be excluded. One investigation (Perry et 
al., 1999) found that perf-/-xg/c/ mice infected with Chlamydia do not have an increased 
level of IL-6, IL-10 and IFN-y.
The reduced mortality I found in the double-deficient mice was not due to the 
inability of MVE to replicate in the brains of these mice because a low dose of virus 
(102 PFU) injected ic produced fatal encephalitis with virus titers in the brains of 
infected perf-/-xg/r/ mice; a result that is comparable to that of wt mice. Could virus- 
immune Tc-cell-mediated lysis of endothelial cells that forms the BBB facilitate the 
entry of MVE into the brain? It is known that WNV can infect human endothelial cells 
(Shen et al., 1997) and that these cells express leukocyte adhesion molecules, making
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them susceptible to NK/Tc-cell-mediated attack. Additionally, in my experiments, the 
time of the first appearance of MVE in the brain of wt mice, after they were inoculated 
with a low iv dose of the virus, was six to eight days pi. This time frame is consistent 
with the induction of an anti-flaviviral Tc-cell response (Kesson et al., 1987). In earlier 
studies by others on perf-/-xg/c/ mice, reduced pathology due to reduced vascular 
leakage and inflammation was observed (Braun et al., 1996; Martin et al., 1998; Rafi et 
al., 1998; Simpson et al., 1998; Kehren et al., 1999; Kreuwel et al., 1999; Perry et al., 
1999). Accordingly, vascular leakage mediated by cytolytic NK/Tc cells, at the level of 
the BBB, in wt mice may explain why they have a greater susceptibility to infection 
with MVE than double-deficient mice.
The reduced susceptibility to MVE infection of mice that are only deficient in 
either the granule exocytosis- or the Fas-mediated effector functions (perf-/-, 
gzmAxB-/-, perfxgzmAxB-/- and gld mice, see Chapter 6) relative to wt mice I found in 
my experiments, supports the notion that cytolytic lymphocytes are mainly deleterious 
in this disease. However, these mice had slightly increased virus titers in the spleen and 
the brain. Even though the virus was detected more often, at an earlier time and with a 
delayed clearance in the tissues of the mutant mice, this did not increase their mortality 
but, on the contrary, reduced and delayed it. This suggests that the presence of the virus 
is not the only factor that contributes to morbidity and mortality. Thus, cell-mediated 
cytotoxicity is important for viral clearance, but it could also contribute to virus- 
triggered immunopathology.
The significantly increased resistance to MVE infection of the B2 -M-/- mice 
compared to wt mice found in my experiments is further support by the detrimental role 
that Tc cells can play in this mouse model during an encephalitic virus infection. 
However, the virus load I found in the peripheral tissues of B2 -M-/- mice was not very
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different from that in wt mice. This finding is consistent with experiments on Sindbis 
virus (SV) infections by Kimura and Griffin (2000), who found that there was no 
difference in the amount of virus that was present in the tissues of wt C57B1/6 and 
B2 -M-/- animals. Thus, experiments with both MVE and SV infections of B2 -M-/- mice 
suggest that CD8+ T cells do not significantly reduce the virus load of these infections.
The Ab response I found in B2 -M-/- mice was intact because functional helper 
CD4+ T cells and B cells were present. However, the increased resistance I found in the 
B2 -M-/- mice cannot be attributed to the antibody response. I found that the Ab titers in 
B2 -M-/- mice, after infection with MVE, were similar to those in wt mice. This was 
probably due to a similar level of antigen exposure, as there was no significant 
difference in MVE titers in tissues of infected B2 -M-/- and wt mice. In other studies, 
B2 -M-/- and wt mice also showed similar levels of Ab production after infection with 
vaccinia (for IgM) or vascular stomatitis (for IgM and IgG) viruses (Spriggs et al.,
1992).
I obtained further evidence that Tc cells are not protective against MVE from 
passive transfer experiments that showed that transfer of MVE-immune T cells (CD4+ 
and CD8+) to wt mice infected with MVE, increased rather than reduced mortality. 
These preliminary results are in accordance with the results by Murali-Krishna et al. 
(1996), who injected JEV-primed T cells peripherally and found that they did not confer 
protection against JEV in mice.
On the other hand, I found that passive transfer of MVE-immune B cells 
provided complete protection from infection with MVE. This highlights the importance 
of Ab in the protection of mice from infection with MVE, and is consistent with recent 
work by Diamond et al. (2003b), which showed that B-cell-deficient mice uniformly 
succumb to WNV infection. Many other studies on the humoral response to flaviviruses
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have also found that humoral immunity is essential for host survival. For example, the 
function of IgM in flaviviral infection is well characterized. The induction of a specific, 
neutralizing IgM response early in the course of WNV infection, limits viremia and 
dissemination of the virus into the CNS, and protects against lethal infection before the 
development of an adaptive IgG response (Diamond et al., 2003c). Low levels of IgM 
against JEV are a risk factor in JEV infection of humans, and the magnitude of anti-JEV 
IgM is considered a major prognostic indicator of disease outcome (Libraty et al.,
2002). The role of immune IgG in protection has also been studied extensively in mouse 
models of flaviviral infections (Heinz et al., 1983; Mathews and Roehrig, 1984; 
Schlesinger et al., 1986; Kimura-Kuroda and Yasui, 1988; Kaufman et al., 1989; Mason 
et al., 1989; Schlesinger and Chapman, 1995; Kreil and Eibl, 1997; Broom et al., 2000; 
Roehrig et al., 2001; Ben-Nathan et al., 2003; Diamond et al., 2003b).
My studies with mice immunodeficient in T and B effector cells (RAG-1-/- 
mice) show that these mice had a significantly higher mortality compared to the wt 
mice. This demonstrates the importance of the adaptive immune response in the 
protection from MVE infection. The RAG-1-/- mice’s increased mortality could be 
explained by their inability to have an antibody response, because they do not have 
B cells. However, compared to the time of death of the wt mice, the mortality of the 
RAG-1-/- mice, after iv inoculation of a low MVE dose, was significantly delayed. This 
observed delay in the onset of clinical signs of encephalitis and in the time to death of 
the RAG-1-/- mice was possibly due to the lack of the deleterious effect of the T cells. 
Cytotoxic effector mechanisms may be involved in the events that lead to neuroinvasion 
and in the pathology caused by the inflammation response in the brain. However, in 
similar work that studied infection with WNV this delay in time to death did not occur
in RAG-1-/- (Halevy et al., 1994) and SCID mice (Diamond et al., 2003b). On the
Chapter 8: Concluding remarks 211
contrary, in the both quoted research papers, the mortality of the immunodeficient mice 
was earlier than that of the wt mice. This difference in the pathogenesis of MVE and 
WNV is more likely due to the fact, alluded to earlier, that the Tc-cell response is 
important in the protection from WNV infection (Shrestha et ah, 2003; Wang et al., 
2003b) but not in the control of infection with MVE. The fact that the detection of MVE 
virus in extraneural and brain tissues of the RAG-1-/- mice in my experiments was also 
delayed (although with increased virus titers) is consistent with their delayed, but 
increased, mortality.
My histopathology results in organs of wt mice show that, even though there is 
mostly a correlation between inflammatory and necrotic foci and the level of MVE 
infection, it is difficult to establish whether brain injury is caused by MVE infection or 
by the resultant immune response of the host (e.g. infiltrating cells) using virological or 
histopathological criteria. My histology results from brain samples of MVE-infected 
B2 -M-/- and RAG-1-/- mice, which showed a reduction in cell infiltration, indicate that 
there was a reduced inflammation. This may simply be due to the lack of CD8+T cells 
in B2 -M-/- mice, and to the lack of T and B cells in RAG-1-/- mice. Tc and NK cell 
infiltration has been found in brains of WNV-infected wt mice (Liu et al., 1989; Wang 
et al., 2003b). RAG and B2 -M-/- mice (similar to SCID mice) harbor functional 
macrophages and NK cells, which could well infiltrate the brains of MVE-infected 
mice, but do not seem to do so. Similarly, in studies made with the encephalitic 
flavivirus Montana Myotis leukoencephalitis, Charlier et al. (2002) found that there was 
little or no infiltration of macrophages or NK cells in the brains of infected SCID mice. 
In my study, the reduced cell infiltration in B2 -M-/- mice may have accounted for the 
reduced and delayed mortality, and for the delayed neuroinvasion of RAG-1-/- mice 
after they had been infected with low to medium doses (0.1 to 105 PFU). However,
Chapter 8: Concluding remarks 212
o
massive virus replication did occur in the brain after inoculation with 10 PFU in both 
immunodeficient strains of mice (similarly to wt mice), although the ATD was delayed.
In summary, the results from my in vivo study of the role of MVE-immune 
T cells and their specific cytotoxic mechanisms have confirmed the deleterious role of 
Tc cells. Lack or deficiency in these cells seem to be responsible for the delay in 
mortality of RAG-1-/- mice, for the delay and reduction in mortality of B2-M-/- mice, 
for the increase in resistance of mice that are deficient in either the degranulation 
(perforin/granzymes) or Fas pathway of cytotoxicity, and for the increase in resistance 
of mice that are deficient in both the degranulation and the Fas pathway of cytotoxicity 
(perf-/-xg/d). These results have been fundamental to further research (presently 
continued by our JCSMR research group) on the local effect of Tc cells in the BBB and 
in the brain of flavivirus-infected mice, and could help to elucidate at what point 
Tc cells contribute to flavivirus pathogenesis.
The questions ‘Does the increase in resistance in mice with a deficiency in 
cytolytic functions, which occurs after infection with MVE, also occur after infection 
with other encephalitic flaviviruses?', and 'Does this resistance occur in humans after 
infection with MVE?’ remain open. It would certainly be of interest to test if this 
increased resistance applies to JEV, the most closely related encephalitogenic flavivirus 
to MVE, and the most important causative agent worldwide of viral encephalitis in
humans.
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The mechanism by which encephalitic Haviviruses enter the brain to inflict a life-threatening encephalomy­
elitis in a small percentage of infected individuals is obscure. We investigated this issue in a mouse model for 
flavivirus encephalitis in which the virus was administered to 6-week-old animals by the intravenous route, 
analogous to the portal of entry in natural infections, using a virus dose in the range experienced following the 
bite of an infectious mosquito. In this model, infection with 0.1 to 10s PFU of virus gave mortality in ~50% of 
animals despite low or undetectable virus growth in extraneural tissues. We show that the cytolytic effector 
functions play a crucial role in invasion of the encephalitic flavivirus into the brain. Mice deficient in either the 
granule exocytosis- or Fas-mediated pathway of cytotoxicity showed delayed and reduced mortality. Mice 
deficient in both cytotoxic effector functions were resistant to a low-dose peripheral infection with the neuro­
tropic virus.
Murray Valley encephalitis virus (MVE) is an Australian 
member of the encephalitic Haviviruses grouped into the Jap­
anese encephalitis virus (JEV) serocomplex, which also in­
cludes West Nile virus (WNV) and St. Louis encephalitis virus 
(7, 37). The viruses are transmitted by mosquitoes to their 
normal vertebrate hosts (predominantly birds) and can cause 
incidental epidemic outbreaks of disease in humans. Most in­
fections of humans with Haviviruses of the JEV serocomplex 
are subclinical, the estimated ratio of inapparent to apparent 
infection being between 200:1 and 1,000:1; however, the case 
fatality rate can be high (up to 50%), and life-long neuropsy­
chological sequelae frequently occur among survivors of flavi- 
viral encephalitis (for reviews, see references 33 and 37). Thus, 
an improved understanding of the pathogenesis of Haviviruses 
in animal models could significantly improve human health.
Mice provide an excellent animal model for flaviviral en­
cephalitis in humans. Members of the JEV serocomplex are 
neurotropic in mice. When directly inoculated into the brain, 
they grow to high titers, causing a mostly fatal encephalomy­
elitis. The disease outcome following extraneural inoculation 
of the encephalitic Haviviruses into mice is strongly host factor 
dependent (for a review, see reference 35). For example, age of 
the animals is particularly important (11, 31, 32); mice up to 3 
to 4 weeks of age are highly susceptible to a low-dose virus 
inoculum, whereas in older animals the peripheral injection of 
these Haviviruses often fails to result in morbidity or mortality 
over a wide dose range.
One disadvantage of the mouse model is the erratic course 
of infection in older mice, which requires a larger number of 
animals to make a reliable determination of the 50% lethal
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dose. A number of factors could cause the age-dependent 
differences in the susceptibility of mice to flavivirus infection; 
these include, but not exclusively, (i) higher peripheral virus 
yield and viremia in younger animals (32), (ii) an age-depen­
dent difference in the permeability of the blood-brain barrier, 
(iii) a stronger tropism of the viruses for developing neurons 
(47, 48), and (iv) absence, delay, or dysfunction of innate 
and/or adaptive immune responses in the younger animals (52, 
55, 63).
The key to controlling viremia is humoral immunity. Pas­
sive transfer of antibodies and vaccination-induced humoral 
immune responses can protect against lethal flavivirus chal­
lenge, including infection via the intracerebral (i.c.) route 
(4, 12, 22, 56). However, the kinetics of induction of humoral 
immunity in a primary flavivirus infection may not be suffi­
ciently rapid to prevent neuroinvasion following peripheral 
virus growth and, in turn, fatal encephalitis. On the other hand, 
cellular antiviral immune responses are raised with a kinetics 
consistent with the requirement for rapid viral elimination (10, 
20, 21). For example, primary WNV-immune cytotoxic T (Tc) 
cells are apparent at 5 days postinfection (p.i.), and the re­
sponse peaks on day 7. Virus-immune Tc cells and natural 
killer (NK) cells have also been isolated from the brains of 
WNV-infected mice (26). However, it is still unclear whether 
these virus-induced cytolytic lymphocytes (NK/Tc cells) are 
necessary for the recovery from encephalitic flavivirus infec­
tion or whether they induce immunopathology, as observed in 
other viral models (5,8,38). Their role in recovery may depend 
on whether their function, when directed against virus-infected 
cells in the periphery, can prevent virus spread into the central 
nervous system (CNS).
Following neuroinvasion, encephalitic Haviviruses efficiently 
infect large numbers of neurons, and this process is accompa­
nied by an inflammatory reaction (13, 15). The relative contri­
butions to neuronal destruction and mortality of flaviviral
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infection of neurons, per se, and of the induced immunopatho- 
logical events remain ambiguous (1, 24, 46).
Perforin-dependent granule exocytosis- and Fas-mediated 
cytotoxicity are the two major pathways causing target cell 
damage by cytolytic lymphocytes (14, 19). The availability of 
mouse strains defective in these cytotoxic elfector pathways as 
a consequence of gene knockout or null mutations allows eval­
uation of the role of these two cytotoxic pathways in viral 
pathogenesis. Here we have applied this approach to a mouse 
model of flaviviral encephalomyelitis and revealed an unex­
pected Tc/NK-dependent pathogenicity component.
MATERIALS AND METHODS
Viruses and cells. The MVE prototype strain MVE-1-51 (9) was used. It has 
been passaged 15 times in suckling mouse brain. Working stocks were prepared 
from either 10% suckling mouse brain homogenates in Hanks’ balanced salt 
solution (HBSS) containing 20 mM HEPES buffer (pH 8.0) and 0.2% bovine 
serum albumin (HBSS-BSA) or from infected Aedes albopictus C6/36 cell culture 
supernatant buffered to pH 8.0. Virus was stored in single-use aliquots at -70°C. 
Titers of working stocks ranged from 5 X 107 to 2 x  109 Vero cell PFU/ml.
Vero cells (African green monkey kidney; obtained from the American Type 
Culture Collection), and the methylcholanthrene-induced fibrosarcoma cells 2R 
(H-2KkDb) and 5R (H-2KhD‘l) and L929 cells (H-2k) were maintained in Eagle’s 
minimal essential medium (EMEM) plus nonessential amino acids and 5% fetal 
calf serum (FCS). C6/36 cells were grown in EMEM plus nonessentiai amino 
acids and 8% FCS at 28°C.
Animals. C57BL/6 (B6) mice, syngeneic gene knockout mice defective in 
perforin (perf~'~) (17), granzymes A and B {gzmAxB ~/_) (58), or granzymes A 
and B plus perforin (perf X gzmAxB~'~) (42), and syngeneic mutant mice with 
defects in the Fas receptor (Ipr) (54) or Fas ligand (gld) (60) were bred under 
specific-pathogen-free conditions and supplied by the Animal Breeding Facilities 
at the John Curtin School of Medical Research, Canberra. Mice doubly deficient 
in the perforin and Fas pathways of cytotoxicity (perf~'~ X gld) were generated 
by back-crossing breeders heterozygous for perforin and homozygous for the Fas 
ligand mutation (perf+/~ x  gld). This protocol was required because female 
perf^'~ X gld mice are infertile (also reported in references 18 and 59). Weanling 
mice obtained from this mating were screened for homozygosity of the perforin 
knockout mutation and kept for experimentation. The screening was done by 
PCR on genomic DNA obtained by tail biopsies using a protocol described 
previously (58).
Plaque assay. Virus was titrated by plaque formation on ^80% confluent 
monolayers of Vero cells (®*3 X 10s cells/well) in six-well plastic tissue culture 
plates (Linbro Scientific Inc., Hamden, Conn.). Samples to be assayed were 
serially diluted in HBSS-BSA on ice, and monolayers were inoculated in dupli­
cate with 0.1-ml aliquots of the diluted virus. Adsorption was for 1 h at 37°C in 
an atmosphere of 5% C 0 2 and 95% air with occasional shaking. An agar overlay 
medium (EMEM plus nonessentiai amino acids containing 1% Bacto-agar 
[Difco, Detroit, Mich.], 2% FCS, penicillin [30 pg/ml; Sigma, St. Louis, Mo.], 
streptomycin sulfate [50 p-g/ml; Sigma], neomycin sulfate [50 p,g/ml; Sigma], and 
amphotericin B [Fungizone; 0.25 pg/ml; Life Technologies, Rockville, Md.]; 4 
ml/well) was added to the monolayer, and the cells were incubated for 72 to 96 h 
at 37°C. The monolayers were stained by the addition of 1.5 ml of 0.03% neutral 
red (BDH Chemicals, Poole, England) in HBSS, and plaques were counted 10 to 
16 h later, following removal of the stain and the overlay.
For virus determination in infected mouse tissues, animals were sacrificed at a 
given time p.i., and tissues were aseptically removed, snap-frozen in liquid ni­
trogen or dry ice, and stored at — 70°C. The 10% (wt/vol) tissue suspensions in 
ice-cold HBSS-BSA were homogenized and clarified by centrifugation (18,000 X 
g for 5 min at 4°C), and supernatants were stored in aliquots at —70°C prior to 
plaque titration. The limits of detection of virus in tissues and serum of infected 
mice by plaque titration were 103 PFU/g and 102 PFU/ml, respectively.
ELISA. MVE antigen-coated 96-well microtiter plates were prepared as pre­
viously described (6). Serial twofold dilutions (50 pl/well) of antisera in phos­
phate-buffered saline (PBS) containing 1% BSA and 0.05% Tween 20 (Sigma; 
PBS/BSA/Tween) were added to the plates and incubated for 2 h at room 
temperature. The plates were washed four times with PBS containing 0.05% 
Tween 20 before the addition of 50-p.l/well horseradish peroxidase-conjugated 
goat anti-mouse immunoglobulin (Ig; Dako, Carpinteria, Calif.) diluted 1:1,000 
in PBS/BSA/Tween for 1 h at room temperature. The wells were washed as 
above, 50 jcl of the peroxidase substrate 2.2'-azino-di[3-ethyl-benzthiazoline sul-
E/T
FIG. 1. MVE infection of B6 mice elicits H-2b-restricted antiviral 
Tc cell responses. Lysis of 51Cr-labeled 2R (□ ) and 5R (O) cells 
infected with MVE (solid line) or left uninfected (dashed line) by 
secondary, in vitro-stimulated MVE-immune Tc cells from B6 mice 
was measured. Representative data from one of four experiments are 
shown. The SEM was always <3%. E/T, effector-to-target cell ratio.
fonate] (ABTS; Kirkegaard & Perry Laboratories, Gaithersburg, Md.) was added 
per well, and the plates were kept at room temperature for —20 min to allow 
color development. The enzymatic reaction was stopped by the addition of 1% 
sodium dodecyl sulfate, and plates were read at 405 nm with a Molecular 
Dynamics microplate reader.
Optical density (OD) cutoff values were established as the mean OD of eight 
negative control wells containing sera from naive mice plus 3 standard deviations 
(SD). OD values were considered positive if they were equal to or greater than 
the OD cutoff. Endpoint titers were calculated as the reciprocal of the last 
dilution that was positive, and the antibody titers are given as log10 values.
Chromium release assay. The generation of secondary in vitro MVE-immune 
effector Tc cells, target cell infections, and 51Cr release assay were performed as 
described previously (27, 51). Briefly, B6 mice were immunized intraperitoneally 
with 5 X 106 PFU of MVE, spleens were harvested at 7 days p.i., and single-cell 
suspensions were prepared. One-fifth of the spleen cell suspension was infected 
with MVE at a multiplicity of 5 PFU/cell for 1 h, washed, and cultured with the 
rest of the splenocytes for 5 days. 2R and 5R target cells were infected with MVE 
at a multiplicity of 50 PFU/cell for 16 h prior to 51Cr labeling for 1 h and 
incubation with titrated numbers of effector cells for 6 h. All samples were 
triplicates, the standard error of the mean (SEM) was always <3%, and spon­
taneous release was between 10 and 20%.
RESULTS
In vitro cytotoxicity of splenocytes from H-2h mice against 
MVE-infected target cells. We investigated the role of the 
cytolytic effector functions of NK and Tc cells in a mouse 
model of flaviviral encephalitis. We have previously reported 
on the H-2k- and H-2d-restricted Tc cell responses against 
MVE (27, 29, 51). To verify that MVE-specific Tc cell re­
sponses are also induced in H-2h (B6) mice, secondary, in 
vitro-stimulated, MVE-immune splenocytes were tested 
against MVE-infected and uninfected 2R (/£*, Cf) and 5R (b? , 
U 1) target cells in 51Cr release assays. Figure 1 shows that Db- 
and Kb-restricted anti-MVE Tc cell responses are elicited in 
MVE-infected B6 mice. No MVE-specific killing of H-2-mis- 
matched MVE-infected target cells (L929, H-2*) by the MVE- 
immune effector cells was observed (data not shown), showing 
that the Db- and Kb-restricted lysis was Tc cell mediated.
Mortality caused by MVE in 6-week-old B6 mice. Inocula­
tion by the intravenous (i.v.) route of 6-week-old B6 mice with 
MVE characteristically failed to produce a dose-dependent
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TABLE 1. Susceptibility of B6 mice, wild type or defective in 
granule exocytosis- or Fas-mediated cytotoxicity, to i.v. infection 
with MVE
Dose
(PFU) Mouse strain
No./
group % Mortality" AST ±  SEM"
0.1 Wild type 27 59 10.3 ± 0.6
p e r f ' - 12 33 11.0 ± 0.7
g zm A x B  1 18 28' 11.6 ± 0.6
perf X gzm A xB ~'~ 6 33 11.0 ± 1.0
gld 10 40 12.3 ± 1.5
Ipr 6 33 14.0 ± 01
102 Wild type 70 46 11.6 ± 0.4
p e r f ' - 15 201 12.3 ± 2.2
g zm A x B  1 20 25 10.8 ± 1.5
perf X g zm A x B ~ l~ 19 32 12.5 ± 0.3
gld 11 27 11.7 ± 0.7
Ipr 11 55 11.3 ± 1.1
103 Wild type 9 56 12.0 ± 0.8
p e r f ' - 16 38 12.8 ± 0.7
105 Wild type 20 40 10.9 ± 0.8
p e r f ' - 12 33 13.3 ± 1.01
gld 14 36 12.8 ± 1.0
Ipr 10 80' 10.8 ± 0.6
10* Wild type 19 100 5.5 ± 0.2
p e r f ' - 10 100 6.6 ± 0.23
g zm A x B  / 6 100 6.2 ± 0.4
perf X gzmA XB~'~ 5 100 9.4 ± 1.43
gld 10 100 6.6 ± 0.32
Ipr 5 100 5.8 ± 0.2
" Statistical significance relative to groups of wild-type mice is indicated by 
superscript numbers as follows: 1, P s  0.1; 2, P s  0.05; and 3, P s  0.01. 
Differences in mortality were assessed using Fisher’s exact test, and differences in 
AST were assessed using the Mann-Whitney test.
increase in mortality. A high virus dose (>  108 Vero cell PFU) 
consistently resulted in 100% death, whereas virus doses in the 
range from 0.1 to 105 PFU killed —50% of the animals (Table 
1). This pattern, which we also observed for the encephalitic 
llavivirus WNV (unpublished data), was reflected in two dis­
tinct kinetics for the average survival time (AST). Mice in­
jected with 108 PFU of MVE died at 5 to 6 days p.i., whereas 
mortality caused by the lower doses occurred from days 9 to 
13 p.i. (Table 1). When 102 PFU of MVE was inoculated by the 
i.c. route into 6-week-old B6 mice, death uniformly occurred at 
days 5 to 7 p.i. (see Fig. 5D).
Accordingly, it appears that i.v. inoculation of 108 PFU re­
sults in early viral invasion of the CNS, with a disease outcome 
comparable to that following i.c. injection of the virus. The 
longer time to death in mice infected i.v. with the lower virus 
doses suggests that peripheral virus growth was required prior 
to the time that neuroinvasion took place. However, a 106-fold 
dilference in the size of the initial i.v. inoculum did not result 
in any significant change in the AST. Animals that succumbed 
to high- or low-dose i.v. infections with MVE showed similar 
clinical signs at 1 to 2 days prior to death, which included 
wasting, ruffled fur, a hunched posture, and hind limb paralysis. 
These observations, in addition to comparable virus titers in 
the brains of moribund mice from groups infected i.v. with 108 
PFU of MVE or the lower doses (see Fig. 3), suggested that in 
both cases viral encephalitis was the cause of death.
Role of perforin and granzymes in the pathogenesis of mice 
infected with MVE. Killing of virus-infected cells by cytolytic 
lymphocytes via the granular exocytosis mechanism involves at
least two defined components of the secreted granules, per­
forin and the granzymes (39). To investigate whether granular 
exocytosis-mediated cytotoxicity by NK/Tc cells is important in 
recovery of mice from infection with an encephalitic flavivirus, 
the outcome of MVE infection was tested in knockout mice with 
defects in perforin {perf~'~), granzymes A and B {gzmAxB~l~), 
and perforin plus the two granzymes (perfx gzmAxB~/_). Groups 
of B6 wild-type and knockout mice were inoculated i.v. with doses 
of MVE ranging from 0.1 to 108 PFU and observed for 3 weeks 
to record mortality and AST.
Table 1 shows that in the dose range of 0.1 to 105 PFU of 
MVE, mortality in the groups o fperf~'~, gzmAxB~'~, andperf 
X gzmAxB~'~ mice was always lower than that for the wild- 
type mice. When mortality data in this dose range for groups of 
perf and gzmAxB~'~ mice are summed, a statistically sig­
nificant increase in resistance to MVE infection is found for 
the two strains relative to wild-type mice {P = 0.022 and 0.014, 
respectively; Fisher’s exact test). Given the relatively small 
number of perf X gzmAxB~'~ mice that were available for this 
study, the dilference in additive mortality values for this knock­
out mouse (8 dead, 17 alive) and those for the wild-type (59 
dead, 59 alive) was not statistically significant (P = 0.125). 
However, a significant increase in AST of perf X gzmAxB~'~ 
(9.4 days) relative to wild-type mice (5.5 days) was noted (P = 
0.009; Mann-Whitney test) in groups injected i.v. with 108 PFU 
of MVE (Table 1). This difference was less obvious for perf^'~ 
and gzthAxB~'~ mice, for which the AST was prolonged by —1 
day. The comparison of the ASTs for groups of mice inocu­
lated with the lower doses of MVE (0.1 to 105 PFU) also 
showed a trend towards a slightly increased AST of mice de­
ficient in the granular exocytosis pathway of cytotoxicity rela­
tive to the wild-type mice.
In summary, the data in Table 1 indicate that granule exo­
cytosis-mediated cytotoxicity of NK/Tc cells has no protective 
value in MVE infection; in fact, it appears to accelerate the 
fatal outcome of viral growth in the CNS and increase mortal­
ity rates.
Role of Fas-mediated cytotoxicity in the pathogenesis of 
mice infected with MVE. The second major cytolytic mecha­
nism of NK/Tc cells involves the engagement of Fas on the 
target cell by Fas ligand (FasL) (for a review, see reference 43). 
This mechanism is essential in immune regulation, demon­
strated by a lymphoproliferative disease in mice with a loss-of- 
function mutation of the Fas gene (Ipr) or a point mutation in 
the FasL gene (gld) (44, 45). The Fas-mediated death pathway 
has been implicated in the control of some viral infections (61, 
62). In the absence of functional FasL expression {gld mutant 
mouse), the mortality inflicted in the i.v. dose range of 0.1 to 
105 PFU of MVE was always less than that found for wild-type 
B6 mice (Table 1). In addition, the AST was significantly in­
creased in gld mice relative to wild-type mice when 108 PFU 
was injected i.v. (P = 0.014). The Fas defect in Ipr mice showed 
no consistent trend in the outcome of infection with MVE 
(Table 1). However, it is known that the Ipr mutation is leaky 
and that small amounts of functional Fas are expressed in the 
mutant mouse (3).
Virus growth in tissues of B6 wild-type mice and mutant 
mice with defects in the granule exocytosis- or Fas-mediated 
cytotoxic effector mechanism. Tissues (spleen, muscle, lymph 
nodes, and liver) from 6-week-old B6 wild-type, perf^ '~ , gld,
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TABLE 2. MVE-specific antibody responses in C57B1/6 wt mice and in mutant mice deficient in granule exocytosis and/or Fas
pathways of cytotoxicity
Expt
no.
Virus dose 
(PFU) Mouse strain
Time 
(days p.i.) No./group % Seroconversion
Mean antibody titer," 
log10 (range)
i 0.1 Wild type 10 6 100 3.7 (2.6-4.1)
p e r T '~ 3 100 4.0 (3.8-4.1)
g zm A xB 4 100 4.2 (4 .1-4.4)
gld 3 100 3.7 (2 .6-4.4)
Wild type 21-25 4 100 4.3 (3.8-4.7)
PerT ' ~ 3 100 4.6 (4.1-5.0)
gld 1 100 5.0
102 Wild type 21-32 11 100 4.0 (2.9-4.7)
p e r T ' - 4 100 4.3 (4.1-4.4)
g zm A xB 5 100 3.8 (3.5-4.1)
p e r f X g zm A  X B ~ '~ 8 100 4.0 (3.8-4.1)
gld 8 100 4.5 (3.5-5.0)*
Ipr 4 100 4.3 (3 .8-4.7)
2 105 Wild type 5 6 100 2.5 (2 .0-2.9)
p e r f^ '~  X gld 3 100 2.7 (2.6-2.9J
Wild type 10 7 100 3.4 (3.2-3.5)
p er f~ '~  X gld 4 100 4.0 (3 .8-4 .4)fc
Wild type 15 7 100 3.7 (3 .5-3.8)
p er f~ '~  X gld 100 4.1 (3 .5-4.7)
Wild type 21 7 100 3.8 (3 .5-4.1)
p e r j^ '~  X gld 4 100 4.5 (4 .1-4 .7)ft
gld 3 100 4.5 (4 .4 -4 .7 )fc
p e r T 1- 3 100 4.0 (3.8-4.1)
" MVE-specific antibody titers were determined by ELISA, and endpoints were calculated as described in Materials and Methods. 
b Statistically significant difference (P s  0.05\ Mann-Whitney test) relative to groups of wild-type mice.
and Ipr mice infected i.v. with 108 or 105 PFU of MVE were 
tested at 1- and 2-day intervals, respectively, for the presence 
of virus or viral RNA by plaque titration and reverse transcrip­
tion (RT)-PCR. Consistent with earlier studies (32), we found 
that MVE grows poorly in extraneural tissues of mice of this 
age. When inoculated i.v. with 105 PFU of MVE, barely de­
tectable virus titers were found in the spleen at 4 days p.i., and 
virus was cleared by 6 days p.i.; virus was not detectable in 
lymph nodes, muscle, liver, or blood (data not shown), al­
though all the mice had seroconverted (Table 2). Inoculation 
i.v. of 108 PFU resulted in virus detection in the spleen, muscle 
(Fig. 2), and lymph nodes, but not the liver (data not shown).
No consistent difference in growth kinetics or magnitude of 
virus titers was apparent between wild-type mice and mice 
defective in NK/Tc cell cytotoxic effector mechanisms. Virus 
titers in the spleen were highest on day 2 and lowest on day 
4 p.i.. This pattern was also found for virus titers in lymph 
nodes (data not shown). MVE appeared to grow in muscle 
from day 2 to day 4 p.i. but was not detectable in all animals. 
No virus was detectable in the blood (<102 PFU/ml) 2 days 
after i.v. injection of 108 PFU of MVE. The apparent inability 
of extraneural tissues to support efficient growth of MVE was 
confirmed by RT-PCR on samples from liver, spleen, muscle, 
kidney, ovaries, lymph nodes, and blood obtained from in­
fected mice at 2, 4, 6, and 8 days p.i. (unpublished data). The 
sensitivity of detection of viral RNA by the RT-PCR method 
was estimated at ~104 templates/reaction.
Unfortunately, these data do not permit us to say whether (i)
NK/Tc cell-mediated cytotoxicity contributes to the control of 
virus infection in these tissues or (ii) the magnitude of virus 
titers in extraneural tissues is a decisive factor that determines 
the incidence of neuroinvasion and thus can account for the 
variability between individuals in the susceptibility to infection 
with MVE.
Kinetics of neuroinvasion and growth of MVE in the brain 
of wild-type mice and mutant mice defective in granule exocy­
tosis- or Fas-mediated cytotoxicity. Groups of 6-week-old mice 
were infected i.v. with either 108 or 102 PFU of MVE. Indi­
viduals were sacrificed at 2, 3, and 4 days after 108 PFU and 6 
and 8 days after 102 PFU inoculations, and virus titers in the 
brain were determined. The dose of 108 PFU i.v. gave detect­
able virus titers in the brains of most animals at 2 days p.i. 
(ranging from 103 to 106 PFU/g), which increased to titers of 
107 to 109 PFU on day 4 p.i. in theperf~'~,gld, and Ipr mice and 
in some of the wild-type mice (Fig. 3). The mean titers of MVE 
in the brains of the four strains of mice were comparable, but 
wild-type mice showed much greater variability than the other 
groups on day 3 and day 4 p.i..
After inoculation i.v. of 102 PFU of MVE, low titers of virus 
were found on day 6 p.i. in brains of a few mice in the gld, Ipr, 
and perf X gzmAxB~,~ but not the wild-type and perf^'~ 
groups (Fig. 3). By day 8 p.i., virus was found in six of eight 
wild-type mice, and titers ranged from 103 to 108 PFU/g. Mem­
bers of the groups o fperf~'~, gld, and perf X gzmAxB~l~ mice 
had high brain titers (107 to 109 PFU/g) on day 8 p.i., but 
overall the majority of mice defective in granule exocytosis- or
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FIG. 2. Growth of MVE in spleen and muscle of B6 wild-type (wt) 
mice and mice deficient in granule exocytosis- or Fas-mediated cyto­
toxicity. Mice (6 weeks old) were infected i.v. with 108 PFU of MVE. 
At the indicated times, animals were sacrificed, and virus titers in 
tissues were determined by plaque titration. Each symbol represents an 
individual mouse. The lower limit of virus detection was 103 PFU/g 
tissue and is indicated by the dashed line.
Fas-mediated cytotoxicity had no detectable virus in the brain, 
consistent with the lower mortality rates in these mice relative 
to wild-type mice.
Resistance to infection with MVE of mice doubly deficient in 
granule exocytosis- and Fas-mediated cytotoxic pathways. The 
above results suggest that mice with functional defects in the 
granule exocytosis- or Fas-mediated pathway of cytotoxicity 
are less susceptible to lethal infection with MVE than wild- 
type mice. This implies that NK/Tc cell-mediated killing con­
tributes to the pathogenesis of encephalitic flaviviruses in their 
vertebrate hosts. Given the possibility of redundancy between 
the two major pathways of cytotoxicity (49, 61, 62), the detri­
mental role of NK/Tc cells in encephalitic flaviviral disease 
may have been missed or underestimated in studies using mice 
defective in only one of the two pathways.
To investigate this possibility, mice defective in both cyto­
toxic effector mechanisms (perj^'~ X gld) were generated. 
Consistent with earlier reports (18, 59), we found that these 
doubly deficient mice developed a severe autoimmune syn­
drome characterized by splenomegaly and lymphadenopathy, 
resulting in weight loss and death between the ages of 4 and 16 
weeks (Fig. 4). About one-third of doubly deficient mice died 
between the ages of 6 and 9 weeks, but the clinical manifesta­
tions of MVE infection were distinguishable from signs of 
lymphoproliferative disease in these animals.
Groups of 6-week-old perf~'~ X gld and wild-type mice were
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FIG. 3. Kinetics of neuroinvasion and growth of MVE in the brain 
of wild-type (wt) mice and mice defective in granule exocytosis- or 
Fas-mediated cytotoxicity. Groups of mice (6 weeks old) were infected 
i.v. with 102 or 108 PFU of MVE. At the indicated times, animals from 
each group were sacrificed, and virus titers in the brain were deter­
mined by plaque titration. Each symbol represents an individual 
mouse. The lower limit of detection of virus titers was 103 PFU/g of 
tissue and is indicated by the dashed line. To calculate mean titers 
(indicated by a horizontal line), values below the limit of detection 
were ignored.
infected i.v. with 102 or 105 PFU of MVE, and morbidity and 
mortality were recorded daily for 21 days. All animals in a 
group of eight perj^'~ X gld mice inoculated with 105 PFU 
survived, in contrast to 40% mortality in the wild-type group 
(Fig. 5B). Similarly, fatal viral encephalitis did not occur in the 
group of perf^'~ X gld mice infected with 102 PFU (Fig. 5A). 
However, 4 of 12 doubly deficient mice in this group died 
without displaying the characteristic clinical signs of viral en­
cephalitis, and MVE could not be recovered from the brains of 
cadavers within a period of 16 h after death had occurred. 
Since acute lymphadenopathy was seen in all cadavers and the 
mortality rate was consistent with that in the uninfected con­
trol group (Fig. 4), we conclude that death was most likely due 
to lymphoproliferative disease.
The susceptibility to i.v. infection with 102 PFU of MVE of 
6-week-old gld mice heterozygous for the perforin knockout 
mutation {perf*~'~ X gld) was marginally lower than that of 
wild-type mice (33 and 45%, respectively; Fig. 5A) and com-
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FIG. 4. Time to death of animals in a cohort of perf~'~ x gld 
mice.
parable to that of gld mice (Table 1). This is indicative of a lack 
of gene dose effect in the contribution of perforin on the gld 
background to the pathogenesis of MVE.
Infection o{perf~/~ X gld mice with 108 PFU of MVE by the 
i.v. route gave 100% mortality in 6-week-old animals and 75% 
mortality in 10-week-old mice (Fig. 5C). These values were 
comparable to those for the wild-type mice. However, the AST 
was longer in the doubly deficient animals relative to wild-type 
mice (7.3 and 5.6 days, respectively, for 6-week-old mice and 
9.7 and 7.0 days, respectively, for 10-week-old mice). Intrace­
rebral injection of 102 PFU of MVE in 6-week-old wild-type 
and perj^'~ X gld mice resulted in 100% mortality, with com­
parable kinetics to death in both mouse strains (Fig. 5D).
To further substantiate that virus growth in the CNS of the 
doubly deficient mice was not suppressed, 6-week-old perf^'~ 
X gld mice were infected i.v. with 108 PFU of MVE, and brain 
titers were determined on days 3 and 4 p.i. No difference was 
found between the MVE titers in the brain of perf~'~ X gld 
mice on day 3 p.i. (3.5 X 106 to 2.5 X 108 PFU/g) and day 4 p.i. 
(2.8 X 109 to 4.5 X 109 PFU/g) and those found in wild-type 
mice (Fig. 3). Thus, in per}w ~ X gld mice, neuroinvasion by 
MVE occurred following high-dose i.v. inoculation, and virus 
growth in the brain was not inhibited.
MVE-specific antibody responses in B6 wild-type mice and 
mutant mice deficient in granule exocytosis and/or Fas path­
way of cytotoxicity. Single vaccination of B6 mice with 106 PFU 
of UV-inactivated MVE does not induce MVE-specific anti­
bodies detectable by ELISA (unpublished data). Seroconver­
sion of mice following inoculation of smaller doses of live virus 
(0.1 to 105 PFU) would therefore be consistent with a produc­
tive infection. To verify that i.v. infections of mice deficient in 
the granule exocytosis- and/or Fas-mediated pathway of cyto­
toxicity with low doses of MVE resulted in virus growth in 
extraneural tissues, and to test whether they showed differ­
ences in the magnitude of the humoral immune response 
against MVE, antibody titers and incidence of seroconversion 
were determined.
The sera from all animals infected with MVE at 0.1 to 105 
PFU were reactive against MVE antigen (Table 2). No dose- 
dependent difference was seen in the magnitude of the anti­
body response in wild-type mice. MVE-specific antibody titers
in p e r f X gld mice were four- to sevenfold higher than those 
in wild-type mice at 10 to 21 days p.i., although the difference 
in mortality between the two groups may have been a biasing 
factor, since only those mice that survived the virus infection 
until serum collection were tested. A significant increase in the 
magnitude of the humoral immune response against MVE was 
also seen in some groups of gld but not perf~'~, gzmAxB~'~, 
perf X gzmAxB~'~, and Ipr mice relative to wild-type mice 
(Table 2).
DISCUSSION
We have investigated the contribution of the cytotoxic ef­
fector functions of NK/Tc cells to recovery from and/or patho­
genesis of encephalitic flavivirus infection using mutant mouse 
strains defective in the granule exocytosis and Fas or pathway 
of cytotoxicity. We first established parameters in immunolog- 
ically mature mice, allowing the study of pathogenesis and 
control of infection with MVE, a member of the JEV sero- 
complex. Using 6-week-old B6 mice, we found that, depending 
on the virus dose used for i.v. inoculation, two kinetically 
distinct disease processes led to fatal encephalitis. A high dose 
of MVE given i.v. (108 PFU) gave pathogenesis comparable to 
that with i.c. injection of 102 PFU with respect to the first 
appearance of signs of encephalitis on day 4 p.i., the AST (5 to 
6 days), and disease outcome (100% mortality). This pattern is 
consistent with the notion that sufficient virus from a high i.v. 
dose can enter the brain directly from blood to establish a 
lethal infection without the requirement for replication in ex- 
traneural tissues.
This rapid mode of invasion of the brain contrasted with the 
delayed kinetics and variable incidence of virus entry into the 
brain when lower i.v. doses of MVE, in the range of 0.1 to 105 
PFU, were used. Virus first appeared in the brain between 6 
and 8 days p.i., and mortality was observed between 9 and 13 
days p.i. in ~50% of infected mice. This disease pattern sug­
gests that the virus first replicated in extraneural tissues prior 
to entering the CNS and that invasion of the brain was a 
stochastic process unrelated to the dose of virus injected in the 
range of 0.1 to 105 PFU. Infection of mice with low doses of 
MVE rarely gave rise to detectable virus in the extraneural 
tissues tested and never produced a detectable secondary vire- 
mia, but all animals seroconverted, confirming productive virus 
infection.
The lack of any difference in AST over a 106 range of i.v. 
virus inocula indicates that the kinetics of neuroinvasion was 
surprisingly dose insensitive and that equalizing factors exist. 
We propose that the kinetics of induction of the antiflaviviral 
Tc cell response, which also displays a remarkably flat dose 
response at low to medium virus concentrations (20), is one 
such factor. In addition, the antiviral alpha/beta interferon 
response is most important in controlling flavivirus growth in 
extraneural tissues, given that adult alpha interferon receptor 
knockout mice rapidly succumb to an acute fulminant infection 
when inoculated with 102 PFU of MVE (unpublished data). 
The magnitude of the interferon response may inversely cor­
relate with the virus dose inoculated.
The mechanism that allows encephalitic flaviviruses to 
breach the blood-brain barrier remains uncertain, but four 
candidate routes for CNS invasion have been canvassed (for
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FIG. 5. Susceptibility of perf~'~ X gld mice to infection with MVE. (A) Groups of 6-week-old wild-type (wt) (n =  11), perf~'~ X gld doubly 
deficient (n = 8), and perf'~  X gld heterozygous (n = 15) mice were infected i.v. with 102 PFU of MVE. Mortality due to lymphoproliferative 
disease occurred in the group of doubly deficient mice on days 9 (n = 1) and 13 (n = 3) and was excluded from the total. (B) Groups of 6-week-old 
wild-type (n = 20) and perj^'~ X gld (n = 8) mice were infected i.v. with 105 PFU of MVE. (C) Groups of 6-week-old and 10-week-old wild-type 
(n =  5 and 10, respectively) and perf~'~ X gld (n = 6 and 8, respectively) mice were infected i.v. with 108 PFU of MVE. (D) Time to death of 
6-week-old wild-type (n =  3) and perf^'~ X gld (n = 3) mice infected i.c. with 102 PFU of MVE. In all experiments, morbidity and mortality were 
recorded daily, and surviving mice were monitored for 21 days.
reviews, see references 16 and 35): (i) by the neuronal route 
after infection of peripheral nerves; (ii) by infection of highly 
susceptible olfactory neurons, which are unprotected by the 
blood-brain barrier (36); (iii) by virus entry into vascular en­
dothelial cells of capillaries in the brain, transcytosis, and re­
lease of virus into the brain parenchyma (25); and (iv) by 
diffusion of virus between capillary endothelial cells in individ­
uals displaying leakiness of the blood-brain barrier due to 
factors unrelated or secondary to the viral infection (13, 23, 
30). Antiviral immune responses could contribute to the fourth 
mechanism by inducing breakdown of the blood-brain barrier. 
Given the distinct modes of disease progression leading to fatal 
encephalitis that were observed when high (108 PFU) and 
lower (0.1 to 105 PFU) doses of MVE were inoculated i.v. and 
the concomitant differences in virus load in the vascular com­
partment, the possibility that encephalitic Haviviruses can 
breach the blood-brain barrier by a number of different mech­
anisms must be considered.
In addition to establishing conditions for investigating the 
role of the cytotoxic effector function of splenocytes in recov­
ery or disease from MVE infections in a mouse model, we have 
confirmed that B6 mice mount H-2b-restricted Tc cell re­
sponses against MVE. The role of NK cells in flavivirus immu­
nity appears to be evaded due to the upregulation of major 
histocompatibility complex (MHC) class I by flavivirus infec­
tion and, as a consequence, the inhibition of NK cell-mediated 
infected target cell lysis (28, 34, 41).
The most striking finding in this study is the demonstration 
that cytotoxic effector pathways of NK/Tc cells contribute to 
accelerated and more severe pathogenesis of encephalitic fla­
vivirus infection. Cytotoxic effector mechanisms may be in­
volved at two stages in the disease process: first, in the events 
leading to neuroinvasion, and second, in the pathology due to 
the inflammatory response in the brain. Both the granule exo- 
cytosis- and the Fas-mediated pathways of cytotoxicity can 
contribute to disease progression with potentially compensa­
tory function in mice when one of the two mechanisms is 
defective. Thus, contrary to the expectation based on the es­
tablished importance of Tc and NK cells and their cytolytic 
mechanism in control and clearance of infection in other virus 
models (2, 17, 39, 40, 64), doubly deficient perj^'~ X gld mice 
displayed a greatly increased resistance to i.v. infection with 
MVE at virus doses which gave ~50% mortality in wild-type 
mice. In support of the detrimental role of CD8+ T cells in the 
recovery from encephalitic flavivirus infection, we also found a 
significantly reduced mortality of ß2-microglobulin knockout
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mice, which lack CD8 ' T cells and expression of their restric­
tion elements, in comparison to wild-type mice when infected 
with 102 PFU of MVE i.v. (data not shown).
The Fas pathway plays a critical role in lymphocyte ho­
meostasis, which accounts for a severe autoimmune syndrome 
characterized by enlarged spleen and lymph nodes and lym­
phocyte infiltration in liver and kidney in Fas receptor (Ipr)- 
and FasL (g/d)-deficient mice (43). This disease is exacerbated 
in the absence of functional perforin, and, consistent with 
previous reports (18, 59),perf~'~ X gld mice died at between 4 
and 16 weeks of age. Mortality due to unchecked expansion of 
activated T cells in perf~'~ X gld mice could be distinguished 
from that caused by MVE infection. Thus, we did not observe 
clinical signs typically associated with flaviviral encephalitis in 
any of the infected perf^'~ X gld mice inoculated i.v. with 102 
or 105 PFU of MVE. In addition, these doses did not result in 
virus titers detectable by plaque titration in the brains of mice 
that died during the virulence assays (most likely due to the 
lymphoproliferative syndrome) or that were sacrificed at 4 
(n = 2), 6 (n = 2), and 8 (n = 4) days p.i. (data not shown). 
Accordingly, we conclude that in the absence of the two major 
cytotoxic pathways of NK/Tc cells, neuroinvasion by encepha­
litic flaviviruses is prevented. Presumably neuroinvasion by 
MVE in this model requires extraneural virus growth for sev­
eral days following primary virus inoculation into the blood­
stream, resembling natural infection by the bite of an infected 
arthropod.
What is the mechanism by which a deficiency in the two 
main cytotoxic effector functions prevents fatal flaviviral en­
cephalitis? It is conceivable that cytotoxic cells disrupt the 
blood-brain barrier by killing infected endothelial cells lining 
the brain capillaries, allowing virus access into the brain pa­
renchyma. perf^'~ and gld mice display a marked decrease in 
vascular leakage resulting from endothelial cell injury (50), and 
the double deficiency in perf~;~ X gld mice may entirely pre­
vent capillary leakage due to the effector functions of cytotoxic 
lymphocytes. A gradation in the severity of vascular endothe­
lium cytolysis in wild-type, perf^ '~ , gld, and doubly deficient 
mice may account for the progressive reduction in mortality 
following i.v. low-dose MVE infection found in these mouse 
strains. Thus, the key stochastic factors allowing neuroinvasion 
in infections with low virus doses would be whether virus in­
fection of capillary endothelial cells in the brain and lysis of 
these by cytotoxic effector cells occurred.
The requirement for cytotoxic effector function in this pro­
cess suggests that alternative mechanisms for neuroinvasion 
(infection of olfactory neurons, transcytosis, or diffusion be­
tween capillary endothelial cells) were not involved. However, 
in mice peripherally infected with a very large virus dose (108 
PFU), it is likely that the rapid virus entry into the brain occurs 
by infection of olfactory neurons or diffusion across the blood- 
brain barrier. The encephalitic flavivirus WNV readily infects 
human endothelial cells, and the expression of leukocyte ad­
hesion molecules is induced at the plasma membrane of the 
infected cells (57), which would thus be susceptible to NK/Tc 
cell-mediated attack. The kinetics of appearance of MVE in 
the brain (at 6 to 8 days p.i.) following i.v. infection with a low 
virus dose is consistent with that of the induction of the anti­
viral Tc cell response (20) and, in turn, Tc cell-induced damage 
of the cells lining the brain capillaries.
We do not have direct experimental evidence supporting the 
hypothesis that damage to the integrity of the blood-brain 
barrier due to the cytotoxic effector pathways allows encepha­
litic flaviviruses to invade the brain. However, we can exclude 
the possibility that the brains of p e r f X gld mice were 
resistant to replication of the virus. When a low dose of MVE 
(102 PFU) was injected directly into the brain or when a high 
dose (108 PFU) was injected i.v., all doubly deficient animals, 
like the wild-type controls, developed fatal encephalitis, and 
virus titers in the brains otperf~'~ X gld mice were comparable 
to those in wild-type mice. The induction of virus-specific an­
tibodies in all infected wild-type and mutant mice confirms that 
infection and extraneural growth of MVE occurred in these 
animals.
The magnitude of the humoral immune response against 
MVE determined by ELISA was elevated in mice defective in 
the Fas receptor (gld and perf~'~ X gld) relative to wild-type 
mice. However, given that the perf~/~ X gld mice were signif­
icantly more resistant to MVE infection than gld mice, it is 
unlikely that antibody-mediated virus clearance accounted for 
the greatly reduced mortality in the former. The ELISA titers 
of serum samples from infected mice correlated closely with 
their respective in vitro neutralization activities against MVE 
measured in plaque reduction neutralization assays (data not 
shown). Unlike reports on other viral infections (53), the lack 
of perforin did not alter anti-MVE antibody titers.
The AST of the doubly deficient mice was prolonged by ~2 
days relative to that in the wild-type group when infected i.v. 
with a high virus dose (108 PFU). A similar finding was also 
recorded in a group of perf X gzmAxB ' m i c e  and to a lesser 
extent in groups of perf~'~ and gld mice. This result suggests a 
second pathogenic consequence of the function of the cytolytic 
effector pathways of NK/Tc cells in encephalitic flavivirus dis­
ease, viz., exacerbation of the contribution of inflammatory 
infiltration into the CNS of infected mice to a fatal disease 
outcome.
In summary, this investigation shows the dependence of a 
neurotropic virus on the major cytotoxic effector pathways for 
CNS invasion following inoculation of a virus dose by a route 
analogous to those in natural infections. A deficiency of both 
the perforin- and Fas-mediated killing pathways was required 
for this pathogenesis component to become clearly apparent. 
These findings may pave the way to designing treatments for 
early times during flavivirus infection to prevent CNS involve­
ment.
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